close

united states

Medical supplies

Over $7 million in medical supplies donated to Ukrainian refugees

Following a request for medical supplies from Moldovan authorities, World Hope International (WHI), Lift Non-Profit Logistics, Globus Relief, Airlink and Flexport.org have teamed up to transport $7 million in humanitarian aid to more than 300,000 Ukrainian refugees.

Supplies were moved from Utah and flown in via a Boeing 747 from Chicago to Amsterdam where Flexport.org then arranged for trucking partners to transport the cargo to Moldova. Responding to the Moldovan authorities’ request for assistance required multi-faceted project coordination and experience in managing complex supply chains. This relief effort required specialized skills to source the requested supplies and transport them from Utah to Moldova via Chicago and Amsterdam.”

“In these difficult times, Moldova is helping Ukrainian refugees with needed shelter and assistance,” said Eugen Caras, Moldova’s Ambassador to the United States. “In this context, we greatly appreciate the efforts that our American friends have made to gather an impressive amount of medical supplies. This support will be used and distributed by the Ministry of Health for Ukrainian refugees in Moldova, and we are very grateful for this. .

“Airlink is thrilled to be part of this coalition of organizations that are using their resources and expertise to provide humanitarian assistance to Moldova for Ukrainian refugees,” said Steven J. Smith, President and CEO of Air link. “There are significant and growing supply chain challenges in the region, so partnership and coordination are essential to ensure that Ukrainian refugees receive the assistance they need.”

Shaimaa Al Wassiti, President of Globus Relief Humanitarian, added: “Globus Relief is equipped to meet the needs of all forms of medical care. are used in first response medical care.”

“The events unfolding in Ukraine and the escalation of violence in the region are beyond tragic on so many levels – and are quickly becoming one of the biggest refugee events of our lifetimes,” said John Lyon, CEO from WHI. “As we look for ways to scale up our support, we hope this week’s effort will have a big impact on those receiving these essential supplies.”

Susy Schöneberg, head of Flexport.org, said, “Humanitarian responses are incredibly complex and require a wide range of coordination from nonprofit organizations. By providing robust air cargo solutions and financial support, we aim to help our nonprofit partners focus on what they do best and respond immediately when disaster strikes.”

The partnership provided over 220,000 pounds of medical supplies to meet a need specifically requested by Moldova’s Ministry of Health.

read more
Prescription drugs

Most Commonly Misused Prescription Drugs in the United States

Cloth

Most Commonly Misused Prescription Drugs in the United States

The Substance Abuse and Mental Health Services Administration, or SAMHSA, reported that among people who abused prescription painkillers in 2020, nearly 65% ​​said their main reason for doing so was to relieve physical pain. The percentage of people reporting drug abuse as a reason for getting high was 11.3%.

Abuse is defined as patients who take prescription drugs in a manner other than that recommended by their doctor. It may be like taking someone else’s prescription or taking their own in larger or more frequent doses, or for a longer period of time.

Citing data from SAMHSA, Zinnia Health identified the most commonly used prescription medications in the United States, all of which are opioid pain relievers or opioid pain relievers. This class of drugs acts on the central nervous system by blocking pain signals to the brain. In addition to relieving pain, these drugs also intensely trigger the brain’s reward centers, releasing endorphins and creating positive feelings commonly referred to as euphoria. This is what makes prescription opioids – and all opioids, for that matter – so dangerously addictive.

Prolonged use of opioids may increase a patient’s tolerance to a particular drug. With higher tolerance, the drug becomes less effective and patients do not experience the same level of pain relief and feelings of euphoria, which often leads people to seek out stronger opioids. This could explain why such a large percentage of people reported misusing prescription opioids for pain relief. For example, someone who has abused and developed a tolerance to morphine may seek something stronger like oxycodone or hydromorphone, whose effects kick in faster and more intensely.

SAMHSA also found that nearly half of people who abused painkillers (47.2%) said they got the drugs from a friend or relative, either by stealing them, buying them, or getting them for free. . About 44% of people said they got prescriptions from a health care provider. Drug diversion—or the disruption of a prescription drug along its legal, intended journey from manufacturer to physician to patient—is a contributing factor to drug abuse. Diversion occurs, among other things, through doctor purchases, theft and tampering.

The United States is in its third wave of the opioid crisis, but it is important to note that this current wave is characterized by illicitly produced synthetic opioids. Overdose deaths from commonly prescribed opioids have declined in recent years. However, knowing the uses and risks associated with these drugs can save lives. Read on to learn about the most commonly used prescription drugs in the United States.



MedStock Photos // Shutterstock

#8. Morphine

– Abuse in the past year (former users): 8.9%
– Misuse in the past year (general population): 0.2%

Known by its brand names Avinza or Kadian, morphine is an opioid used to treat acute and chronic pain. Although morphine can be given intravenously, it is most often taken as tablets or capsules. Morphine is closely related to other painkillers like hydrocodone and oxycodone. The potency of other opioids is often determined or compared against the potency of morphine.



chatuphot // Shutterstock

#7. Tramadol

– Abuse in the past year (former users): 9.0%
– Misuse in the past year (general population): 0.5%

Tramadol, commonly referred to by its brand name Ultram, is a synthetic opioid used to treat moderate to severe pain, usually after surgery. The drug is commonly prescribed in the form of extended-release tablets to relieve severe chronic pain caused by conditions such as fibromyalgia. In 2019, approximately 5.5 million people were prescribed Tramadol, totaling almost 20 million prescriptions. It was the 35th most prescribed drug in the United States



Joe Mamer // Shutterstock

#6. Codeine

– Misuse in the past year (former users): 12.2%
– Misuse in the past year (general population): 0.9%

Codeine is an opioid used to treat mild to moderate pain and is most commonly prescribed as a cough suppressant. It can also be used to treat gastrointestinal issues like diarrhea. Because codeine is milder than other opioids, users with misuse intentions increase doses to achieve a higher high. Codeine abuse can lead to more intense opioid abuse.



Cloth

#5. Hydrocodone

– Misuse in the past year (former users): 12.6%
– Misuse in the past year (general population): 1.7%

Hydrocodone is the most frequently prescribed opioid in the United States In 2020, 4.7 million people misused hydrocodone products, making it the most commonly used type of prescription pain reliever this that year. Hydrocodone, also known by its brand name Vicodin, is given to patients with moderate to severe pain, usually after surgery or injury, or to relieve pain associated with medical conditions such as cancer. In combination with homatropine, hydrocodone can also be used as an antitussive. Unlike other opioids, hydrocodone is not often illicitly manufactured and the vast majority of diverted hydrocodone is pharmaceutical.



Cloth

#4. Oxycodone

– Abuse in past year (former users): 14.5%
– Misuse in the past year (general population): 1.1%

Oxycodone is an opioid prescribed to treat persistent severe pain. OxyContin and Percocet are two of the most recognizable brands, the former being a pure form of oxycodone and the latter a combination of oxycodone and aspirin. About 3.2 million people abused oxycodone products in 2020, making it the second most misused painkiller behind hydrocodone. Oxycodone abuse is prevalent across the spectrum of geographic, demographic, and socioeconomic conditions.



PureRadiancePhoto // Shutterstock

#3. Fentanyl

– Misuse in the past year (former users): 14.8%
– Misuse in the past year (general population): 0.1%

The pharmaceutical fentanyl, which this data refers to, can be up to 100 times more potent than morphine and is most commonly used to treat pain associated with advanced cancer. Legally produced fentanyl is usually given in the form of patches or lozenges. According to the Drug Enforcement Administration, misuse of these products may include ingesting the gel inside the patches or freezing the patches, cutting them into pieces, and placing them inside the cheek to absorb the contents. . Because a percentage of fentanyl remains in used patches even after three days of use, used patches are also targeted for misuse. Illegally manufactured, non-pharmaceutical fentanyl is at the heart of the third and current wave of the opioid epidemic in the United States.



Cloth

#2. Hydromorphone

– Misuse in the past year (former users): 16.6%
– Misuse in the past year (general population): 0.1%

Hydromorphone, commonly referred to by the brand names Dilaudid or Exalgo, is an opioid prescribed to treat severe pain in patients resistant to less potent opioids. It is about eight times stronger than morphine and the effects of a 1-2 mg dose can be felt in as little as 15 minutes. Hydromorphone carries a high risk of addiction and is only prescribed in certain medical circumstances, such as cancer pain management or cancer-related treatment. According to the Drug Enforcement Administration, hydromorphone was once the most commonly misused or misused drug, now supplanted by oxycodone and hydrocodone.



PureRadiancePhoto // Shutterstock

#1. Buprenorphine

– Abuse in the past year (former users): 26.5%
– Misuse in the past year (general population): 0.2%

Buprenorphine is an opioid used in the drug treatment of opioid use disorder, or OUD, specifically to reduce intense withdrawal symptoms that can lead to relapse. It works by stimulating the brain in the same way as heroin or methadone, but to a lesser degree, creating a limit to its effects. It can produce euphoria without the risk of suppressing breathing, which is the true cause of death in opioid overdose. Since prolonged use of opioids inhibits the brain’s ability to produce dopamine on its own, the right dosage of buprenorphine and a comprehensive treatment plan allow patients with OUD to feel “normal” or equilibrium.

This story originally appeared on Zinnia Health
and was produced and distributed in partnership with Stacker Studio.


read more
Prescription drugs

Global Prescription Drugs Market – Applications in various verticals will emerge in favor of market growth to increase sales revenue

Global Prescription Drugs Market Report Highlights Latest Market Advancements Amid COVID-19 Pandemic

Market research store has released the latest report on the Global Prescription Drugs Market. The report provides all the valuable data based on the fundamental fragmentation of the market into different sectors. In this research report, different vital elements including competitive landscape, geographical spread, market dynamics, market share, and other market growth attributes. The report on the prescription drug market also covers market breakdown and size through detailed study of regional and company profiles. The report entails all the information about the Global Prescription Drugs Market, breakdown, competitive players, applications, and more. decoded. The study also innately determines the market status, barrier analysis, sales breakdown, risks, growth drivers, and opportunities to guide through the in-depth market analysis.

Get Free Sample Report + All Related Charts & Graphs (with COVID 19 Impact Analysis): https://www.marketresearchstore.com/sample/prescription-drugs-market-813432

Prescription Drugs Market Size, Status and Forecast 2028

1 Market Overview
2 manufacturer profiles
3 Global Prescription Drugs Sales, Revenue, Market Share and Competition by Manufacturer
4 Global Prescription Drugs Market Analysis by Regions
5 Prescription Drugs in North America by Country
6 Europe Prescription Drugs by Countries
7 Asia-Pacific Prescription Drugs by Countries
8 South America Prescription Drugs by Countries
9 Middle East and Africa Prescription Drugs by Countries
10 Global Prescription Drugs Market Segment by Type
11 Global Prescription Drugs Market Segment by Application
12 Prescription Drugs Market Forecast
13 Sales channel, distributors, traders and resellers
14 Research findings and conclusion
15 Appendix

In addition, key market players mentioned in the report include Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche AG, Allergan PLC, AstraZeneca PLC, Johnson & Johnson, Eli Lilly and Company, Shire PLC, Novartis International AG, Novo . The company profile provides comprehensive market revenue, future development, industry policies, strategies, and demand analysis with the help of comprehensive market analysis. The study also details the market status, regional distribution, latest innovations, and government policies pertaining to the prescription drugs market. The regional segmentation United States, Canada, and Mexico into North America, Peru, Brazil, Argentina, and Rest of South America as part of South America, Germany, Italy, United Kingdom, France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia- The Pacific (APAC), South Africa, Saudi Arabia, United Arab Emirates, Kuwait, Israel, Egypt, the rest of the Middle East and Africa (MEA) offers the understanding, reach and application of this market. A valuable source of relevant data can be obtained from the report through the competitive and strategic analysis.

Read the full report @ https://www.marketresearchstore.com/market-insights/prescription-drugs-market-813432

The report also covers the details such as economic, environmental, social, technological, and political status of the Prescription Drugs market after observing and studying various factors. Regional profiling of market revenue, size and volume will provide insight into the growth rate of the market over the forecast period. The comprehensive summary of Prescription Drugs Market will provide readers with a clear overview of the investment potential in the market. The market research report provides a clear picture to fight competition in the market. All macroscopic and microscopic imprints of the market are well explained in the Prescription Drugs Market report.

Segmentation:

By product : Brand name drugs, Generic drug

By app : Hospital, Clinic, Other

Here are the questions answered by the market report:

What are the objectives of the report?

This market report shows the projected market size for the prescription drugs market by the end of the forecast period. The report also examines historical and current market sizes.

Based on various indicators, the charts present the year-on-year growth (%) and the compound annual growth rate (CAGR) for the given forecast period.

The report includes market overview, geographic scope, segmentation, and financial performance of key players.

The report examines the current state of the industry and potential growth opportunities in North America, Asia-Pacific, Europe, Latin America, Middle East and Africa.

The research report includes various factors contributing to the growth of the market.

The report analyzes the growth rate, market size and market valuation over the forecast period.

For an additional revised list of market players in 2021, request a sample report: https://www.marketresearchstore.com/sample/prescription-drugs-market-813432

What factors are taken into consideration while evaluating the major market players?

The report analyzes companies around the world in detail.

The report provides an overview of the major market vendors including key players.

The reports include information about each manufacturer, such as profiles, revenue, product prices, and other relevant information about the products produced.

This report includes a comparison of market competitors and a discussion of key player perspectives.

Market reports provide information on recent developments, mergers and acquisitions involving key players.

Get more information before buying@ https://www.marketresearchstore.com/inquiry/prescription-drugs-market-813432

What are the main conclusions of the report?

This report provides comprehensive information about the factors that are expected to influence market growth and market share in the future.

The report presents the current market status and future prospects for various geographical regions.

This report provides qualitative and quantitative insights into the competitive landscape of the market.

Combined with Porter’s five forces analysis, it serves as a SWOT analysis and competitive landscape analysis.

It provides an in-depth analysis of the market, highlighting its growth rates and growth opportunities.

read more
Medical supplies

Volunteers pack medical supplies and military equipment donated to Ukraine – Metro Philadelphia

Sign up for our Daily Email newsletter to stay up to date with the latest local news across Philadelphia.

By Barbara Goldberg

In a corner of a cavernous warehouse, a woman in a yellow Tweety Bird sweatshirt separated catheters from blood-stopping gauzes. Another volunteer sealed a box of energy bars and gloves, while a ponytailed man sorted through batteries and diapers.

“I am a Ukrainian – every Ukrainian should do something,” said Roman Pylypiv, 27, who had driven from his home in Philadelphia to the New Jersey warehouse to help prepare donations for Ukrainians.

“There are men my age fighting there,” said Pylypiv, who moved to the United States eight years ago from the western Ukrainian town of Ivano-Frankivsk. where his family lives. “It’s nothing like what they do.”

Hundreds of volunteers descended on the warehouse run by Meest-America Inc, a shipping company specializing in deliveries to Eastern Europe, to sort and pack medical supplies, clothing, military equipment and equipment. other goods destined for Ukraine.

REUTERS/Eduardo Munoz

Its warehouse spans 92,000 square feet — bigger than an American football field — just 14 miles from Newark Liberty International Airport.

Inside are 35 long rows of orange-painted racks, each three shelves high and overflowing with bundles of toys, household items and other goods – typical shipments that have been put on hold since the invasion. of Ukraine by Russia.

Over the past two weeks, nearly all of Meest-America’s work has shifted to organizing humanitarian aid deliveries donated by churches, charities and individuals, operations director Natalia Brandafi said in an interview.

The company, whose name means bridge in Ukrainian, charges a reduced rate of 30% for the humanitarian goods it manages, funded by monetary donations, she said. He was able to obtain export permits for sensitive items such as body armor and helmets.

In the past week alone, the Meest, New Jersey warehouse shipped more than 260,000 pounds (120,000 kg) of humanitarian aid, almost all first aid kits, medical supplies and food non-perishable, Brandafi said.

The demand for medical supplies and military equipment replaced an earlier call for warm clothes and baby items.

More than 2 million Ukrainians fled the country, many with only what they had on their backs. Almost all of them are women and children, as the men have been asked to stay and fight, and the government has provided them with weapons to strengthen the defense of the Ukrainian Armed Forces.

For donation requests, Meest consults with the Ukrainian Embassy in Washington, the Ukrainian Consulate in New York and the delivery company’s headquarters in the western Ukrainian city of Lviv, said Brandafi.

In a corner of the warehouse, Valentyna Goloborodko, a native of Odessa and an intern at Montefiore Medical Center in New York, rolled up the sleeves of her Tweety Bird sweatshirt on her third day of volunteering.

She separated donated “medical goods” from more urgent “tactical drugs”, such as haemostatic gauze from the first aid kit to bandage a wound and stop bleeding.

“These are simple things that could save someone’s life on the battlefield,” Goloborodko said.

Reuters

read more
Medical products

Hot Extrusion Medical Products Market Trends by 2026 with Major Key Players – BASF Pharma, Formex, Omipa, Biogrund, AbbVie and Lubrizol

This global Hot Extrusion Medical Products Market is an attempt to analyze the global opportunities in the field of the global industry, its current capabilities and the potential of selected countries and regions in the market. The report to businesses and companies provides a better understanding of their ability to invest in the market. The report provides the most business-critical issues of the leading organizations in the Global Hot Melt Extrusion Medical Devices Market globally. The report aims to explain to market players the business outlook, key developments and drivers of the global hot melt extrusion medical products market.

The challenges and opportunities of the Hot Melt Extrusion Medical Products market are presented in the report. The report highlights critical value chain destinations of the global hot extrusion medical products market. The report also highlights issues and concerns of local and foreign market players and provides recommendations for policy makers and actions for industrials to grow in the global Medical Hot Melt Extrusion Products market. The report makes projections based on the current global economic scenario. The uncertainties and difficulties faced by the Hot Extrusion Medical Devices market players are included.

Request a sample report: https://www.orbisresearch.com/contacts/request-sample/6239962?utm_source=Sgir

Major Players of Global Hot Extrusion Medical Products Market:

AbbVie
Formex
BASF Pharmaceuticals
omipa
Biogrund
Lubrizol

Points covered in the Hot Melt Extrusion Medical Products Market report:

• Overview of the global hot melt extrusion medical products market by studying different segments.
• The employment contribution of the global hot melt extrusion medical products market to economies around the world.
• The economic contribution of the global hot melt extrusion medical products market to economies around the world.
• Key players’ marketing approaches to attract foreign markets for hot extrusion medical products.
• Domestic and global regulatory constraints faced by the Hot Extrusion Medical Products market players.
• Global and/or regional trends in the medical hot melt extrusion industry in selected countries.
• Financial information and capital market information of hot melt extrusion medical products are provided in the report.

Type of hot extrusion medical products industry includes:

Movies
Taste masking
Drug eluting devices
Others

Hot extrusion medical products industry applications consist of:

Research Laboratory
Contract manufacturing organization
Pharmaceutical companies

This report analyzes the recent Hot Melt Extrusion Medical Devices industry trends along with the production chain, consumption patterns, regional and international level business activities and other industry related fields. The report emphasizes the potential of the global hot extrusion medical products market in developed countries. The data used to study all the factors of the global hot extrusion medical products market uses data from 2010 to 2020 also considering the latest year for performing the analysis. The report compares the growth rates of the strongest segments and consumption and production patterns. The report provides a detailed study of the performance of major Hot Melt Extrusion Medical Products market on the domestic and global fronts. Additionally, the report highlights the countries with the greatest potential for future growth.

Investigate before accessing the report at: https://www.orbisresearch.com/contacts/enquiry-before-buying/6239962?utm_source=Sgir

Why Buy This Hot Melt Extrusion Medical Products Market Report?

• This report helps the Hot Melt Extrusion Medical Products market players to strengthen their market position, improve their business, reach markets and gain competitive advantages.
• The Hot Melt Extrusion Medical Products report focuses on the strategies implemented by manufacturers in their operations, purchasing, and supply chain management.
• The report leverages the capabilities of Hot Melt Extrusion Medical Devices market players to seize new opportunities.
• The report offers supply chain visibility to enable improvisation for Hot Melt Extrusion Medical Devices market players who wish to expand their business into new international markets.
• The Hot Melt Extrusion Medical Products report compares the growth rates of the strongest segments and consumption and production patterns.
• The supply chain visibility provided in this report aids in understanding the drivers of the Global Hot Melt Extrusion Medical Devices Market and helps them maintain their leading position in the Global Hot Melt Extrusion Medical Devices Market over the course of years of forecasting.

About Us:

Orbis Research (orbisresearch.com) is a one-stop-shop for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in delivering customized reports according to our clients’ requirements. We have complete information about our publishers and therefore are sure of the accuracy of the industries and verticals of their specialization. This helps our clients map their needs and we produce the perfect market research required for our clients.

Contact us:

Hector Costello
Senior Manager – Client Engagements
Central Highway 4144N,
Suite 600, Dallas,
Texas – 75204, USA
Telephone number: United States: +1 (972)-362-8199 | IND: +91 895 659 5155
Email ID: [email protected]

Buy the full report at: https://www.orbisresearch.com/contact/purchase-single-user/6239962?utm_source=Sgir

read more
Prescription drugs

5 charged with attempted smuggling of prescription drugs into Michigan

GRAND RAPIDS, Mich. (WILX) – Five defendants have been charged with conspiring to smuggle prescription drugs into the United States, for distribution in the Western District of Michigan and elsewhere.

On Friday, US Attorney Andrew Birdge announced that five men had been charged in connection with the investigation. They have been identified as Joshua Ford of Troy, Michigan; James Funaro of Atlanta, Georgia; Jeremy Walenty of Tampa, Florida; Taylor McLaren of Colorado Springs, Colorado; and Brendon Gagne of Fountain, Colorado.

Related: Michigan Prescription Drug Task Force Recommendations Announced

Two of the defendants, Gagné and Funaro, are also charged with money laundering conspiracy. Funaro alone is charged with one count of money laundering.

According to court documents, the defendants operated two websites that sold prescription drugs and certain controlled substances. These sites were ExpressPCT.com and ExpressPEDS.ws.

The United States has shut down two websites suspected of illegally selling prescription drugs.(WILX)

Birge said in a statement that ExpressPEDS.ws also sells anabolic androgenic steroids.

The US government is now arguing that the drugs sold on these sites were largely, if not entirely, manufactured outside the United States and smuggled into the country to be sold to people in the United States. According to the indictment, the sites did not ask for prescriptions from customers even though the drugs being sold require a person to be under the supervision of a licensed practitioner.

Related: Michigan governor signs bills to cut prescription drug costs

ExpressPCT.com accepted Bitcoin as well as other forms of payment, including payments sent through digital payment networks such as Zelle and Cash App.

The indictment says that if customers chose to pay using alternative payment methods other than cryptocurrency, the co-conspirators directed payments through accounts linked to Funaro. It alleges that Funaro then converted proceeds from the scheme into cryptocurrency before it was transferred to accounts held by a group of co-conspirators.

Birge alleges that this group of co-conspirators included foreign nationals residing abroad.

Investigators say they have traced at least $12 million in revenue to the drug trafficking program. If convicted of conspiracy to smuggle drugs into the United States, the defendants face a legal maximum of five years in prison and a fine of up to $250,000. If Gagne and Funaro are convicted separately of the money laundering conspiracy charge, they face a legal maximum of twenty years in prison and a fine of up to $500,000 or double the value of the funds laundered. , whichever is greater.

Criminality: ‘I’ve been advocating for this day for a long time’ – Man who saved sister from heinous attack sees bipartisan public safety bills signed

Copyright 2022 WILX. All rights reserved.

Subscribe to our News newsletter 10 and get the latest local news and weather straight to your email every morning.

read more
Generic drugs

Global generic drug market to reach $507.8 billion by 2026

  • Global competitiveness and percentage market shares of main competitors
  • Market presence in multiple geographies – Strong/Active/Niche/Trivial
  • Peer-to-peer collaborative online interactive updates
  • Access to our digital archives and the MarketGlass research platform
  • Free updates for one year

Editing: 7; Published: February 2022
Executive Pool: 1974
Companies: 42 – Players covered include Abbott Laboratories; Apotex Inc.; ASKA Pharmaceutical Co., Ltd. ; Aspen Pharmacare Holdings Limited; AstraZeneca Plc; Baxter International Inc.; Dr. Reddy’s Laboratories Limited; Eli Lilly and company; Endo International plc; Fresenius Kabi; GlaxoSmithKline Plc. ; H.Lundbeck A/S; Hospira; Lupine Pharmaceuticals, Inc.; Mylan NV; Novartis International SA; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Sandoz International GmbH; Sanofi-Aventis US LLC; STADA Arzneimittel AG; Sun Pharma; Teva Pharmaceutical Industries Ltd. and others.
Blanket: All major geographies and key segments
segments: Type (small molecule generics, biosimilars); Therapeutic application (cardiovascular, central nervous system (CNS), dermatology, oncology, respiratory, other therapeutic applications)
Geographies: World; United States; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia Pacific; Australia; India; South Korea; Rest of Asia Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UNITED ARAB EMIRATES; Rest of Middle East; Africa.

Free Project Preview – This is an ongoing global program. Preview our research program before making a purchasing decision. We provide free access to qualified executives in strategy, business development, sales and marketing, and product management roles at featured companies. Insights provide insider access to business trends; competing brands; profiles of experts in the field; and market data models and much more. You can also create your own bespoke report using our MarketGlass™ platform which offers thousands of bytes of data with no obligation to purchase our report. Registry overview

ABSTRACT-

Global generic drugs market to reach $507.8 billion by 2026
Generic drugs are described as the bioequivalent versions of brand name drugs in terms of safety, quality, stability, impact, strength, dosage form, and route of administration. Over the years, generic drugs have become safe and effective alternatives to brand name formulations. Generic variants differ from brand names in certain characteristics such as color, flavor and shape, although these factors have no impact on the safety and effectiveness of the drugs compared to the original version. Generic drugs are drugs that are made with the same active ingredient found in brand name drugs and also have the same therapeutic impact as their brand name counterparts. Medications are also prescribed in the same quantity as brand name medications. The method of consumption (route of administration) is also similar to brand name drugs. Generic drugs can only be marketed after the brand name drug patents have expired. The drugs are offered at much lower prices even though they are manufactured under the same strict manufacturing and safety procedures and maintain equivalent quality. A key advantage for generic drug manufacturers is that they do not need to invest time and money in drug R&D and marketing efforts, as generic drug prices are significantly lower compared to their branded counterparts.

Amid COVID-19 Crisis, Global Generic Drugs Market Estimated at US$402.9 billion in 2022, is expected to reach a revised size of US$507.8 billion by 2026, growing at a CAGR of 5.6% over the analysis period. Generic small molecules, one of the segments analyzed in the report, is expected to grow at a CAGR of 5.2% to reach US$325.7 billion at the end of the analysis period. After a thorough analysis of the business implications of the pandemic and the induced economic crisis, the growth of the biosimilars segment is readjusted to a revised CAGR of 6.3% for the next 7-year period. This segment currently accounts for a 37.7% share of the global generic drug market. With several factors encouraging growth contributing to wider adoption, biosimilars are poised to increase their share of the global generic drug market in the coming years. The rise of biosimilars has notably reduced overall drug spending in recent years, a trend that is expected to continue for the foreseeable future. The emergence of biosimilars in the market leads to increased competition, the next generation of biologics under development aims to improve safety, efficacy and cost factors compared to the drugs of the previous generation, which further adds to the competitive heat in the market.

The US market is estimated at $121.8 billion in 2022, when China is expected to reach $91.2 billion by 2026
The generic drug market in the United States is estimated at US$121.8 billion in 2022. The country currently accounts for a 30.46% share of the global market. Chinaworld’s second largest economy, is expected to reach an estimated market size of US$91.2 billion in 2026 with a CAGR of 7.2% over the analysis period. Other notable geographic markets include Japan and Canada, each predicting growth of 3.8% and 5% respectively over the analysis period. In Europe, Germany is expected to grow at around 4.3% CAGR while the rest of the European market (as defined in the study) will reach US$97.6 billion at the end of the analysis period.

The market is expected to be driven by the ever increasing risk of various chronic diseases such as hypertension, obesity and diabetes. Although pharmaceutical companies continue to develop branded drugs due to the shortage of new blockbuster drugs coming to market, generic drugs are expected to continue to meet the majority of these therapeutic needs of the population, especially the elderly population. in expansion. With the high cost of brand name drugs becoming a financial burden on people, efforts have intensified to develop cost-effective generic variants. Many branded drugs are unable to extend their exclusivity, resulting in the loss of patents and making way for affordable generics to be manufactured. The major application areas of generic drugs include cardiology, anti-infection, anti-arthritis, CNS, anti-cancer, and respiratory, among others. Generic drugs for cardiovascular diseases currently represent the dominant segment, accounting for the majority share of the overall market. Cardiovascular diseases such as heart failure, high blood pressure, circulatory disorders, dyslipidemia, cholesterol, arrhythmias, strokes and angina pectoris are the leading causes of death worldwide. The cardiovascular segment is expected to cover a larger portion of the global generic drugs market due to several patent expirations of these drugs. Generic drugs for infectious diseases would gain popularity over the next few years, mainly due to the increasing number of cases around the world. The COVID-19 pandemic has emerged as a significant growth driver for the generic drug market over the past year. As nations’ economies collapsed due to rising unemployment, the demand for cheaper substitutes for brand name drugs grew. Continued

MarketGlass™ Platform
Our MarketGlass™ platform is a free comprehensive knowledge center that can be custom configured to meet the intelligence needs of today’s busy business executives! This interactive, influencer-focused research platform is at the heart of our core research engagements and draws on the unique perspectives of participating executives from around the world. Features include – enterprise-wide peer-to-peer collaborations; overviews of research programs relevant to your business; 3.4 million profiles of experts in the field; profiles of competitive companies; interactive research modules; custom report generation; follow market trends; competing brands; create and publish blogs and podcasts using our primary and secondary content; follow domain events around the world; and much more. Client companies will have privileged access to the project’s data stacks. Currently used by over 67,000 domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our mobile application which has just been released on iOS Where android

About Global Industry Analysts, Inc. and StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher, the only influencer-focused market research company in the world. Proudly serving over 42,000 clients in 36 countries, GIA has been recognized for its accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
E-mail: [email protected]

CONNECTIONS
Join our group of experts
https://www.strategyr.com/Panelist.asp

Connect with us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow us on twitter
https://twitter.com/marketbytes

Journalists and media
[email protected]

SOURCE Global Industry Analysts, Inc.

read more
Medical products

This week’s big story: Stop banning medical product exports, report says

A new report from the National Academies of Sciences, Engineering and Medicine in the United States calls for an international treaty to prevent countries from banning exports of medical products, in a bid to prevent supply shortages.

The paper, called Strengthen the resilience of the country’s medical product supply chains, cites the restrictions that a number of countries have imposed on the export of medical products during the pandemic. Many of these still remain, as according to the World Trade Organization (WTO), 45 countries still had more than 70 restrictions in place in 2021, many of which applied to medical products.

The authors of the article go on to warn that export restrictions “can be dangerously counterproductive. What makes sense in an isolated emergency can be seriously detrimental in a global crisis.”

Globalization and the pharmaceutical industry

The pandemic has highlighted how dependent countries have become on imports to ensure they can meet domestic drug demand. China produces most of the active pharmaceutical ingredients (APIs) needed to manufacture common drugs such as penicillin and acetaminophen. India, in turn, relies heavily on imports from China to manufacture drugs for the US market, where it is the largest supplier of generic drugs.

The Russian invasion of Ukraine also raises fears that global supply chains could be disrupted. Russia signed an executive order this week banning exports of medical products from a list of countries it has deemed “unfriendly”, including the UK, EU, Canada, New Zealand, US States, Switzerland and Japan. This ban will apply to products stored in warehouses in Russia, or which pass through customs controls.

The need for collaboration

In the paper, the authors urge the US federal government to consider a multilateral agreement with major exporters of medical products that would be overseen by the World Trade Organization (WTO). They also suggest that the WTO could impose sanctions on countries that have not joined the agreement.

The 336-page document calls for greater international cooperation to prevent supply chain disruptions. It also contains detailed recommendations to prevent national shortages, such as pharmacy teams working with hospitals to inform them of a potential shortage and suggest alternative forms of treatment.

Earlier this year, the US Food and Drug Administration (FDA) made permanent its guidance to prevent supply shortages in the wake of the Covid-19 pandemic. This included requiring manufacturers to submit a notification at least six months before a product is permanently discontinued.

Also in the news:

google launched a new campaign featuring women entrepreneurs in Africa, including the story of Vivian Nwakah who launched Medsaf, a pharmaceutical supply chain solution to help Nigerians access quality pharmaceutical healthcare.
Pharmaceutical Logistics IQ has launched a new survey with SkyCell to get your perspective on the issues facing pharmaceutical supply chains today and the role hybrid container solutions could play. Share your thoughts with us and enter our draw to win a $100 Amazon gift card.

Get exclusive access to articles, reports, videos, interviews, webinars and other members-only premium content from industry experts and thought leaders by signing up for Pharma Logistics IQ here.

read more
Medical supplies

Two women from Mass. travel to the Ukrainian border to deliver medical supplies

BOSTON, MASS. (WLNE)- Two Massachusetts women of Ukrainian descent make a special delivery in war-torn Ukraine.

Ulana Nosal and Terry Reid have hopped on a plane to Poland and plan to deliver six duffel bags full of medical supplies to help refugees, on behalf of the Sunflower of Peace organization.

Natives of North Attleboro and Walpole say this is a personal mission for them.

Nosal came to the United States from Ukraine when she was 12 years old, and Reids’ grandmother is from Ukraine.

“I’m preparing for this, it’s what I was taught to do, I don’t know how to do anything but fight in a certain way,” Reid says.

Once in Poland, the two women will drive for hours and deliver supplies directly to the border.

“Surrounding countries are running out of their product and some fear they may even be running out,” says Nosal.

Thanks to generous donations, they then plan to pick up families at the border, feed them and help them find accommodation.

Nosal and Reid said they had to take action to help Ukrainians and are grateful to everyone who helped.

“The money just started coming in,” Nosal said. “Our Venmos are exploding and people really want to help.”

If you would like to donate to help with housing, you can donate to the Ukrainian American Youth Association Boston through Venmo @CYM-Boston.

read more
Medical products

Stereotactic Biopsy Table Market Size 2022-2029

New Jersey, United States,-Global Stereotactic Biopsy Table Market Size, Status and Forecast 2022-2028. This research report covers key aspects of the Stereotactic Biopsy Table market including drivers, limitations, past and current trends, regulatory scenarios, and technological developments. An in-depth study of industry’s role in the COVID-19 outbreak. A comprehensive risk assessment and industry recommendations have been made for market research reports and industry analysis over a specific period of time. The report compares the market before Corona 19 and after Corona 19. The impact of COVID-19 on the local economy is also considered in the study.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=448109

The term Based Stereotactic Biopsy Table market study provides helpful insights such as studying the effects on significant aspects, alternatives, and restraints. Graphical analysis of the Emotion Detection and Recognition demand forecasts for the predicted periods can demonstrate the financial requirements of the global Emotion Detection and Recognition industry. Likewise, the study highlights features which limit demand growth, adequately predict Stereotactic Biopsy Table Market quantities, and have long term effects over the predicted period.

The impact of the Corona 19 outbreak on the global Emotion Sensing and Awareness industry, growth rates, correct supply chain analysis, scale in various scenarios, and responses Corporate critiques of the outbreak are all examined in research on emotion sensing and sensitization. The research focuses on emotion detection and recognition in global markets, particularly in North America, Europe and the Asia-Pacific region, as well as South America, the Middle East and Africa. The study divides the market into four parts: manufacturer, region, type and application.

Major Players Covered in Stereotactic Biopsy Tables Markets:

  • MPI Medical
  • Devicor medical products
  • Siemens
  • Aurora imaging technology
  • Hological
  • Planmeca
  • Metaltronics

Stereotactic Biopsy Tables Market Split By Type:

  • Mechanically operated stereotactic biopsy table
  • Electronically controlled stereotactic biopsy table

Stereotactic Biopsy Tables Market Split By Applications:

  • Hospital
  • diagnostic center
  • Others

The Stereotactic Biopsy Table market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Stereotactic Biopsy Tables Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Stereotactic Biopsy Tables market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=448109

Scope of the Stereotactic Biopsy Tables Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Market Analysis Stereotaxic Biopsy Chart can be represented as follows:

Each regional Stereotaxic Biopsy Table sector is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global stereotaxic biopsy table market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-stereotactic-biopsy-table-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Prescription drugs

Non-prescription Drug Consumption Market Size 2022-2029

New Jersey, United States,-Global Non-prescription Drug Consumption Market Size, Status and Forecast 2022-2028. This research report covers key aspects of the Non-Prescription Drug Consumption market, including drivers, limitations, past and current trends, regulatory scenarios, and technological developments. An in-depth study of industry’s role in the COVID-19 outbreak. A comprehensive risk assessment and industry recommendations have been made for market research reports and industry analysis over a specific period of time. The report compares the market before Corona 19 and after Corona 19. The impact of COVID-19 on the local economy is also considered in the study.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=419998

The term based Non Prescription Drug Consumption market research provides useful insights such as the study of the effects on important aspects, alternatives, and restraints. Graphical analysis of the Emotion Detection and Recognition demand forecasts for the predicted periods can demonstrate the financial requirements of the global Emotion Detection and Recognition industry. Likewise, the study highlights the features which limit the demand growth, adequately predict the OTC Drug Consumption market quantities and have long term effects over the predicted period.

The impact of the Corona 19 outbreak on the global Emotion Sensing and Awareness industry, growth rates, correct supply chain analysis, scale in various scenarios, and responses Corporate critiques of the outbreak are all examined in research on emotion sensing and sensitization. The research focuses on emotion detection and recognition in global markets, particularly in North America, Europe and the Asia-Pacific region, as well as South America, the Middle East and Africa. The study divides the market into four parts: manufacturer, region, type and application.

Major Players Covered in Non-prescription Drug Consumption Markets:

  • Pfizer
  • rock
  • Sanofi
  • Johnson & Johnson
  • Merck & Co. (MSD)
  • Novartis
  • AbbVie
  • Gilead Sciences
  • GlaxoSmithKline (GSK)
  • Amgen
  • Astra Zeneca
  • Bristol Myers Squibb
  • Eli Lily
  • Suits you
  • Bayer
  • Novo Nordisk
  • Allergan
  • County
  • Boehringer Ingelheim
  • Takeda

Non-Prescription Drug Consumption Market Breakdown by Type:

Non-prescription Drug Consumption Market Split By Application:

The Non-Prescription Drug Consumption Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Non-Prescription Drug Consumption Market in the coming years. This segmental analysis will surely prove a useful tool for readers, stakeholders, and market players to get a complete picture of the global Non-Prescription Drug Consumption market and its growth potential in the coming years. .

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=419998

Scope of Non-Prescription Drug Consumption Market Report

Report attribute Details
Market size available for years 2022 – 2029
Reference year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Market Analysis OTC Drug Consumption can be represented as follows:

Each regional Non-Prescription Drug Consumption industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global non-prescription drug consumption market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-non-prescription-drugs-consumption-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Generic drugs

Savings on Generic Drugs Continue to Grow, Says Canadian Pharmacy Intermediary SaveRxCanada.to

VANCOUVER, BC, March 3, 2022 /PRNewswire/ — SaveRxCanada.to, a Leading Canadian Pharma Intermediary Since 2002, Continues to See an Uptrend Among Americans buy generic drugs. Generic drugs contain the same active ingredients with the same strength and purity as their brand name counterparts, but at a fraction of the cost.

the Rx Select The SaveRxCanada program was one of the first programs of its kind launched in 2004 to provide access to generic drugs. By adding several international pharmacies to their network, patients were able to find many generic and branded drugs not available in Canada.

The RxSelect program offers free shipping and 5% in rewards points that can be redeemed on future orders.

In United States76 million patients consult at least one prescription drug in 2020.

the 2021 U.S. Generic and Biosimilar Drug Savings Report highlighted the increased cost savings on generic drugs. Some key research findings:

  • $338 billion: US healthcare system savings
  • 90%: Portion of U.S. prescriptions filled with generic drugs
  • $6.61: The average generic share
  • $7.9 billion: savings on biosimilars
  • $109.6 billion: Medicare savings

The savings of individual consumers and the health care system as a whole continue to grow, reaching $338 billion in 2020. Tens of millions of Americans trust their health to generics and biosimilars. These savings are the main component of an often overlooked success story in public health.

About SaveRxCanada.to

SaveRxCanada.to has been a reliable, affordable and reliable Canadian pharmaceutical intermediary for over 18 years.

The company is committed to providing affordable prescription drugs to patients around the world through its network of licensed Canadian pharmacies and international pharmacies.

Visit SaveRxCanada.to to learn more about the company.

Customer service

Toll free: 1-866-799-3435 – Use reference #100048
Monday Friday 9:00 a.m. to 5:00 p.m. (EST)

All orders required a valid prescription from a licensed physician or physician.

This press release was published via 24-7PressRelease.com. For more information, visit http://www.24-7pressrelease.com.

SOURCESaveRxCanada.com

read more
Medical supplies

Drugmakers and device makers say sanctions could hamper medical supply in Russia

March 3 (Reuters) – Western drugmakers and medical device companies are warning that their plans to continue selling products to Russia could be complicated by economic sanctions targeting the country and its major banks as punishment over Moscow’s invasion of Ukraine.

Sanctions imposed by the United States, Britain, Europe and Canada against Russia do not apply to medicines and medical equipment, and the industry has a responsibility under international humanitarian law to to continue supplying these products, said industry trade groups, policy experts and business officials.

International aid groups are pushing for essential medicines to keep flowing into Ukraine, where Russian troops are seeking to take control of major cities, prompting more than 870,000 Ukrainians to flee their country and millions to shelter from airstrikes. Already, pharmacies are reporting shortages of medical supplies. Read more .

Join now for FREE unlimited access to Reuters.com

Register

Many Western companies have said they will stop selling everything from cars to movies in Russia. Transactions related to drugs and medical devices, as well as food, were permitted despite US and EU sanctions.

But the sanctions that have cut off Russian banks from the international financial system, as well as decisions by major shipping companies to suspend services to the country, could also hamper the delivery of medical supplies.

The withdrawal of seven Russian banks from the SWIFT international payment system – as well as the ongoing assault on Ukraine – could cause disruptions, said MedTechEurope, the European lobby group for medical device companies. Without access to this payment system, it becomes more difficult to transact with Russia. Read more

“The freezing of bank transfers could indeed have an impact on the export of medical devices from the EU to Russia, and we are actively examining the extent of this and will see how the situation develops,” the spokesperson said. of MedTechEurope.

In a statement, the European Federation of Pharmaceutical Industries and Associations called for the safe passage of medicines and vaccines to people in need in Ukraine, neighboring EU member states and Russia.

US pharmaceutical industry group PhRMA said it supported maintaining exemption from all sanctions for drugs and the materials needed to make them.

Under international humanitarian law, everyone has the right to access essential medical services and supplies, including medicines and vaccines, said Lawrence Gostin, a public health law expert at Georgetown University.

“In times of conflict, this right to uninterrupted access to essential medical supplies has often been violated,” Gostin said. “Governments imposing sanctions are also supposed to make an exception for medical supplies. Yet sanctions often disrupt medical services and supply chains.”

The United States, in a general license issued last week, authorized transactions related to the export or re-export of drugs and medical devices with Russia. It also issued exclusions for energy-related payments and international organizations, among others.

The US Treasury Department declined to comment on the matter.

The EU supplied Russia with 6.5 billion euros ($7.23 billion) worth of pharmaceuticals in 2020, around 8.4% of the region’s total exports to Russia, according to data from Eurostat. It sent around 1.6 billion euros worth of medical equipment to the country in the 12 months ending in September 2021, according to MedTech Europe.

US government data shows that in 2021, pharmaceuticals and medical equipment accounted for about 8% of all US goods exported to Russia. It sent $355 million in medicine and $157 million in medical equipment to the country.

Reuters Charts

Leading shipping group AP Moller-Maersk (MAERSKb.CO) warned on Wednesday that shipments to Russia, including medical supplies, risk being damaged or spoiled due to significant delays at ports and customs. Read more

Drugmakers including Switzerland’s Novartis (NOVN.S), Denmark’s Novo Nordisk (NOVOb.CO) and Lundbeck, Britain’s GlaxoSmithKline (GSK.L) and America’s Eli Lilly, said they were working guarantee patients continuous access to their medicines.

Novo Nordisk, the world’s largest maker of diabetes drugs, said it would do “everything we can to maintain supply in Ukraine and Russia”, but it expects sanctions will make that more difficult. He has had problems delivering medicine to Ukraine before.

“The supply of medicines may be indirectly affected by sanctions in other areas, and we will do everything possible to ensure that Russian citizens receive their life-saving medicines,” Novo Nordisk said in an emailed statement.

Lundbeck, which specializes in treatments for depression, said it will continue to serve patients who need medication in Russia.

“As long as we can get medicine to patients in Russia under the current sanctions, we will,” Chief Commercial Officer Jacob Tolstrup said in a written comment.

Join now for FREE unlimited access to Reuters.com

Register

Reporting by Francesco Guarascio in Brussels, Michael Erman in New Jersey and Stine Jacobsen in Copenhagen; Additional reporting by Jennifer Rigby in London, Jason Lange and Daphne Psaledakis in Washington, Julie Steenhuysen in Chicago and Dan Burns in New York; Editing by Caroline Humer and Bill Berkrot

Our standards: The Thomson Reuters Trust Principles.

read more
Prescription drugs

Manchin presents a Democratic bill he can support: taxes, prescription drugs, climate cash

“If you do that, the revenue producing [measures] would be taxes and drugs. Spending will be climate-related,” Manchin said.

“And social issues, we basically have to deal with them” afterwards, he added.

Manchin, who also chairs the Senate Energy Committee, said the climate portion of any moot bill will be different now that Russia is invading Ukraine. He calls on the United States to ban oil imports from Russia and increase domestic energy production, including fossil fuels. He would back big investments in clean energy as part of a potential deal, he said, but wants domestic oil, gas and coal production to remain a big part of the mix.

“Do you want to be able to defend your people, have reliable, reliable and affordable energy? You have to use “all of the above,” Manchin said, defending his support for clean energy investments. “They say ‘Manchin doesn’t care… he’s killing the environment.’ I don’t kill anything.

Though he prefers everything in Congress to be bipartisan, Manchin said he’s “come to this conclusion” that changing the tax code so the wealthy and corporations pay their fair share can only be done with Democratic votes. On whether he thinks his party finally understands its parameters for joining the talks, he said Democrats “know where I am. They just think I’m going to change.

To realize Manchin’s vision, Democrats would also have to negotiate with the senator. Kirsten Sinema (D-Arizona) who last year steered the party toward surtaxes and minimum corporate taxes — and away from raising personal and corporate tax rates. Manchin acknowledged that he and Sinema “might have a different take on this whole thing”, but did not see it as fatal to future negotiations.

Asked about Manchin’s much narrower proposal, Rep. Barbara Lee (D-California) scoffed, saying that would not satisfy many frustrated Liberals in the House. She seemed more interested in trying to change Manchin’s mind about expanding the child tax credit and other national programs than agreeing to his plan.

“I hope he reconsiders and realizes how many people are being left behind,” Lee said. “We have to keep going and try to get everything we can get.”

But other progressives are willing to accept just about anything they can do with just 50 Senate Democrats and a slim majority in the House. After all, the midterm reviews are now eight months away; recreating the momentum to put a big bill on the floor can take months.

“We just have to fish or cut the bait on reconciliation. Enough of that,” the senator said. Elizabeth Warren (D-Mass.). there are so many things we all agree on, that we should be able to reach a deal, bring it together and do it”

Biden’s State of the Union address called for congressional action on some of the individual parts of the sweeping social spending measure the House passed last year, including drug pricing, childcare, and more. children, tax hikes on the rich and climate change. The momentum Democrats had garnered for their trillion-plus proposal has largely evaporated, and some lawmakers are increasingly open to slimmed-down legislation or even stand-alone bills to respond. to their political priorities.

“I basically said as far as I’m concerned, it’ll be like found money if we find anything,” the Senate Majority Whip said. Dick Durbin. “I assume nothing with a reconciliation bill. [Expectations are] as low as they go.

And while Manchin said no “formal” discussions were taking place with the White House, there were “informal back and forths.” He declined to say if he had spoken to Biden about it recently: “Various members of the White House contact us, and we talk from time to time.”

Meanwhile, aggravation with the senator from West Virginia remains high in the House, where members saw no action on the multi-trillion-dollar social spending plan that required them to burn huge amounts of political capital to be adopted.

“I think Mr. Manchin is a good, decent man who is out of step with the goals of the American public,” the rep said. Emmanuel Cleaver (D-Mo.) said, adding that he was unaware of any of Manchin’s recent pivots toward energy or deficit reduction.

Sarah Ferris contributed to this report.

read more
Medical products

Metal Fiduciary Marks Market Analysis by 2030

New Jersey, United States,-The Metal Fiduciary Marks Market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, actual value, overall size, share and future development factors.

Metal Fiduciary Marks Market Overview:

The research report on global “Metal Fiduciary Marks Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Metal Fiduciary Marks market study provides up-to-date information on the technical advancements and potential market opportunities based on the local landscape.

This Metal Fiduciary Marks Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=245961

The report includes a detailed segmentation study of the global Metal Fiduciary Brands market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Metal Fiduciary Marks Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Metal Fiduciary Marks Market.

Key Players Covered in Metal Fiduciary Marks Markets:

  • CIVCO Radiotherapy
  • IZI medical products
  • Naslund Medical AB
  • IBA
  • Boston Scientific Society
  • Medtronic

Metal Fiduciary Marks Market Split By Type:

  • pure gold
  • Gold alloys
  • Other metal-based markers

Metal Fiduciary Marks Market Split By Application:

  • Hospitals and outpatient facilities
  • Independent radiotherapy centers
  • Cancer research centers

The Metal Fiduciary Marks Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Metal Fiduciary Brands Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Metal Fiduciary Marks market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=245961

Scope of the Metal Fiduciary Marks Market Report

Report attribute Details
Market size available for years 2022 – 2029
Reference year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Metal Fiducial Marks Market analysis can be represented as follows:

Each regional Metal Fiduciary Brands industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global metal fiat brands market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-metal-fiducial-marks-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Generic drugs

Global Multi-Cancer Generic Drugs Market 2021 Manufacturer Landscape, Revenue and Volume Analysis to 2027 – Business Ethics

The research report MarketQuest.bizto Global market for generic drugs for several cancers reviews important industry and market trends, as well as historical and anticipated market data. The research has implications for the stock market as well as other terms and definitions. Analytics promotes its products by application, sort and location in terms of volume and value.

The market accurately reflected the total sales and marketing volume, maximum production and consumption costs, profit margins, import and export, cost structure analysis, in-depth price analysis , vendor landscapes, and other critical market variables. The research helps identify new marketing opportunities and offers a complete picture of the existing global market for generic drugs for multiple cancers.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/45315

The study is significant for organizations or individuals looking to enter the Generic Drugs for Multiple Cancers industry as it provides detailed qualitative and quantitative insights. It also examines how changing patterns, COVID-19, and inflation are affecting market growth. Additionally, supply chain analysis, profit margin analysis, and price research are all covered in depth to help businesses and give them an estimate of how much money they will need to join this market.

Market segmentation based on region:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
  • South America (Brazil, Argentina, Colombia and rest of South America)
  • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of Middle East and Africa)

Player Market Segmentation:

  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Merck
  • Celgene
  • Teva pharmaceutical
  • Mylan
  • Aurobindo Pharmacy
  • Hikma Pharmaceuticals
  • rock
  • Redsenol

Segment the market by product type:

  • Cytotoxic drug
  • Non-cytotoxic drugs

Market segmentation based on application

  • Hospital pharmacy
  • Retail pharmacies
  • Online pharmacies

ACCESS FULL REPORT: https://www.marketquest.biz/report/45315/global-generic-drugs-for-multiple-cancers-market-2021-by-key-countries-companies-type-and-application

In addition, a framework of study has been created to emphasize future events and possibilities in the global Generic Multiple Cancer Drugs industry in recent years. According to the research study, the market will face a variety of drivers and restraints, opportunities and challenges throughout the forecast period. The report also examines the geographical characteristics of the market, which will impact its growth from 2021 to 2027.

Report customization:

This report can be customized to meet customer requirements. Please contact our sales team ([email protected]), who will ensure that you get a report tailored to your needs. You can also get in touch with our executives at +1-201-465-4211 to share your research needs.

Contact us
mark the stone
Business Development Manager
Call: +1-201-465-4211
E-mail: [email protected]

read more
Medical supplies

Medical supplies for Ukraine stuck in warehouse in Tempe | Arizona News

TEMPE, AZ (3TV/CBS 5) – Thousands of dollars worth of medical supplies for Ukraine sit in a warehouse in Tempe, unable to be delivered amid escalating conflict.

“It’s heartbreaking for us to know that what’s sitting here could save lives out there right now,” said Charles Irion, with Project CURE “They’re going to be needed more now because of all the injuries and suffering that is So the sooner we can hopefully get this container out, the better.

Project CURE is a non-profit organization that collects donations of medical supplies and equipment from hospitals in Arizona and ships them to 138 different countries that may not have access to these items.

“I’ve been seeing this equipment for two weeks, and I myself have wondered why it’s sitting here? And yesterday it got even sadder and heartbreaking that it’s not going where it’s supposed to go to help people. people…mothers, children, the elderly, the Ukrainian community. They can’t get their supplies,” said Ruth Sanchez, executive director of Project CURE in Arizona.

Sanchez says between $250,000 and $1 million goes into 40-foot shipping containers.

“It’s all medical. We don’t do pharmaceuticals. We do equipment, biomedical, x-rays, ultrasound, and then PPE – the gowns, the gloves, the masks, the syringes, that’s there too,” Sanchez explained. “We have wheelchairs, we have baby warmers. Everything you see in the boxes you see for Ukraine is what you and I easily have at any facility here in the United States. United.” This shipment was due to leave the warehouse for Ukraine yesterday. “We actually planned two weeks, and we finally got confirmation two days ago that it would be here, and overnight it changed, and the freight forwarder said we weren’t there. comfortable sending anything to this area.”

Sanchez says Project CURE is working with government officials to find a safe way to get supplies to Ukraine. They plan to ship the container to Poland or Germany. “We’re working really hard to fix this and another two weeks, and we’re talking about saving lives here,” Sanchez said.

The CURE project now has a donation campaign to help Ukraine. If you would like to donate, click here.


Copyright 2022 Gray Media Group, Inc.

read more
Medical products

Tongue Depressor Market Forecast 2022 by 2029

New Jersey, United States,-The Tongue Depressor Market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, actual value, overall size, share and future development factors.

Overview of the Tongue Depressor market:

The research report on “Global Tongue Depressor Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Tongue Depressor market study provides up-to-date information on technical advancements and potential market opportunities based on the local landscape.

This Tongue Depressor Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=208333

The report includes a detailed segmentation study of the global Tongue Depressor market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Tongue Depressor Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Tongue Depressor Market.

Major Players Covered in Tongue Depressor Market:

  • Puritan Medical Products
  • Agaplastic
  • medical dtr
  • Fazzini
  • Fl Medical
  • FASA Group
  • Francois Mensch
  • Parburch Medical Developments
  • Plasti Lab
  • Dental Shufa
  • timesco
  • We Ophthalmic
  • A. Algeo
  • Dental Asa

Tongue Depressor Market Split By Type:

  • wooden tongue depressor
  • Metal tongue depressor
  • plastic tongue depressor

Tongue Depressor Market Split By Application:

  • Hospitals
  • Clinics
  • Academic research institutes

The Tongue Depressor Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Tongue Depressor Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a comprehensive picture of the global Tongue Depressor market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=208333

Scope of the Tongue Depressor Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Tongue Depressor Market Analysis can be represented as follows:

Each regional Tongue Depressor industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global Tongue Depressor market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/%ef%bb%bftongue-depressors-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Generic drugs

Generic Drugs Market Continues to Grow Due to Rising Incidence of Chronic Diseases Worldwide | Teva Pharmaceutical Industries, Mylan NV, Novartis International AG, Pfizer, Inc.

Market Overview:

Generic drugs are those that have the same active chemical substance as a brand name drug. Before generics became available, generic drugs were made using identical active ingredients, the only difference being the chemical makeup or dosage. Generic drugs can be sold without any authorization from the Food and Drug Administration. Generic drugs can also be manufactured and approved at the same time as the patented drug if the company that holds the patent for the drug can meet the necessary requirements. Once these requirements are met, a generic drug can be marketed. Generic drugs, however, are not available without a doctor’s prescription because generic drugs lack the safety offered by brand name drugs.

Request a PDF brochure here @ https://www.coherentmarketinsights.com/insight/request-pdf/1132

Key Market Drivers:

Rising cases of chronic diseases across the world is the major factor that is expected to drive the growth of the global generic drugs market. For example, according to the World Health Organization, approximately 422 million people worldwide have diabetes and approximately 1.6 million deaths are directly related to diabetes each year. Generic drugs are manufactured using the same facilities and methods as brand name drugs. In fact, it is usually the same product created with the same quality and consistency. However, generic drugs are manufactured to meet or exceed the safety and efficacy requirements of the United States Food and Drug Administration. Generic drugs can be sold without the need for an expensive marketing campaign because generic drugs can be manufactured at lower prices than brand name drugs. Increase in product launches by major market players is estimated to propel the growth of the global generic drugs market.

Covid-19 impact analysis:

The rising incidence of COVID-positive cases globally has significantly affected the growth of the global generic drugs market. For example, according to Springer, in April 2020, the number of individuals infected with SARS-CoV-2 was approximately 0.9 million with a fatality rate of approximately 1.38%. Additionally, increasing transportation restrictions and lockdown restrictions in several countries has also affected the market growth.

Key points to remember:

  • The global generic drugs market size was valued at around US$263 billion in 2020 and at a CAGR of 6.58%, it is estimated to reach around US$385 billion in 2026, owing to the increase in chronic diseases worldwide. For example, according to the International Agency for Research on Cancer, in 2020 the global cancer burden was approximately 19.3 million.
  • North America is expected to hold a major share of the global generic drug market, owing to the growing prevalence of drug manufacturers in the region. For example, according to Pharmapproach, in 2019 the United States generated approximately US$490 billion in revenue.
  • Asia-Pacific is expected to experience high growth in the global generic drug market, owing to the growing prevalence of pharmaceutical companies in developing regions. For example, according to India Briefing, there are over 3,000 pharmaceutical companies in India, along with 10,500 manufacturing units.

Buy this report directly with a fixed discount of 2000 USD @ https://www.coherentmarketinsights.com/promo/buynow/1132

Reasons to Buy this Generic Drugs Market Report

➡ Save time conducting entry-level research by identifying the size, growth and key players in the emerging Generic Drugs market

➡Use five forces analysis to determine the competitive intensity and hence the attractiveness of the emerging generic drugs market

➡Key Company Profiles Reveals Details of Major Generic Drugs Market Players Emerging from Five Transactions and Financial Performance

➡Add weight to presentations and presentations by understanding the future growth prospects of the emerging Generic Drugs market with five-year historical forecasts

➡Compares data from North America, South America, Asia-Pacific, Europe and the Middle East, as well as individual chapters on each region.

Contents

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Scope of research
1.4 Market Analysis by Regions
1.5 Generic Drugs Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Impact on Generic Drugs Industry

Chapter 2 Global Generic Drug Competition by Types, Applications and Top Regions and Countries
2.1 Global Generic Drugs (Volume and Value) by Type
2.3 Global Generic Drugs (Volume and Value) by Regions

chapter 3 Generation market analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Generic Drug Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Generic drugs market To analyse
Chapter 6 Analysis of the generic drugs market in East Asia
Chapter 7 Analysis of the generic drugs market in Europe
Chapter 8 South Asia Generic Drugs Market Analysis
Chapter 9 Southeast Asia Generic Drugs Market Analysis
Chapter 10 Analysis of the generic drugs market in the Middle East
Chapter 11 Analysis of the generic drugs market in Africa
Chapter 12 Analysis of the Generic Medicines Market in Oceania
Chapter 13 Analysis of the generic drugs market in South America
Chapter 14 Company profiles and key figures of the generic drugs sector
Chapter 15 Global Generic Drugs Market Forecast (2021-2027)
Chapter 16 conclusion
Research Methodology

Get Sample PDF Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/1132

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Contact:

Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

read more
Medical products

Laryngeal Stents Sales Market Outlook Forecast by 2029

New Jersey, United States,-The Laryngeal Stents Sales Market report contains a detailed overview of the industry along with gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, the actual value, overall size, share and future development factors.

Laryngeal Stent Sales Market Overview:

The research report on the global “Laryngeal Stents Sales Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification . The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Laryngeal Stents Sales market research provides up-to-date information on the technical advancements and potential market opportunities based on the local landscape.

This Laryngeal Stents Sales Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=524591

The report includes a detailed segmentation study of the global Laryngeal Stents sales market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the segment attractiveness index, allowing players to inform about profitable revenue pockets in the global Laryngeal Stents Sales Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Laryngeal Stents Sales market.

Key Players Covered in Laryngeal Stents Sales Markets:

  • Boston Medical Products (bess AG)
  • Hood Laboratories
  • Stening S.r.l.

Laryngeal Stents Sales Market Split By Type:

  • Hooded laryngeal stent
  • Laryngeal Tubular Stent Segment by Users
  • Child
  • Competitive landscape for adults: factors such as cost analysis
  • marketing strategy
  • factor analysis
  • distributors
  • sourcing strategy
  • and industrial chain

Laryngeal Stents Sales Market Split By Application:

The Laryngeal Stents Sales Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Laryngeal Stents Sales Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Laryngeal Stents sales market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=524591

Scope of the Laryngeal Stents Sales Market Report

Report attribute Details
Market size available for years 2022 – 2029
Reference year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Laryngeal Stents Market Analysis Sales can be represented as follows:

Each regional Laryngeal Stents Sales Industry is carefully researched to understand their current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global laryngeal stent sales market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/laryngeal-stents-sales-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Thermoplastic Orthotics Market Size 2031

New Jersey, United States,-The Orthopedic Thermoplastics market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service delivery, value actual, overall size, share and future development factors.

Orthopedic Thermoplastics Market Outlook:

The research report on the global “Orthopedic Thermoplastics Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, orthopedic thermoplastics market research provides up-to-date information on technical advancements and potential market opportunities based on the local landscape.

This Thermoplastic Orthotics Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=520938

The report includes a detailed segmentation study of the global orthopedic thermoplastics market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the segment attractiveness index, allowing players to inform about the profitable revenue pockets of the global orthopedic thermoplastics market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus on the right areas of the global orthopedic thermoplastics market.

Major Players Covered by Orthopedic Thermoplastics Markets:

  • Medical clarity
  • Performance Health
  • Chesapeake Medical Products
  • Orfit Industries
  • T-Tape Company
  • Allard International
  • Breg
  • North

Orthopedic Thermoplastics Market Split By Type:

  • Minimum stretch resistance
  • Moderate resistance to stretching
  • Maximum stretch resistance

Orthopedic Thermoplastics Market Split By Application:

  • hand and arm
  • Foot and Knee

The Thermoplastic Orthotics Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global orthopedic thermoplastics market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Orthopedic Thermoplastics market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=520938

Scope of the Orthopedic Thermoplastics Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Orthopedic Thermoplastics Market Analysis can be represented as follows:

Each regional Orthopedic Thermoplastics industry is carefully researched to understand their current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global thermoplastic orthotics market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/orthotic-thermoplastics-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Pneumatic Compression Devices for Lymphedema Consumption Market Size 2031

New Jersey, United States,-Pneumatic Compression Devices for Lymphedema Consumption 2022 Industry Outlook Analysis: Pneumatic Compression Devices for Lymphedema Consumption Market 2022 is expected to be profitable. As the trends rise, investors, research methodologies, CEOs, traders, vendors, directors, presidents, research and media, and a better understanding of the Consumer Pneumatic Compression Devices market of lymphedema.

The report specifically focuses on the Virtual Reality Cardboards in North America, Europe, Asia-Pacific, South America, Middle East and Africa, and global market. The report categorizes the market based on manufacturer, region, type and application. QYResearch market research analysts believe factors such as low cost of VR headsets to drive the market growth over the next five years. The assembly parts used to make the VR cartons are cost effective and do not require heavy machinery or huge manufacturing plants to produce these VR cartons. This low cost of VR cardboard is a prediction period for pneumatic compression devices for consumption of lymphedema. a new GIR (Global Information Research) study, of XX million US $ in 2017.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=429826

The report includes a detailed segmentation study of the global Pneumatic Compression Devices for Lymphedema Consumption market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment attractiveness index, allowing players to inform about profitable revenue pockets of the global Pneumatic Compression Devices for Lymphedema Consumption Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Pneumatic Compression Devices for Lymphedema Consumption market.

Key Players Covered in Pneumatic Compression Devices for Lymphedema Consumer Markets:

  • Devon Medical Products
  • Medical Touch
  • ArjoHuntleigh (Getinge AB)
  • LymphaPress?
  • Global DJO
  • Inc.
  • XIAMEN SENYANG CO.
  • LTD
  • Medline Industries
  • Inc.
  • Biocompression systems
  • Inc.
  • B?sl Medizintechnik

Pneumatic Compression Devices for Lymphedema Consumption Market Split By Type:

  • Pneumatic compression pump
  • Pneumatic compression garments

Pneumatic Compression Devices for Lymphedema Consumption Market Split By Application:

The Pneumatic Compression Devices for Lymphedema Consumption Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Pneumatic Compression Devices for Lymphedema Consumption market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Pneumatic Compression Devices for Lymphedema Consumptions market and its growth potential in coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=429826

Scope of Pneumatic Compression Devices for Lymphedema Consumption Market Report














Report attribute Details
Market size available for years 2021 – 2028
Base year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

The regional analysis of Pneumatic Compression Devices for Lymphedema Consumption Market can be represented as follows:

Each regional Pneumatic Compression Devices for Lymphedema Consumption industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global Pneumatic Compression Devices for Lymphedema Consumption market has been segmented as follows:

    • North America includes the United States, Canada and Mexico

    • Europe includes Germany, France, UK, Italy, Spain

    • South America includes Colombia, Argentina, Nigeria and Chile

    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-pneumatic-compression-devices-for-lymphedema-consumption-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Generic drugs

Generic Drugs Market Share, Size, Business Opportunity, Supply Chain Analysis, Companies and Forecast Report by 2026

global generic drug market

SHERIDAN, USA, Feb. 22, 2022 /EINPresswire.com/ — IMARC Group’s latest research report, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021- 2026”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

The global generic drug market share reached a value of US$386 billion in 2020. Looking ahead, IMARC Group expects the market to show moderate growth during the period 2021-2026. A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

Important Attribute and Report Highlights:
• Detailed global market share analysis
• Market segmentation by therapeutic area, drug delivery and distribution channel.
• Historical, current and projected market size in terms of volume and value
• Latest industry trends and developments
• Competitive landscape for the generic drugs market
• Strategies of key players and product offerings

The global market is mainly driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer’s disease and Parkinson’s disease. Additionally, significant growth in the pharmaceutical industry has boosted the growth of the market across the globe. Apart from this, increased expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Additionally, the growing geriatric population has positively influenced the growth of the market. Additionally, the upcoming patent expiration of many branded drugs is expected to drive the market towards growth.

Key Players Covered in the Generic Drugs Market Research Report:
• Teva Pharmaceuticals Industries Ltd.
• Mylan SA
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co.
• Lupine Limited
• Endo Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Aspen Pharmacare Holdings Limited

Do you know more information, contact our analyst at– https://www.imarcgroup.com/generic-drug-manufacturing-plant

Overview of the impact of COVID-19:

We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Key Market Segmentation:

Breakdown by therapeutic area:
• Central nervous system
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Rupture by administration of drugs:
• Oral
• Injectables
• Dermal/Topical
• Inhalers

Breakdown by distribution channel:
• Retail pharmacies
• Hospital pharmacies

Breakdown by region:
• North America (United States, Canada)
• Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, others)

Table of Contents of Generic Drugs Market Research Report:
• Preface
• Scope and methodology
• Abstract
• Introduction
• Global generic drugs market
• SWOT analysis
• Value chain analysis
• Price analysis
• Competitive landscape

Other related reports from the IMARC group:
WiFi chipset market: https://www.imarcgroup.com/wifi-chipset-market
Biometrics Market: https://www.imarcgroup.com/biometrics-market
Bakery Ingredients Market: https://www.imarcgroup.com/bakery-ingredients-market
Plant-Based Meat Market: https://www.imarcgroup.com/plant-based-meat-market
Kidney/Renal Function Test Market: https://www.imarcgroup.com/kidney-renal-function-test-market
Aircraft Seating Market: https://www.imarcgroup.com/aircraft-seating-market
Cochlear implants market: https://www.imarcgroup.com/cochlear-implants-market
Shape memory alloys market: https://www.imarcgroup.com/shape-memory-alloys-market
Submersible pumps market: https://www.imarcgroup.com/submersible-pumps-market
Night Vision Devices Market: https://www.imarcgroup.com/night-vision-devices-market

Who we are:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Elena Anderson
IMARC Group
+16317911145
write to us here

read more
Generic drugs

Generic Drugs Market – EIN Presswire

generic drugs market report

SHERIDAN, USA, Feb. 22, 2022 /EINPresswire.com/ — IMARC Group’s latest research report, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021- 2026”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

The global generic drug market share reached a value of US$386 billion in 2020. Looking ahead, IMARC Group expects the market to show moderate growth during the period 2021-2026. A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

Important Attribute and Report Highlights:
• Detailed global market share analysis
• Market segmentation by therapeutic area, drug delivery and distribution channel.
• Historical, current and projected market size in terms of volume and value
• Latest industry trends and developments
• Competitive landscape for the generic drugs market
• Strategies of key players and product offerings

The global market is mainly driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer’s disease and Parkinson’s disease. Additionally, the significant growth in the pharmaceutical industry has boosted the growth of the market across the globe. Apart from this, increased expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Additionally, the growing geriatric population has positively influenced the growth of the market. Additionally, the upcoming patent expiration of many branded drugs is expected to drive the market towards growth.

Key Players Covered in the Generic Drugs Market Research Report:
• Teva Pharmaceuticals Industries Ltd.
• Mylan SA
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co.
• Lupine Limited
• Endo Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Aspen Pharmacare Holdings Limited

Do you know more information, contact our analyst at– https://www.imarcgroup.com/generic-drug-manufacturing-plant

Overview of the impact of COVID-19:

We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Key Market Segmentation:

Breakdown by therapeutic area:
• Central nervous system
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Rupture by administration of drugs:
• Oral
• Injectables
• Dermal/Topical
• Inhalers

Breakdown by distribution channel:
• Retail pharmacies
• Hospital pharmacies

Breakdown by region:
• North America (United States, Canada)
• Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, others)

Table of Contents of Generic Drugs Market Research Report:
• Preface
• Scope and methodology
• Abstract
• Introduction
• Global generic drugs market
• SWOT analysis
• Value chain analysis
• Price analysis
• Competitive landscape

Other related reports from the IMARC group:
WiFi chipset market: https://www.imarcgroup.com/wifi-chipset-market
Biometrics Market: https://www.imarcgroup.com/biometrics-market
Bakery Ingredients Market: https://www.imarcgroup.com/bakery-ingredients-market
Plant-Based Meat Market: https://www.imarcgroup.com/plant-based-meat-market
Kidney/Renal Function Test Market: https://www.imarcgroup.com/kidney-renal-function-test-market
Aircraft Seating Market: https://www.imarcgroup.com/aircraft-seating-market
Cochlear implants market: https://www.imarcgroup.com/cochlear-implants-market
Shape memory alloys market: https://www.imarcgroup.com/shape-memory-alloys-market
Submersible pumps market: https://www.imarcgroup.com/submersible-pumps-market
Night Vision Devices Market: https://www.imarcgroup.com/night-vision-devices-market

Who we are:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Elena Anderson
IMARC Group
+1 631-791-1145
write to us here

read more
Prescription drugs

Prescription Drugs Market Global Production, Growth, Share, Demand and Application Forecast to 2027 – ZNews Africa

Prescription Drug Market Research Overview

Global Prescription Drugs Market exhibits comprehensive information which is a valuable source of insightful data for business strategists during the decade 2017-2027. Based on historical data, the Prescription Drugs market report provides key segments and their sub-segments, revenue and demand and supply data. Given the technological breakthroughs in the market, the prescription drug industry is likely to emerge as a laudable platform for emerging investors in the prescription drug market.

The results of recent scientific endeavors towards the development of new prescription drug products have been studied. Nonetheless, factors affecting major industry players to adopt synthetic sourcing of market products have also been studied in this statistical survey report. The findings provided in this report are of great value to major industry players. Every organization involved in the global production of the Prescription Drugs Market products has been mentioned in this report, to study the information on cost-effective manufacturing methods, competitive landscape and new application avenues.

This report contains an in-depth analysis of pre-pandemic and post-pandemic market scenarios. This report covers all recent developments and changes recorded during the COVID-19 outbreak.

Get a sample report: https://www.marketresearchupdate.com/sample/355929

Major Key Players in the Market:
F. Hoffmann-La Roche AG, Eli Lilly and Company, Pfizer, Inc, Novo Nordisk A/S, Amgen, Inc, Merck & Co., Inc, Sanofi, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Bristol- Myers Squibb Company, AbbVie, Inc, GlaxoSmithKline PLC, Allergan PLC, Bayer AG, Celgene Corporation, Novartis International AG, Boehringer Ingelheim GmbH, Gilead Sciences, Inc, Shire PLC

The types covered in this report are:
brand name drugs
General medicine

Based on the app:
Sold online
Hospital
Clinical
Other

With the current market norms being revealed, the Prescription Drugs market research report has also illustrated the latest strategic developments and patterns of the market players in an unbiased manner. The report serves as a presumptive business document that can help the buyers in the global market to plan their next courses towards the future position of the market.

Check Prescription Drugs Market Report @ https://www.marketresearchupdate.com/discount/355929

Regional Analysis of the Prescription Drugs Market

North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)

Why B2B companies around the world rely on us to grow and sustain revenue:

  • Get a clear understanding of the prescription drugs market, how it works, and the different stages of the value chain.
  • To understand the current market situation and future growth potential of the Prescription Drugs Market throughout the forecast period.
  • Develop marketing strategies, market entry, market expansion and other business plans by understanding the factors that influence market growth and buyer buying decisions.
  • Understand your competitors’ business structures, strategies and prospects and react accordingly.
  • Make more informed business decisions using relevant primary and secondary research sources.

This report provides:

  1. A detailed overview of the global prescription drugs market.
  2. Assessment of global industry trends, historical data from 2015, projections for the upcoming years and anticipation of compound annual growth rates (CAGR) by the end of the forecast period.
  3. Discoveries of new market insights and targeted marketing methodologies for Global Prescription Drugs
  4. Discussion on R&D and demand for new product launches and applications.
  5. Varied company profiles of major industry players.
  6. The composition of the market, in terms of dynamic molecule types and targets, highlighting the key industry resources and players.
  7. The growth of patient epidemiology and market revenue for the global market and among key players and market segments.
  8. Study the market in terms of generic and premium product revenues.
  9. Determine business opportunities in the market sales scenario by analyzing trends in licensing and co-development agreements.

Get the full report @ https://www.marketresearchupdate.com/industry-growth/prescription-drugs-report-2022-2027-355929

Ultimately, the Prescription Drugs Market report includes analysis of investments and development trends. Present and future opportunities of the fastest growing international industry segments are covered throughout this report. This report additionally presents the product specification, manufacturing method, product cost structure, and price structure.

Contact us:
[email protected]

read more
Medical products

Disposable Pressure Transducers Market Outlook by 2030

New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global disposable pressure transducers market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global disposable pressure sensors market, analysts have segmented the market based on applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Disposable Pressure Transducers market.

Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the assessment of these vendors’ financial outlook, Disposable Pressure Sensors market growth strategy and expansion plan during the forecast period. All the information presented in the Global Disposable Pressure Sensors Market research report has been certified by market experts.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=403765

The report includes a detailed segmentation study of the global Disposable Pressure Sensors market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Disposable Pressure Transducers Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Disposable Pressure Transducers market.

Key Players Covered in Disposable Pressure Transducers Market:

  • Edwards life sciences
  • Utah Medical Products
  • Smith’s Medical
  • Elcam Medical
  • Medical intensive care
  • Argon Medical
  • Biosensors International
  • Medical Merit Systems
  • Shenzhen Antmed
  • B. Braun
  • Cook Regentec
  • PendoTECH
  • SCW Medicath
  • George Phillips
  • DeRoyal Industries
  • Lepu Medical
  • copper medical technology
  • medical ace
  • Biometrix B.V.
  • Metko Ltd.
  • Guangdong Baihe Medical
  • Tianck Medical

Disposable Pressure Transducers Market Split By Type:

  • Single channel transducers
  • Dual channel transducers
  • Three-channel transducers

Disposable Pressure Transducers Market Split By Application:

The Disposable Pressure Transducers Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Disposable Pressure Transducers Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Disposable Pressure Sensors market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=403765

Scope of the Disposable Pressure Transducers Market Report

Report attribute Details
Market size available for years 2021 – 2028
Base year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Disposable Pressure Transducers Market Analysis can be represented as follows:

Each regional Disposable Pressure Sensors industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global disposable pressure sensors market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-disposable-pressure-transducers-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. customers, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Prescription drugs

Anti-Obesity Prescription Drugs Market Key Vendors, Opportunities, In-Depth Analysis by Regional and Country Perspective

the Prescription Anti-Obesity Drugs Market The report covers the whole scenario of the global market including key players, their future campaigns, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. Its objective is to rationalize the company’s costs. You can also find interest and expense points on current income here. The best thing about the Prescription Anti-Obesity Drugs market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market that are highlighted here will go a long way in moving the business forward. Knowing the current market situation is the most important thing discussed here to help major players survive in the deadly market.

This Prescription Obesity Drugs Market study outlines the economic catastrophe caused by the covid-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to various industrial closures and loss of income. A high degree of information is offered here to assess the market situation.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=109105

The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures about the Prescription Anti-Obesity Drugs market and its important factors such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

Major Players Covered in Anti-Obesity Prescription Drugs Markets:

  • F Hoffmann La Roche SA
  • Alizyme
  • Arena Pharmaceuticals
  • Therapeutic Ordemanden
  • Boehringer Ingelheim
  • Novo Nordisk A/s
  • Lived
  • Glaxosmithkline

    Prescription Anti-Obesity Drugs Market Split By Type:

  • Orlistat
  • Phentermine and Topiramate
  • Bupropion and Naltrexone
  • Lorcaserin
  • Liraglutide

    Anti-Obesity Prescription Drugs Market Split By Application:

  • Pediatric
  • Adult

    The Prescription Anti-Obesity Drugs Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=109105

    Scope of Anti-Obesity Prescription Drugs Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Anti-Obesity Prescription Drugs report provides information about the market, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate for each region, country and sub-region over the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Aims and objectives of Anti-Obesity Prescription Drugs Market Research

    • Understanding the opportunities and advancements in Anti-Obesity Drugs determines the market strengths, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Prescription Anti-Obesity Drugs market and the dynamics of the Prescription Anti-Obesity Drugs in the market.
    • Categorize the Anti-Obesity Prescription Drugs segments with increasing growth potential and assess the market for the futuristic segment.
    • To analyze the most important trends related to the various segments which help decipher and convince the Prescription Anti-Obesity Drugs market.
    • Check region-specific growth and development in the Prescription Anti-Obesity Drugs Market.
    • Understand the major stakeholders of the Prescription Anti-Obesity Drugs market and the competitive image value of the Prescription Anti-Obesity Drugs market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Prescription Anti-Obesity Drugs Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Anti-obesity prescription drug historical distribution data from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=109105

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Prescription Obesity Drugs Market Segmentation by Types

    4 Prescription Obesity Drugs Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Core Products of Anti-Obesity Drugs Market by Major Countries

    7 North America Anti-Obesity Drugs Landscape Analysis

    8 Europe Obesity Drugs Landscape Analysis

    9 Asia-Pacific Obesity Drugs Landscape Analysis

    10 Latin America, Middle East and Africa Obesity Drugs Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account Manager

    WE: +1-970-672-0390

    E-mail: [email protected]

    Website: Reportsglobe.com

  • read more
    Medical supplies

    Prepackaged Medical Supplies Market Overview, High Growth Opportunities, Segmentation, Trends by 2022-2028

    the Prepackaged Medical Supplies Market The report covers the whole scenario of the global market including key players, their future campaigns, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. Its objective is to rationalize the company’s costs. You can also find interest and expense points on current income here. The best thing about the Prepackaged Medical Supplies market report is the provision of guidelines and strategies followed by major market players. The investment opportunities in the market that are highlighted here will go a long way in moving the business forward. Knowing the current market situation is the most important thing discussed here to help major players survive in the deadly market.

    This Prepackaged Medical Supplies Market study describes the economic disaster caused by the covid-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to various industrial closures and loss of income. A high degree of information is offered here to assess the market situation.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=134558

    The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures about the Prepackaged Medical Supplies market and its important factors such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

    The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

    Major Players Covered in Prepackaged Medical Supplies Market:

  • Angiokard Medizintechnik
  • Scientific Boston
  • B Braun Melsung
  • Med-Italia Biomedica
  • Molnlycke Healthcare
  • Social
  • Teleflex Medical
  • 3M Healthcare
  • Cardinal Health
  • Covidian
  • Cypress Medical Products
  • Hogy Medical
  • Medical action industries
  • Smith and nephew

    Prepackaged Medical Supplies Market Split By Type:

  • Needle and Syringe
  • Anesthesia kit
  • Protective equipment
  • General surgery and instrument kit
  • Other

    Prepackaged Medical Supplies Market Split By Application:

  • Hospital
  • Clinical
  • Family first aid
  • Other

    The Prepackaged Medical Supplies market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=134558

    Scope of the Prepackaged Medical Supplies Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Prepackaged Medical Supplies report provides information on the market area, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate for each region, country and sub-region over the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Goals and Objectives of Prepackaged Medical Supplies Market Research

    • To understand the Prepackaged Medical Supplies opportunities and advancements determines the market highlights, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Prepackaged Medical Supplies market and the dynamics of the Prepackaged Medical Supplies in the market.
    • Categorize the prepackaged medical supplies segments with increasing growth potential and assess the futuristic segment market.
    • To analyze the most important trends related to the different segments that help decrypt and convince the Prepackaged Medical Supplies market.
    • Check region-specific growth and development in the Prepackaged Medical Supplies Market.
    • Understand the major stakeholders in the Prepackaged Medical Supplies market and the competitive image value of the Prepackaged Medical Supplies market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Prepackaged Medical Supplies Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical distribution data for prepackaged medical supplies from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=134558

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Prepackaged Medical Supplies Market Segmentation by Types

    4 Prepackaged Medical Supplies Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Product Commodity Medical Devices Market by Major Countries

    7 North America Prepackaged Medical Supplies Landscape Analysis

    8 Europe Prepackaged Medical Supplies Landscape Analysis

    9 Asia Pacific Prepackaged Medical Supplies Landscape Analysis

    10 Latin America, Middle East and Africa Prepackaged Medical Supplies Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account Manager

    WE: +1-970-672-0390

    E-mail: [email protected]tsglobe.com

    Website: Reportsglobe.com

  • read more
    Medical supplies

    Samaritan’s Purse transports medical supplies to Ethiopia | News

    The Samaritan’s Purse DC-8 cargo plane carried more than 13 tons of essential medical supplies from Piedmont Triad International Airport in Greensboro to Ethiopia on February 15.

    These supplies, including two anesthesia machines, an X-ray machine and an ultrasound machine, were sent to Mersa Regional Hospital, which is the main provider of medical care for some 350,000 people.

    A Samaritan’s Purse press release said the hospital had been significantly affected by the violent internal conflict in the region and lacked the resources to effectively treat the sick and injured. It is in the Amhara region.

    “The situation in Ethiopia is heartbreaking. Many innocent people are caught up in the conflict and local healthcare facilities are unable to serve their patients due to a lack of resources,” said Franklin Graham, President of Samaritan’s Purse.

    “We are airlifting these desperately needed supplies to save lives and let the people of Ethiopia know that God loves them. Please join me in praying for peace and unity in this conflict-torn country.

    Fitsum Arega, Ethiopian Ambassador to the United States, joined Edward Graham, Vice President of Operations for Samaritan’s Purse, to see the plane take off and spoke about the partnership and the airlift.

    “I would like to thank you on behalf of the Ethiopian people for this generous donation,” Arega said. “People in the northern regions of Ethiopia have suffered greatly from the conflict and many hospitals and health centers have been looted and damaged due to the war. So many people are in distress. That you come to bless us with this kind of support tells us who you are. Thank you a lot. God bless you. We really need your prayers for the conflict to end and for peace to be restored in Ethiopia.

    Edward Graham said: “This is the fifth flight of our DC-8 to Ethiopia to some areas where hundreds of thousands of people are without medical care,” he said. “At the invitation of the Ethiopian government and the Ministry of Health, Samaritan’s Purse is able to respond and meet these immediate needs. And we do all of this in the name of Jesus Christ.

    He continued: “We want our neighbors to know that we care for them, and just like the story of the Good Samaritan, we meet the immediate need of those who are suffering and also take care of them in the long term and share the hope of Jesus Christ. , our Lord and Saviour.

    In addition to hospital resupply, Samaritan’s Purse launched a food program in eight schools in the conflict region to provide families with basic necessities.

    The scope of work includes a three-month food supply for at least 1,600 school-aged children. We will also provide water, sanitation facilities and hygiene items including soap, toothbrushes, toothpaste and water treatment supplies to provide safe drinking water.

    The plane was greeted upon arrival in the Ethiopian capital, Addis Ababa, by the country’s Minister of Health, Dr Lia Tadesse, as well as members of the Samaritan’s Purse Disaster Response Team. , which have responded to the needs created by the conflict in the Tigray and Amhara regions over the past year.

    Samaritan’s Purse has a long history in Ethiopia, dating back to 1989 when we installed fresh water wells and instituted agricultural programs in the country during widespread drought and famine.

    Samaritan’s Purse is based in Boone but has a major presence in North Wilkesboro with offices and warehouses.

    read more
    Medical supplies

    Zipline expands drone medical supply deliveries to Kenya

    Zipline, a global leader in instant logistics, is launching operations in another African country with on-demand drone deliveries of medical supplies to Kisumu County in Kenya.

    Under the agreement between the two parties, Zipline will establish a mode of operation similar to that originally rolled out in Rwanda in 2016, and has since improved and expanded through partnerships with Ghana, Nigeria and Côte d’Ivoire. ‘Ivory. Once its storage and flight management center in Kenya is ready, Zipline will conduct automated drone flights of medicines and supplies to health facilities in Kisumu County.

    The link is another example of how officials across Africa have turned to Zipline to create regular drone delivery networks of medical supplies to remote or hard-to-reach areas that often need them the most. . It’s part of a rapidly spreading ambition across the continent to create universal healthcare by taking treatment by air to underserved locations.

    “We have made great efforts to improve the overall delivery of health care to our people,” said Kisumu County Governor, HE Prof. Anyang’ Nyong’o. “It is therefore heartening to note that our mission to achieve universal health coverage is well on its way with this historic partnership which will ensure that no one is left behind because of their location.”

    Under the agreement, the new UAV logistics center in Kisumu County – a member of the Lake Region Economic Bloc (LREB) representing 14 million people, or 30% of Kenya’s population, will gradually serve health projects and clinics in 16 other western counties as well.

    “It is our commitment as LREB to deliver an aggressive program of building a robust health care delivery system that will serve not just the few, but the vast majority of people in LREB counties,” said LREB Chairman Wycliffe Oparany. “Zipline’s technology is one we can use to accelerate the transformation of our healthcare systems to deliver timely healthcare solutions to the people whose mandate we serve.”

    Once the new Zipline Logistics Center is operational, it will oversee on-demand drone deliveries of up to 1.8 kg of blood products, COVID-19 vaccines and other potentially life-saving medical supplies. The drone can cruise up to 110 km/h on round trips of up to 160 kilometers, even in adverse weather conditions, and it will operate seven days a week to ensure that healthcare payloads reach their destination in 30 minutes.

    In addition to just-in-time deliveries of urgent medications, routine flights of medical supplies by Zipline drones will help facilities avoid running dangerously low on supplies.

    “We’ve seen how on-demand automated delivery can transform healthcare systems to make them more efficient, effective and equitable,” said Keller Rinaudo, CEO of Zipline, which also operates in the United States. “Zipline’s expansion into Kenya, our seventh country, in partnership with Kisumu County, is a critical step in extending these important benefits to more communities around the world.”


    Subscribe to DroneDJ on YouTube for exclusive videos

    read more
    Medical products

    2021 Enforcement Review: FDA Regulated Medical Products – Food, Drug, Healthcare, Life Science


    United States: 2021 Enforcement Review: FDA Regulated Medical Products

    To print this article, all you need to do is be registered or log in to Mondaq.com.

    Although the continuing public health emergency related to COVID-19 remained an obstacle to many Food and Drug Administration (“FDA”) inspections in 2021, the pandemic did not prevent criminal and civil actions. related to major violations of FDA regulations, particularly matters that have been under investigation since before the pandemic. The Department of Justice (“DOJ”) has announced numerous indictments, civil and criminal settlements, and criminal convictions involving individuals accused of violating the Federal Food, Drug, and Cosmetic Act (“FDCA”) ) and other laws related to product schemes. COVID-19 fraud remained a top priority, as did cases involving opioids and clinical trial fraud.

    This app review of 2021 covers major criminal and civil actions against life sciences companies, starting with those related to the ongoing COVID-19 pandemic. It then discusses actions involving the illicit distribution of opioids, which continue to be a DOJ priority, and then focuses on a new area of ​​interest for law enforcement: clinical trial fraud. The article then examines other enforcement actions brought under the FDCA and related criminal statutes, as well as civil misrepresentation law, which are based on a somewhat broader variety of alleged violations of the FDA regulations. The article ends by looking forward to what FDA-regulated companies can expect on the enforcement horizon in 2022.

    The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

    POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

    read more
    Medical products

    Analysis of investments in the axillary crutches market

    A new research study from JCMR with the title Global Axillary crutches Market Research Report 2021 provides an in-depth assessment of Armpit Crutches, including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies and strategies. Research Study Provides Predictions For Axillary Crutches investments until 2029.

    The report includes the latest post-pandemic market research on the Axillary Crutches market.

    Competitive Analysis: Cardinal Health, Home Medical Products Inc, New York Millennium Pharmaceutical, AMG Medical, BREG, Chinesport, Dr. Med, Mikirad, Ossenberg GmbH,

    Request Free Sample PDF Report @: jcmarketresearch.com/report-details/97013/sample

    Frequently Asked Questions:

    • How fast is the market expected to grow

    Year-over-year growth for 2021 is estimated at XX% and additional growth for Armpit Crutches market is estimated to be USD xxx million.

    Get Up To 40% Off Corporate Copy & Customization available for the following regions and countries: North America, South and Central America, Middle East and Africa, Europe, Asia-Pacific

    • Who are the key players in the Axillary Crutches market?

    Cardinal Health, Home Medical Products Inc, New York Millennium Pharmaceutical, AMG Medical, BREG, Chinesport, Dr. Med, Mikirad, Ossenberg GmbH,

    • What are the key drivers and challenges for the Axillary Crutches Market?

    The demand for ASW capacity building is one of the major factors driving the axillary crutches market.

    • What is the size of the armpit crutches market in North America?

    The North America region will contribute XX% of the Axillary crutches market share

    Survey for Axillary Crutches Segment [email protected]/report-details/97013/enquiry
    This customized Arm Crutches report will also help clients track new product launches in the direct and indirect markets related to COVID-19, upcoming vaccines and pipeline analysis, and significant developments in the operations of the suppliers and government regulations.

    Geographical analysis of axillary crutches:

    • Axillary crutches industry North America: United States, Canada and Mexico.

    • Axillary crutches industry South and Central America: Argentina, Chile and Brazil.

    • Axillary crutches industry Middle East and Africa: Saudi Arabia, United Arab Emirates, Turkey, Egypt and South Africa.

    • Armpit crutches industry Europe: United Kingdom, France, Italy, Germany, Spain and Russia.

    • Asia-Pacific armpit crutches industry: India, China, Japan, South Korea, Indonesia, Singapore and Australia.

    Market Analysis by Types & The market analysis by applications is as follows:

    [Segments]

    Some of the Points Covered in the Global Axillary Crutches Market Research Report are:

    Chapter 1: Global Axillary Crutches Market Overview (2013-2025)
    • Definition of axillary crutches
    • Specifications of axillary crutches
    • Classification of axillary crutches
    • Applications of axillary crutches
    • Axillary crutches regions

    Chapter 2: Axillary Crutches Market competition by players/suppliers 2013 and 2018
    • Axillary Crutches Manufacturing Cost Structure
    • Raw material and suppliers of axillary crutches
    • Axillary crutches manufacturing process
    • Industry Chain Structure of Armpit Crutches

    Chapter 3: Axillary Crutches Sales (Volume) and Revenue (Value) by Region (2013-2021)
    • Sales of axillary crutches
    • Axillary crutches revenue and market share

    Chapter 4, 5 and 6: Global Axillary Crutches Market by Type, Application and Player/Supplier Profiles (2013-2021)
    • Armpit Crutches Market Share by Type and Application
    • Growth rate of Underarm Crutches by type and application
    • Factors and opportunities of axillary crutches
    • Basic information about axillary crutches company

    Continue……………

    Note: Please share your budget by call/mail. We will try to meet your needs. @ Call: +1 (925) 478-7203 / E-mail: [email protected]
    Find more research reports on Axillary crutches industry. By JC Market Research.

    Thank you for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

    About the Author:

    JCMR’s global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities, but also to empower and inspire you to create visionary growth strategies for the future, through our extraordinary depth and breadth of thought leadership, research, tools, events and experience. that help you turn your goals into reality. Our understanding of the interplay between industry convergence, megatrends, technologies and market trends provides our clients with new business models and opportunities for expansion. We are focused on identifying the “Accurate Forecast” in each industry we cover so that our clients can reap the benefits of being early market entrants and can achieve their “Goals and Objectives”.

    Contact us: https://jcmarketresearch.com/contact us

    JCMARKETRESEARCH

    Mark Baxter (Business Development Manager)

    Call: +1 (925) 478-7203

    E-mail: [email protected]

    Connect with us at – LinkedIn

    read more
    Medical supplies

    An ambulance and medical supplies headed from the capital region to the epicenter of last year’s deadly earthquake in Haiti – The Daily Gazette

    Ballston Spa and Schenectady Rotarians, along with Saratoga County officials, recently joined forces to ship a used ambulance and medical supplies to one of the world’s least developed countries.

    Thanks to two local Rotarians, a surplus ambulance belonging to the Community Emergency Corps. from Ballston Spa is en route to Port-au-Prince, the capital of Haiti, with its ultimate destination Les Cayes, a port city about an eight-hour drive southwest.

    Les Cayes was the chosen destination for the ambulance as it is the epicenter of a 7.2 magnitude earthquake which struck on August 14, killing more than 2,200 people, injuring nearly 13,000 and more of 300 missing, as well as property damage estimated at $1.5. billion.

    The non-profit organization Ballston Spa had to take the ambulance out of service because it had received a new one, Ray Otten, executive director of the Community Emergency Corps, said this week.

    The trade-in value for used ambulances is $3,000 to $5,000, basically peanuts for a vehicle that costs between $150,000 and $200,000 when bought new, said Otten, a Rotarian from Ballston. Spa.

    The director determined that donating it to the country in need would be the best course of action, and with proper maintenance, the ambulance could still have five to 10 years of life, he said.

    Otten said he had heard of responders in Haiti using pickup trucks and station wagons — anything they could get their hands on — to transport sick patients.

    Additionally, Otten said he hates waste.

    “So when you combine those values, we being EMTs, we tend to understand that we need to help where we can,” Otten said. “If we have something that maybe someone could use, why not? We have to take care of each other.”

    Otten contacted Brian Merriam, a Rotarian from Schenectady who drove the capital area ambulance about 1,800 miles to Miami last week.

    While this project was in motion, Merriam solicited donations from his own Rotary club and others in the area. The effort generated more than $8,000, which was transferred to the Rotary Club of Camp-Perrin in Les Cayes.

    Merriam also carried 500 pounds of medical equipment — items such as backboards, stethoscopes, leg splints, EMS bags and even three CPR training dummies — that Saratoga County officials donated.

    Merriam cited Mike McEvoy of the Saratoga County Office of Emergency Services, Lori Prock of Saratoga County Public Health Services and Tracy Weir and the Waterford Rescue Squad for providing the medical equipment.

    In addition, Ellis Hospital donated a used ultrasound machine along with a stand and operating software, Merriam said.

    Medical equipment had to be shipped separately, rather than inside the ambulance, due to freight company rules.

    This posed a problem for boxing nine 6-foot panels, Merriam said. Luckily, a local funeral director had cremation “caskets” to hold the panels in place.

    Merriam said he traveled to Florida because he didn’t want to incur the cost of renting a flat bed. The cost of diesel was $3.80 to $4.19 a gallon, and on their best day of travel they got 15 miles per gallon.

    Otten said he was pleased to hear the ambulance had no mechanical problems en route to Miami.

    “These rigs don’t usually take those long runs,” he said.

    Merriam’s travel companion was his friend Chris Hedlund, a former EMT from Eau Claire, Wisconsin.

    This is the second time Merriam and Hedlund have driven and shipped a used ambulance to Carrefour, Haiti.

    In 2019, they drove a used ambulance that Hedlund helped secure from Mohawk Ambulance and the Mayo Clinic Ambulance Service. They drove 1,100 miles from Wisconsin to Schenectady, held a press conference in Electric Town, then drove 600 miles to Baltimore to have the ambulance dispatched to Haiti.

    Prior to this effort, Merriam said he mentioned to Hedlund to keep an eye out for ambulances, due to the huge need in Carrefour, Haiti.

    Merriam said his friend, Dr Dorgu Pettit-homme president of the Rotary Club of Camp-Perrin in Lecayes, will receive the ambulance which has been donated by the Ballston Spa organization.

    Although there is a fear that the ambulance will be stolen by gang communities in Port-au-Prince, Dr. Pettit-homme, who runs a Haitian clinic, and the others are hopeful that it will reach its destination, being given that it will be used to help a lot, Merriam said.

    Merriam, whose 126-year-old former family insurance company in Schenectady, Merriam Agency, was acquired last year by Arthur J. Gallagher & Co., says he wants to keep helping Haitians .

    “It’s really hard to appreciate how needy a country can be unless you’ve been there – and I’ve been going there since 1999,” he said. “I just fell in love with the place. The average Haitian earns $1,900 a year – so just a few dollars a day, if you’re doing well.

    Due to its corruption, violence, and gang activity—along with an average Haitian living to be 62 and an infant mortality rate 14 times higher than in the United States—Haiti is “a terrible place to live”, and Merriam said “anytime I can do anything for these people, I’m always happy to do it.

    Merriam said he would also like to help Carrefour with its garbage crisis.

    He said the town mayor asked him to dispatch a garbage truck.

    But it will be a challenge, Merriam said.

    “The garbage problem in Haiti is just amazing to see,” he said. “When you drive from the airport, you pass rivers filled with garbage. You can’t go in the water. It’s just wall-to-wall trash. And there are piles of garbage. Some of the piles will be set on fire. Others, you will have pigs digging and you will have humans digging.

    Merriam said he came to recognize the huge need in other parts of the world at the age of 15, when his father took him on trips to 24 countries covering most major continents in three month.

    “So when each of my three children turned 15, I brought them to Haiti with me so they could see how many people actually live in the world,” he said. “It’s only a four hour flight from JFK airport. It’s only a 90 minute flight from Miami. It is therefore a neighboring country to ours and the people live in terrible conditions.

    Contact journalist Brian Lee at [email protected] or 518-419-9766.

    More from The Daily Gazette:

    Categories: News, Saratoga County, Schenectady County

    read more
    Medical products

    Tetra Bio-Pharma partners with Avicanna to bring medical cannabinoid products to LATAM

    Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) is teaming up with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to bring Tetra’s products to Latin America.

    On Monday, the Ottawa-based cannabinoid drug developer revealed a non-binding terms sheet with Avicanna consisting of three strategic areas.

    The first involves the registration and marketing of Tetra’s prescription cannabinoid products through Avicanna’s sales channels in Latin America. The second provides co-development and support for Avicanna’s pharmaceutical pipeline through level clinical development and registration with Canadian regulatory authorities.

    The partnership also involves a supply of active pharmaceutical ingredients (APIs) from Avicanna for Tetra’s pharmaceutical pipeline.

    In a statement, Tetra’s chief commercial officer, Steeve Neron, said his company will need multiple reliable API vendors to support operations related to its painkiller QIXLEEF, which has a fixed ratio of THC and CBD that complies with regulations. cGMP from the United States.

    “QIXLEEF is Tetra’s proprietary investigational new drug and is currently being evaluated in two US FDA-cleared clinical trials,” says Neron.

    Avicanna’s established distribution channels in Latin America could help advance the commercialization of Tetra’s products in certain jurisdictions, he adds.

    Other Tetra products slated for commercialization include anti-nausea, cannabinoid drug REDUVO, bio-delivery technology AdVersa and painkiller CAUMZ.

    Read more: Avicanna Reports Record Sales of $1 Million

    Read more: Avicanna subsidiary obtains GACP certification in Colombia

    Avicanna CEO Aras Azadian said Tetra has proven to be a pioneer in cannabinoid-based pharmaceuticals.

    “As the global industry continues to mature and focus on evidence-based medicines, the two companies are well positioned to work synergistically on multiple projects and leverage their leadership position to achieve successful business outcomes. “

    Under the Aureus brand, Avicanna sells raw materials in 12 countries and offers seeds, flowers, full-spectrum extracts and other isolated cannabinoids like CBD.

    The products come from its majority-owned Colombian subsidiary Santa Marta Golden Hemp SAS, which is GACP-certified and has USDA National Organic Program certification for its hemp cultivar.

    The company also has patent-pending drug candidates that are in various stages of clinical development and commercialization.

    Its RHO Phyto brand includes medical and wellness products with different ratios of CBD and THC in different forms such as creams, pills and transdermal patches.

    Follow Mugglehead on Twitter

    Like Mugglehead on Facebook

    Follow Natalia Buendia Calvillo on Twitter

    [email protected]

    read more
    Generic drugs

    Bureau of Generic Medicines 2021 Annual Report

    Message from the director

    Welcome to the seventh annual report of the Office of Generic Drugs (OGD) of the Center for Drug Evaluation and Research (CDER) of the United States Food and Drug Administration (FDA).

    Ensuring that patients who need safe and effective drugs have better access to them is a public health priority for the FDA. As you will read in this report, the priority of access to more affordable medicines goes hand in hand with OGD’s mission to ensure that affordable, high-quality generic medicines are available to the American public. In this report, I am pleased to share with you a snapshot of our successes.

    Currently, 90% (9 out of 10) of all prescriptions dispensed in the United States are for generic drugs. To make this possible, the Generic Drug Program approves safe, effective, high-quality drugs and monitors these drugs once they hit the market.

    How did we do in 2021?

    Last year, the Generic Drug Program approved hundreds of abbreviated new drug applications (ANDAs) and thousands of application supplements. Our office has prioritized the evaluation of generic drug submissions for potential treatments and supportive therapies for patients with COVID-19, approving more than 75 original ANDAs, some in record time,1 and since the start of the pandemic, more than 1,200 supplements. We have funded approximately $20 million in science and generic drug research programs. We published 149 product-specific guidelines for generic drug development, including 54 for more difficult-to-develop complex drugs, to support agency thinking on the most appropriate methodology and evidence needed to support development specific generic drugs.

    Innovation has helped ensure public access to more affordable medicines

    In 2021, OGD’s scientific and programmatic innovations supported our generic drug evaluation work. For example, we have established the scientific basis to support alternative bioequivalence (BE) approaches for several generic drugs. One such example included a novel in vitro BE approach that directly led to the development, evaluation and approval of the first generic difluprednate (Generic Durezol) ophthalmic emulsion used to treat ocular swelling and pain after eye surgery.

    Another innovation came with the approval this year of the first generic paliperidone palmitate extended-release injectable suspension (Generic Invega Sustenna), a long-acting injectable indicated for the acute and maintenance treatment of schizophrenia in ‘adult. The FDA has developed modeling and simulation approaches for pharmacokinetic study designs and BE assessments, which the applicant has used. In yet another example, we approved the first generic complex for injection of ferumoxytol (generic Feraheme), a parenteral (non-oral) iron product that treats iron deficiency anemia. Our scientific investment in product characterization and advanced BE study designs were key to this approval. Another programmatic innovation successfully deployed was increasing the frequency of certain updates from monthly to bi-monthly in the FDA’s electronic Orange Book. This change in the frequency of updates provides even more timely information on listed pharmaceutical products, including their market status.

    Scientific and regulatory collaboration has moved the needle

    Sally Choe, Ph.D. Director, Bureau of Generic Drugs

    Scientific and regulatory collaborations have helped us create new approaches to support generic drug review in 2021.

    FDA’s partnership with the University of Maryland and the University of Michigan (the Complex Generics Research Center) has reached thousands of stakeholders around the world with workshops that have stimulated innovative dialogue and generated new insights into science and research crucial to the development of complex generic drugs.

    Additionally, the continued implementation of the Competitive Generic Therapy (CGT) pathway established by Congress helped us reach an important milestone in 2021: approving 100 ANDAs designated as CGTs. The CGT pathway for generic drugs helps incentivize market entry of drugs with ‘inadequate generic competition’. This milestone is a sign that the CGT program is achieving its goal – the development and marketing of safe and effective generic drugs in areas of the market that previously had little or no competition.

    Globally, 2021 marked the launch of a joint FDA and European Medicines Agency pilot program to provide parallel scientific advice to developers of complex generic drugs. The pilot project allows reviewers from both agencies to simultaneously communicate their views on scientific issues, in real time, to manufacturers working on the development of complex generic drugs. This collaboration can help shorten the time it takes for these important products to gain regulatory approval. The FDA also launched the Global Generic Drug Cluster, the first forum created for major regulatory agencies to increase scientific alignment around topics relevant to generic drug development.

    In 2021, despite the unique challenges caused by the ongoing pandemic, OGD continued to innovate and conduct scientific research to advance the generic drug agenda. Today, the generic drug program is stronger than ever and continues to take timely steps to improve access to generic drugs. As always, this is good news for the American public.

    Sally Choe, Ph.D.
    Director, Bureau of Generic Drugs

    read more
    Medical products

    Proctology Table Market Size and Forecast by 2029

    New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global Proctology Table Market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global proctology table market, analysts have segmented the market on the basis of applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Proctology Table market.

    Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the evaluation of these vendors’ financial outlook, proctology table market growth strategy and expansion plan during the forecast period. All information presented in the Global Proctology Table Market research report has been certified by market experts.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=308775

    The report includes a detailed segmentation study of the global Proctology Table market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the Global Proctology Table Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Proctology Table Market.

    Major Players Covered in Proctology Table Markets:

    • AR-EL MEDICAL PRODUCTS
    • promotional
    • INDUSTRIAL ECHOME
    • SCHMITZ and. Sohne
    • B?Çakc?lar
    • NQR
    • Wardray premise

    Proctology Table Market Split By Type:

    • Adjustable Proctology Table
    • Non-Adjustable Proctology Table

    Proctology Table Market Split By Application:

    • Hospital
    • Clinical
    • Ambulatory surgery centers

    The Proctology Table Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Proctology Tables market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a comprehensive picture of the global Proctology Tables market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=308775

    Scope of the Proctology Tables Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    The Regional Proctological Table Market Analysis can be represented as follows:

    Each regional sector of the Proctological Table is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    On the basis of geography, the global Proctology Table market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-proctologic-table-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US Toll Free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical supplies

    In-depth research of the global latex-free medical supplies market, industry statistics 2022

    the Latex-Free Medical Supplies Market The report covers the entire global market scenario including key players, their future campaigns, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. Its objective is to rationalize the company’s costs. You can also find interest and expense points on current income here. The best thing about the Latex-Free Medical Supplies market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market that are highlighted here will go a long way in moving the business forward. Knowing the current market situation is the most important thing discussed here to help major players survive in the deadly market.

    This Latex-Free Medical Supplies Market study describes the economic disaster caused by the covid-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to various industrial closures and loss of income. A high degree of information is offered here to assess the market situation.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=131898

    The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures about the Latex-Free Medical Supplies market and its important factors such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

    The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

    Key Players Covered in Latex-Free Medical Supplies Market are:

  • Unigloves
  • Davis Schottlander and Davis
  • Hair salon
  • Ansel
  • Aurelia gloves
  • BM Polyco
  • Medline Industries
  • Robinson Healthcare
  • Paul Hartman
  • HPC Healthline
  • Biological examination
  • shermond
  • Ambu
  • Cardinal Health Inc.
  • Fannin
  • Alliance Rubber Co.

    Latex-Free Medical Supplies Market Split By Type:

  • Latex-free tourniquets
  • Latex-free glove
  • Latex-free breathing bag

    Latex-Free Medical Supplies Market Split By Application:

  • Hospital
  • Clinical
  • Other

    The Latex-Free Medical Supplies Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=131898

    Scope of the Latex-Free Medical Supplies Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Latex-Free Medical Supplies report provides information on the market area, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate for each region, country and sub-region over the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Goals and Objectives of Latex-Free Medical Supplies Market Research

    • To understand the Latex-Free Medical Supplies opportunities and advancements determines the market highlights, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Latex-Free Medical Supplies market and the dynamics of Latex-Free Medical Supplies in the market.
    • Categorize the latex-free medical supplies segments with growing growth potential and assess the market for the futuristic segment.
    • To analyze the most important trends related to the various segments which help decipher and convince the Latex-Free Medical Supplies market.
    • Check region-specific growth and development in the Latex-Free Medical Supplies Market.
    • Understand the major stakeholders in the Latex-Free Medical Supplies market and the competitive image value of the Latex-Free Medical Supplies market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Latex-Free Medical Supplies Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical breakdown data for latex-free medical supplies from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=131898

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Latex-Free Medical Supplies Market Segmentation by Types

    4 Latex-Free Medical Supplies Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Product Commodity Latex-Free Medical Supplies Market by Major Countries

    7 North America Latex-Free Medical Supplies Landscape Analysis

    8 Europe Latex-Free Medical Supplies Landscape Analysis

    9 Asia Pacific Latex-Free Medical Supplies Landscape Analysis

    10 Latin America, Middle East and Africa Latex-Free Medical Supplies Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account manager

    WE: +1-970-672-0390

    E-mail: [email protected]

    Website: Reportsglobe.com

  • read more
    Prescription drugs

    Prescription Animal Drugs Market Size and Forecast by 2029 – Sox Sphere

    New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global animal prescription drug market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global animal prescription drugs market, analysts have segmented the market on the basis of applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Animal Prescription Drugs market.

    Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the assessment of these vendors’ financial prospects, Pet Prescription Drugs market growth strategy and expansion plan during the forecast period. All information presented in the Global Animal Prescription Drugs Market research report has been certified by market experts.

    Get | Download Sample Copy with TOC, Charts and List of Figures @ https://www.marketresearchintellect.com/download-sample/?rid=228630

    The report includes a detailed segmentation study of the global Animal Prescription Drugs market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the attractiveness index of the segment, allowing players to inform about the profitable revenue pockets of the global Animal Prescription Drugs Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus on the right areas of the global Animal Prescription Drugs Market.

    Major Players Covered in Animal Prescription Drugs Market:

    • Elanco Animal Health
    • Ceva Animal Health
    • MSD Animal Health
    • Zoetis
    • Virbac
    • Dechra
    • Vetoquinol
    • animal group
    • Ourofino Sauce Animal
    • Boehringer Ingelheim

    Animal Prescription Drugs Market Split By Type:

    • oral-type
    • Smear type
    • Type of injection
    • Type of spray

    Animal Prescription Drugs Market Split By Application:

    • Pet
    • Livestock

    The Animal Prescription Drugs Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Animal Prescription Drugs Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Animal Prescription Drugs market and its growth potential in the coming years. .

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=228630

    Scope of the Animal Prescription Drugs Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Base year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Analysis of the Animal Prescription Drugs Market can be represented as follows:

    Each regional Veterinary Drugs industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global animal prescription drug market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-animal-prescription-drugs-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. customers, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical products

    Swab Market Size and Growth

    New Jersey, United States,- This swab market The report includes an in-depth competitive analysis with the aim of estimating financial growth and maximizing the company’s profit potential. It helps in making reasonable investment decisions based on consumer needs. It also forecasts the overall growth of the market over the years 2022-2029. It displays objective data useful for professional industry analysis, as well as consumer buying habits. This Swab market research also makes it easy to know the likes and dislikes of different customers, which helps the company generate significant revenue. It serves as a comprehensive reference guide for key new businesses to learn about industry variables and business methodologies that will help them grow their business in the market. New participants will gain a solid understanding of how to run a successful business by executing tactics such as acquisitions, partnerships and new product launches. The market growth statistics presented here are backed by hard facts and figures. The data collected here at a granular level is very useful for predicting productivity.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketreports.com/download-sample/?rid=32528

    This Swabs Market report study examines the sales in depth. It is also a useful tool for participants, suppliers and players. Market research assessment constantly attempts to conduct surveys to provide accurate market insights. It explains how COVID-19 has impacted key market segments. It also explains how COVID-19 will impact each industry for years to come. Business owners can make the right decisions to stand out from their competitors with the help of such unique and excellent market analysis. The scope of this Swabs market report also helps in identifying the best opportunities to earn big profit. When launching a new product or entering the market as a beginner, it’s usually a good idea to check out a solid market report. It also describes how these industries are trying to recover from their dire situation. This Swabs Market report helps companies to increase sales and maintain reputation by providing up-to-date marketing data.

    Key Players Mentioned in the Swabs Market Research Report:

    Puritan Medical Products, Sarstedt, MWE, SARSTEDT, Clean Cross, GPC Medical, Citotest Labware Manufacturing, Q-TIPS, ELMEX

    Swabs Market Segmentation:

    By Product Type, the market is primarily split into:

    • Absorbent cotton
    • Non-absorbent cotton

    By application, this report covers the following segments:

    • Pharmaceutical
    • Microbiological
    • Laboratory
    • Others

    Get a discount on the purchase of this report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=32528

    Scope of Swabs Market Report

    ATTRIBUTES DETAILS
    ESTIMATED YEAR 2022
    YEAR OF REFERENCE 2021
    FORECAST YEAR 2029
    HISTORICAL YEAR 2020
    UNITY Value (million USD/billion)
    SECTORS COVERED Types, applications, end users, and more.
    REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

    Geographic segment covered in the report:

    The Swab report provides information on the market area, which is further sub-divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region over the estimated period.

    • North America (USA and Canada)
    • Europe (UK, Germany, France and rest of Europe)
    • Asia-Pacific (China, Japan, India and the rest of the Asia-Pacific region)
    • Latin America (Brazil, Mexico and rest of Latin America)
    • Middle East and Africa (GCC and Rest of Middle East and Africa)

    Answers to key questions in the report:

    1. Who are the top five Swab market players?

    2. How will the swab market evolve over the next five years?

    3. Which product and application will occupy the lion’s share of the Swab market?

    4. What are the Swab Market drivers and restraints?

    5. Which regional market will show the strongest growth?

    6. What will be the CAGR and size of the Swab market throughout the forecast period?

    For more information or query or customization before buying, visit @ https://www.verifiedmarketreports.com/product/global-swab-market-size-and-forecast-to-2025/

    Visualize the swab market using verified market intelligence:-

    Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

    VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

    Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

    Most Popular Reports

    Global Wearable Skin Patches Market Size and Forecast

    Global Fetal Monitoring Market Size and Forecast

    Global dental consumables market size and forecast

    Global Automated Hospital Bed Market Size and Forecast

    Global Urinalysis Testing Market Size and Forecast

    Global Swabs Market Size and Forecast

    Global Lichen Nitidus Treatment Market Size and Forecast

    Global Wolff Parkinson White Syndrome Market Size and Forecast

    Global Hammertoe Market Size and Forecast

    Global Hydronephrosis Market Size and Forecast

    About Us: Verified Market Reports

    Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

    We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

    Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

    Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

    Contact us:

    Mr. Edwyne Fernandes

    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    E-mail: [email protected]

    Website: – https://www.verifiedmarketreports.com/

    read more
    Generic drugs

    Inhalation & Nasal Spray Generic Drugs Market Size, Scope, Growth – Teva, Sandoz (Novartis AG), Mylan, Allergan PLC – Sox Sphere

    New Jersey, United States,- the Generic Inhalation and Nasal Spray Market The report covers the entire global market scenario including key players, their future promotions, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. It aims to rationalize the expenses of the company. You can also find the current revenue generation rate and spend score here. The best thing about the Generic Drugs for Inhalation and Nasal Spray market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market highlighted here will be of great help in moving the business forward. Knowing the current state of the market is the most important thing covered here to help big players survive in the cutthroat market.

    This Generic Inhalation and Nasal Spray Drugs Market study outlines the economic catastrophe induced by the COVID-19 outbreak, which has affected all sectors of the business. A great global economic loss has occurred due to several industrial closures and loss of income. Here, a high degree of information is offered to assess the market situation.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketreports.com/download-sample/?rid=128218

    Key market observation is conducted to draw key conclusions about the growth of the business. In the Competitive Assessment section, this Generic Inhalation and Nasal Spray Drugs Market report sheds light on the list of manufacturers, market conditions, current trends, company profiles and market innovations. It becomes easy for the market players to seize the right opportunities as this report analyzes the weaknesses and strengths of the various competitors in detail. The regional market as well as applications analyzed here to provide the right business opportunities for the business players. This Generic Inhalation and Nasal Spray Drugs Market report is the perfect blend of customer performance and economic trends to enhance business ideas. It also facilitates the task of the main actors of the company by reducing the risks associated with the activity.

    Key Players Covered in the Generic Inhalation and Nasal Spray Market Research Report:

    Teva, Sandoz (Novartis AG), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Sun Pharma (Ranbaxy), Nephron Pharma, Beximco Pharma, Hikma (Roxane), XIANJU PHARMA

    Generic Inhalation and Nasal Spray Market Segmentation:

    By Product Type, the market is primarily split into:

    • Corticosteroids
    • Bronchodilators
    • Combinations
    • Decongestant sprays
    • Others

    By application, this report covers the following segments:

    • Asthma
    • COPD
    • Allergic rhinitis
    • Other

    Get a discount on the purchase of this report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=128218

    Scope of the Generic Drugs for Inhalation and Nasal Spray Market Report

    ATTRIBUTES DETAILS
    ESTIMATED YEAR 2022
    YEAR OF REFERENCE 2021
    FORECAST YEAR 2029
    HISTORICAL YEAR 2020
    UNITY Value (million USD/billion)
    SECTORS COVERED Types, applications, end users, and more.
    REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

    Geographic segment covered in the report:

    The Inhalation & Nasal Spray Generic Drugs report provides information about the market, which is sub-divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region over the estimated period.

    • North America (USA and Canada)
    • Europe (UK, Germany, France and rest of Europe)
    • Asia-Pacific (China, Japan, India and the rest of the Asia-Pacific region)
    • Latin America (Brazil, Mexico and rest of Latin America)
    • Middle East and Africa (GCC and Rest of Middle East and Africa)

    Answers to key questions in the report:

    1. Who are the top five players in the Generic Inhalation and Nasal Spray market?

    2. How will the generic inhaler and nasal spray market develop over the next 5 years?

    3. Which products and applications will capture the lion’s share of the Generic Inhalation and Nasal Spray market?

    4. What are the drivers and restraints of the Generic Inhalation and Nasal Spray market?

    5. Which regional market will show the strongest growth?

    6. What will be the CAGR and size of the Generic Inhalation and Nasal Spray market throughout the forecast period?

    For more information or query or customization before buying, visit @ https://www.verifiedmarketreports.com/product/global-inhalation-nasal-spray-generic-drugs-market-report-2019-competitive-landscape-trends-and-opportunities/

    Visualize the Generic Inhalation and Nasal Spray Market using Verified Market Intelligence:-

    Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

    VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

    Visualize the Generic Inhalation and Nasal Spray Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

    Most Popular Reports

    Global Pediatric Pulse Oximeter Market Size and Forecast

    Global Guanine Market Size and Forecast

    Global Solid Oral Contraceptives Market Size and Forecast

    Global Personal Emergency Response Systems (Pers) Market Size and Forecast

    Global Pipette Fillers Market Size and Forecast

    Global Heparin Market Size and Forecast

    Global Vacutainer Tubes Market Size and Forecast

    Global Generic Drugs for Inhalation and Nasal Spray Market Size and Forecast

    Global Capillary Blood Collection Tube Market Size and Forecast

    Global Nasal Cannulas Market Size and Forecast

    About Us: Verified Market Reports

    Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

    We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

    Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

    Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

    Contact us:

    Mr. Edwyne Fernandes

    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    E-mail: [email protected]

    Website: – https://www.verifiedmarketreports.com/

    read more
    Prescription drugs

    Biden aims to revive efforts to fight expensive prescription drugs

    President Joe Biden will address the high cost of prescription drugs at an event on Thursday, an issue for which there is some bipartisan support and which could help the White House make progress on its stalled national agenda.

    AP: Biden stresses drug prices as he tries to revive agenda

    President Joe Biden is trying to revive progress on his stalled national agenda by refocusing attention on one of his most popular proposals, limiting the cost of prescription drugs. Biden is traveling to Culpeper, Va., on Thursday, where White House press secretary Jen Psaki said the president would draw attention to the “unacceptable” cost of the drugs. (Megerian, 2/10)

    Fox Business: Biden Trip to Emphasize Lower Drug Prices as He Tries to Revive Agenda

    President Biden will travel to Culpeper, Va., on Thursday and is expected to draw attention to the “unacceptable” cost of drugs in the United States as part of his effort to realize one of his key program proposals: limiting the cost of prescription drugs. The trip is seen as a chance to get his stalled national agenda back on track. Biden’s trip will also be an opportunity for him to begin promoting his party’s candidates in the November midterm elections. He is expected to appear alongside Rep. Abigail Spanberger, D-Va., who faces losing her seat representing a central Virginia district. Prescription drugs will be the focus of Biden’s visit. (Martin, 2/10)

    And the White House pushes back on crack pipe ‘misinformation’ –

    The Hill: White House challenges reports on federal funds for crack pipes

    The Biden administration on Wednesday pushed back against what it called “misinformation,” saying a federal grant program intended to reduce harm to drug users does not include taxpayer funding for pipes that can be used. to smoke crack or methamphetamine. The Department of Health and Human Services (HHS) released a statement clarifying “no federal funding will be used directly or through subsequent reimbursement to recipients to put pipes into safe smoking kits.” (Samuel, 2/9)

    AP: No money for drug pipes: Feds quell social media storm

    Putting out a firestorm on social media, the Biden administration said Wednesday that a grant program to combat the harms of illicit drugs would not pay for safer pipes for smoking crack or meth. The White House has been put on the defensive as outrage from the political right, some of it racially charged, mounts online. “No federal funding will be used directly or through subsequent reimbursement to recipients to put pipes into safe smoking kits,” said Health and Human Services Secretary Xavier Becerra and drug policy adviser of White House Rahul Gupta in a joint statement. (Alonso-Zaldivar and Dupuy, 2/9)

    More details emerge after Biden science adviser resigns –

    Politico: Lander held on to vaccine maker’s stock for months

    As Biden’s top science adviser, Eric Lander, the head of the Office of Science and Technology Policy, publicly promoted Covid-19 vaccination efforts while having a significant financial investment in one of the vaccine makers, according to financial disclosures. Under the White House ethics accord Lander signed, he had 90 days to dispose of his shares after being confirmed by the Senate on May 28. While Lander lost most of those shares in June — including shares of BioNTech SE, the German biotech company and Pfizer’s Covid-19 vaccine partner — he waited until August 5 to sell the $500,000 to $1 million of remaining stock he held in that company. When Lander finally sold the stock 69 days after it was confirmed, it was the company’s second-highest price ever at $404.92 per share, after climbing more than $50 per share two days earlier. . (Thompson, 2/9)

    Stat: The fall of Eric Lander and the end of science’s ‘big ego’ era

    Eric Lander’s resignation as President Biden’s chief science adviser is not just a blow to a president’s plans to advance research, but a sign on the death march in a way to do science. It’s not quite “big science”, which leads nowhere. Call it “big ego”. In science, the “big ego” is not exactly a new phenomenon. But in recent decades it has grown with the emergence of researchers who can both handle the kind of gloveless debate that can mark academic discourse and mobilize vast resources to make certain kinds of scientific discoveries, like mapping genomes or understanding molecular changes in a cell. lead to cancer. (Herper, 2/9)

    This is part of the KHN Morning Briefing, a summary of health policy coverage by major news outlets. Sign up for an email subscription.

    read more
    Medical supplies

    Medical Supplies Market 2022 Key Global Industry Players, Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2028

    Overview of the medical supplies market

    Market Research Future (MRFR) expects medical supplies market reach around $132 billion by 2027. The market will continue to flourish at a breathtaking rate from 2020 to 2027, adds MRFR.

    Growth drivers and challenges

    Growing number of surgeries across the globe coupled with increasing cases of acute and chronic diseases would favor the medical supplies market over the next few years. The global market size is also aided by growing concerns over cross-contamination in hospitals as well as increasing base of elderly patients affected by a wide range of diseases. The notable increase in bone fractures along with the growing number of medical facilities in emerging countries would present exciting opportunities for major industry players in the coming years.

    The modernization of healthcare institutions in emerging countries, coupled with the dramatic increase in hospital admission rate due to the increase in disposable income, will also benefit the global market in the future. Manufacturers are focusing their efforts on developing medical supplies for a wide range of end-use sectors, for which they are increasingly using modern technologies. They use their own technologies or deploy technologies licensed from other vendors. These efforts by players to develop high-quality and efficient medical supplies, while keeping in mind the growing consumer demand and preferences, will be a major growth driver in the years to come.

    Get sample copy from “Medical Supplies Marketplace” @ https://www.marketresearchfuture.com/sample_request/2433

    Medical supplies market

    Key players

    Some of the major players in the medical supplies market are 3M Company (USA), Braun Melsungen AG (Germany). Johnson & Johnson (USA), Baxter International Inc. (USA), Medtronic plc (Ireland), Boston Scientific Corporation (USA), Thermo Fisher Scientific Inc. (USA) and Halyard Health, Inc. (United States)

    Medical supplies market Segmentation

    The medical supplies market has been considered for type, application, as well as end users.

    The types of medical suppliers listed in the MRFR analysis are blood collection tubes, infusion products, blood glucose test strips, dialysis consumables, wound care products, adult incontinence products, surgical fields, etc.

    The application-based segments covered by the MRFR study include wound care, urology, sterilization and anesthesia.

    The main end users in the global industry are clinics, nursing homes and hospitals.

    Browse full report details @ https://www.marketresearchfuture.com/reports/medical-supplies-market-2433

    Regional Analysis of the Medical Supplies Market

    During the assessment period, the global medical supplies market will be led by North America, given the surge in COVID-19 cases and the resulting increase in demand for a variety of medical supplies. Business growth in the United States is quite robust in response to frequent technical innovations and the launch of highly advanced new products. The North American market has a number of large manufacturers, such as Johnson & Johnson (USA), Boston Scientific Corporation (USA) and Thermo Fisher Scientific Inc. (USA), which offer extensive ranges of medical supplies with multiple applications.

    The second position in the global medical supplies market belongs to Europe, thanks to the booming healthcare sector and the imposition of strict policies and regulations aimed at reducing cross-contamination in hospitals. Medical supply manufacturers in Europe are focusing on strengthening their distribution networks and supply chains to meet growing demand, which is also supporting business growth.

    Asia-Pacific is expected to become the fastest growing market for medical supplies, owing to the incredible expansion of the healthcare industry and the accelerating number of surgeries. The rapid industrialization and growing manufacturing capabilities of emerging countries like the Philippines, India, China, and Vietnam are also adding value to the APAC market. Additionally, Japan and South Korea are gradually using industrial robots during the manufacturing process to increase the supply rate of medical supplies, which is expected to further expand the market share in the region.

    About the future of market research

    AT Future Market Research (MRFR), we enable our clients to unravel the complexity of various industries through our Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous Feed Research (CFR) and Studies market and advisory services .

    The MRFR team has the overriding goal of providing our clients with the highest quality market research and intelligence services. Our market research by products, services, technologies, applications, end users and market players for market segments at global, regional and country level, enables our clients to see more, know more and do more, which helps answer all their most important questions.

    In order to stay up to date with technology and industry work processes, the MRFR often plans and organizes meetings with industry experts and industrial visits for its research analyst members.

    Contact us:

    Market Research Future (part of Wantstats Research and Media Private Limited),

    99 Hudson Street, 5th Floor,

    New York, New York 10013

    united states of america

    +1 646 845 9312

    E-mail: [email protected]

    read more
    Medical supplies

    Medical Supplies Market to Witness Huge Growth by 2027

    New Jersey, United States,- The research approach of this Medical supplies market report is a mix of primary research, secondary research and expert panel assessments. Secondary research includes industry-related documents as well as press releases, annual reports, and research reports. Other sources for obtaining specific data on strategic expansion opportunities in this market report are trade journals, industry magazines, government websites and associations. The primary research involves conducting phone interviews with numerous industry experts as well as sending email questionnaires (email interactions) and in some cases face-to-face contact for a more comprehensive and unbiased review of this Medical Supplies Market report across multiple regions.

    Also, it captures the adverse effects of the COVID-19 virus on each country business sector. Some other crucial elements discussed here are buying attitude of customers, strategies followed by major players, key developments, price structure and market share. Topographical observation of the market is also done here on the market environment as well as competitor details. This Medical Supplies Market report helps in making the right investment in launching the product and earning huge profits.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=144345

    Business owners need to be aware of the latest marketing environment. With this knowledge, business owners thrive. The Medical Supplies market maps competitor reactions and enables business players to remain innovative and reduce business risks. This allows players to avoid repetitive mistakes in the business. One of the easiest ways to run a successful business is to get insightful data on market growth and learn more about market segmentation. The Medical Supplies Market report focuses on market segmentation to enable business owners to compare the progress. The competitive analysis conducted here for the forecast period 2022-2029 is of great help in helping market players to make relevant changes for the launch of the new product. It helps in understanding important statistics and the level of competition in the market.

    Key Players Mentioned in the Medical Supplies Market Research Report:

    Johnson & Johnson, Coloplast Group, Fresenius Medical care AG & Co. KGaA, Teleflex Incorporated, Terumo Japan, Stryker, Merit Medical Systems, Cook Medical, Abbott ConvaTec Group Plc.

    Medical Supplies Market Segmentation:

    Medical Supplies Market, By Type

    • Individual protection equipment
    • Disinfectants
    • Intubation and ventilation supplies
    • Infusion and injectable supplies
    • Diagnostic supplies
    • Others

    Medical Supplies Market, By Application

    • Cardiology
    • Infection control
    • Respiratory
    • Radiology
    • Wound care
    • Others

    Medical Supplies Market, By End User

    • Hospitals
    • Clinics/Doctors’ offices
    • Others

    Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=144345

    Scope of the Medical Supplies Market Report

    ATTRIBUTES DETAILS
    ESTIMATED YEAR 2022
    YEAR OF REFERENCE 2021
    FORECAST YEAR 2029
    HISTORICAL YEAR 2020
    UNITY Value (million USD/billion)
    SECTORS COVERED Types, applications, end users, and more.
    REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

    It becomes easy to determine the pulse of the market with this detailed analysis of the medical supplies market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

    Answers to key questions in the report:

    1. Who are the top five players in the medical supplies market?

    2. How will the medical supplies market evolve over the next five years?

    3. Which product and which application will occupy the lion’s share of the medical supplies market?

    4. What are the drivers and restraints of Medical Supplies Market?

    5. Which regional market will show the strongest growth?

    6. What will be the CAGR and size of the Medical Supplies market throughout the forecast period?

    For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/medical-supplies-market/

    Visualize the Medical Supplies Market Using Verified Market Intelligence:-

    Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

    VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

    Visualize the medical supplies market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

    About Us: Verified Market Research®

    Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

    Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

    At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

    Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

    Contact us:

    Mr. Edwyne Fernandes

    Verified Market Research®

    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US Toll Free: +1 (800)-782-1768

    E-mail: [email protected]

    Website:- https://www.verifiedmarketresearch.com/

    read more
    Medical products

    3 medical products stocks poised to beat this earnings season

    Despite the resurgences of COVID-19, so far the fourth quarter reporting cycle has shown improvement for the Medical products companies in the wider medical sector. It should be mentioned that the Medical is expected to be one of the seven fastest growing sectors in earnings in the fourth quarter.

    By the last Earnings overview, 33.9% of companies in the medical sector, accounting for nearly 53.7% of the market capitalization of the sector, reported profits through February 2. Profits improved 10% year over year on revenue up 12.1%. A total of 36.8% of corporate earnings and revenue beat Zacks’ consensus estimate.

    This dashboard highlights stability in the United States, thanks to the continued economic reopening amid the resurgence of COVID-19 cases. However, this resurgence has led to supply chain disruptions that persist. Additionally, several of the international markets affected by COVID are still suffering due to lower cash flow and difficult economic conditions.

    Companies in the medical products sector saw a sequential decline in collective business versus legacy core business in the third quarter. On a positive note, the fourth quarter reporting cycle so far has shown a recovery in these activities despite the resurgence of COVID-19. The substantial increase in vaccination campaigns has helped people gradually return to pre-pandemic normality. This, in turn, has likely resulted in some recovery in hospital visits and core hospital activities in the current reporting cycle, which in turn may have boosted non-COVID legacy activities and electives in the medical sector. Although companies are seeing a sequential recovery in their core business, the improvement in the overall trend is still below pre-COVID levels.

    Meanwhile, due to the resurgence of COVID-19 and rising case numbers, manufacturers of tests, vaccines and therapeutics have witnessed massive market uptake of their products and services. of COVID-related healthcare support in the fourth quarter. Diagnostic test stocks have so far seen phenomenal growth, driven by an increase in demand for COVID-19 tests, in line with industry trends. For example, in the fourth trimester, Abbott Laboratories‘ABT’s underlying legacy diagnostic activity continued to improve. This was due to strong sales of ABT’s COVID-19 tests thanks to strong demand for the BinaxNOW, Panbio and ID NOW rapid test platforms. Sales of Abbott’s rapid diagnostics and point-of-care diagnostics both grew organically.

    Stocks set to beat fourth-quarter earnings estimates

    Given the high degree of diversity in the medical products industry, finding the right stocks with the potential to beat estimates could be quite a task.

    However, our proprietary Zacks methodology makes this quite simple.

    We focus on actions that combine a positive effect ESP Earnings and a Zacks rank #1 (strong buy), 2 (buy) or 3 (hold). You can see the full list of today’s Zacks #1 Rank stocks here.

    Our research shows that for stocks with this combination, the chance of a positive earnings surprise is as high as 70%.

    The ESP of earnings provides the percentage difference between the most accurate estimate and the Zacks consensus estimate. You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

    Here we feature three stocks that are expected to top earnings estimates in this reporting cycle.

    Baxter International, Inc. BAX: Increased demand for acute therapy products due to the COVID-19 pandemic, and continuous renal replacement therapy (CRRT), related devices and consumables are likely to have boosted Acute business performance Baxter’s Therapies in Q4 2021. BAX’s strong product pipeline and expected launch of therapies and products may be reflected in Q4 revenue.

    The combination of Baxter’s ESP gains of +3.50% and a Zacks #2 ranking raises the possibility of an earnings surprise in the quarter to report.

    The company is expected to release its fourth quarter results on Feb. 17, before the market opens.

    Baxter International Inc. Awards and EPS Surprise

    Baxter International Inc. price-eps-surprise | Baxter International Inc. Quote

    Henry Schein, Inc. HSIC: According to the third quarter 2021 earnings call, the company has seen stronger demand in the global dental and medical markets as practices gradually reopen and global patient traffic has stabilized over the past few months. months, even in countries with stricter lockdown rules. . This recovery trend is expected to have continued through the fourth quarter, boosting the company’s revenue.

    HSIC is expected to release its fourth quarter 2021 results on February 15.

    Henry Schein has a +1.94% Earnings ESP and a #2 Zacks rank.

    Henry Schein, Inc. Awards and EPS Surprise

    Henry Schein, Inc. Awards and EPS Surprise

    Henry Schein, Inc. price-eps-surprise | Quote from Henry Schein, Inc.

    DENTSPLY SIRONA Inc. XRAY: DENTSPLY SIRONA’s Consumables segment is expected to have seen improved revenue in the fourth quarter. The rebound in sales of all product categories may have contributed to the increase. The Technology & Equipment segment may have shown growth in the reportable quarter, driven by recovery across all product categories.

    XRAY is expected to report its fourth quarter 2021 results on February 28.

    DENTSPLY SIRONA has a Gain ESP of +1.06% and a Zacks Rank #3.

    DENTSPLY SIRONA Inc. Price and EPS Surprise

    DENTSPLY SIRONA Inc. Price and EPS Surprise

    DENTSPLY SIRONA Inc. price-eps-surprise | Quote DENTSPLY SIRONA Inc.

    Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

    Just Released: Zacks Top 10 Stocks for 2022

    In addition to the investment ideas discussed above, would you like to know our top 10 buy and hold tickers for all of 2022?

    Last year 2021 Zacks Top 10 Stocks the portfolio generated gains as high as +147.7%. Now, a brand new portfolio has been selected from over 4,000 companies covered by the Zacks ranking. Don’t miss your chance to participate in this long term shopping

    Access the Top 10 Zacks Stocks for 2022 today >>

    Click to get this free report

    Abbott Laboratories (ABT): Free Inventory Analysis Report

    Baxter International Inc. (BAX): Free Stock Analysis Report

    DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis Report

    Henry Schein, Inc. (HSIC): Free Stock Analysis Report

    To read this article on Zacks.com, click here.

    Zacks Investment Research

    The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

    read more
    Generic drugs

    U.S. Generic Drugs Market Report 2021: Small

    Dublin, 07 Feb. 2022 (GLOBE NEWSWIRE) — The “Generic Drug Market in the United States, by Type (Generic to Small Molecule vs. Biosimilars), by Application, by Mode of Drug Delivery, by Form, by Source, by Distribution The Report Channel, by Region, Competition, Forecast and Opportunities, 2026” has been added to from ResearchAndMarkets.com offer.

    The U.S. Generic Drugs Market was valued at USD 70.78 Billion in 2020 and is expected to grow at a CAGR of 9.43% during the forecast period and may reach the market value of USD 126.74 Billion by 2026 .

    Factors such as the cost-effective nature of generic drugs and growing demand from developing economies are majorly responsible for this futuristic growth estimate of the generic drugs market in the United States over the next five years. Generic drugs do not require extensive research and development as in the case of prescription drugs and patent drugs.

    Market players and research institutes are investing heavily in patented pharmaceuticals. Moreover, FDA approvals for generic drugs are not required as generic drugs contain the same composition as that of the previously patented drug and thus support the growth of the generic drug market in the United States over the next five years . The healthcare industry in the United States, in terms of generic drugs, has gone from an 80% growth in 2020 to a previous growth of 20% in 2015.

    The increase in generic drug exports to developing economies like Kenya, India, etc. also justifies the growth of the US generic drug market over the next five years.

    The US generic drugs market is segmented on the basis of type, drug delivery route, form, manufacturing source, application, company, and regional distribution. Based on type, the market can be divided into generics and small molecule biosimilars. Small molecule generics are expected to register the largest market revenue shares and dominate the market segment over the next five years owing to their simpler and easier manufacturing processes.

    When producing small molecule generics, generic drug manufacturers are required to prove that the final product contains the same chemical compounds as the patented drug. With similar functions and pharmacokinetic properties, the generic small molecule is accepted. Additionally, the demand for cost-effective generic drugs is expected to further support the growth of the generic drug market in the United States over the next five years.

    Based on applications, the market can be fragmented into cardiovascular diseases, diabetes, neurology, oncology, infectious diseases, and others. Cardiovascular diseases are expected to dominate the market segment while recording the highest market revenue shares over the next five years owing to the increasing cases of cardiovascular diseases in the United States.

    Additionally, increased demand for treatment and extended medication protocols is driving the growth of cardiovascular disease sub-segment while sustaining the growth of the generic drug market in the United States over the next five years.

    The increase in pharmaceutical research and development for the oncology disease is expected to drive the growth of the oncology sub-segment and drive the growth of the US generic drug market over the next five years.

    Major market players in the United States leading the growth of the generic drugs market include:

    • Teva Pharmaceuticals USA, Inc.
    • Pfizer Inc.
    • Sandoz US
    • Endo Pharmaceuticals Inc.
    • Aurobindo Pharma USA, Inc.
    • Abbott Laboratories Inc.
    • Eli Lilly and company
    • Sun Pharma Inc.
    • Lupine Pharmaceuticals, Inc.
    • Zydus Pharmaceuticals USA Inc.

    Report Scope:

    Years considered for this report:

    • Historical years: 2016-2019
    • Reference year: 2020
    • Estimated year: 2021
    • Forecast period: 2022-2026

    Generic Drugs Market in the United States, by Type:

    • Generic Small Molecule
    • Biosimilars

    Generic Drugs Market in the United States, by Application:

    • Cardiovascular illnesses
    • Diabetes
    • Neurology
    • Oncology
    • Infectious diseases
    • Others

    Generic Drugs Market in the United States, by Mode of Drug Delivery:

    • Oral
    • Parenteral
    • Topical
    • Others

    Generic Drugs Market in the United States, by Form:

    • Tablet
    • Capsule
    • Injection
    • Others

    Generic drugs in the United States, by source:

    • In-house manufacturing
    • Contract manufacturing organizations

    Generic Drugs Market in the United States, by Distribution Channels:

    • Retail pharmacies
    • Online pharmacies
    • Hospital pharmacies
    • Others

    For more information on this report visit https://www.researchandmarkets.com/r/3b41r9

    • Generic drugs market in the United States

    
            
    read more
    Medical products

    Hot Melt Extrusion Medical Products Market Growth Analysis 2022, Industry Dynamics 2026

    The global Hot Melt Extrusion Medical Devices industry market study provides important insights that can help companies to set priorities, better position their businesses, devise well-thought-out business strategies and make business decisions. investment for the future. The report mainly includes the current status of the Hot Melt Extrusion Medical Products market, products, materials, services and other key aspects of the market. In this research, the report explores the status of the Hot Melt Extrusion Medical Products market in key regions. It includes an overview of how the Hot Extrusion Medical Devices industry fits into the global market landscape, key trends influencing market companies and consumers, and information about what players in the hot extrusion medical products market might want to focus to support and be competitive in the market. Marlet. The report studies the segments that are major contributors to the market and are expected to dominate the hot melt extrusion medical products market in the coming years.

    Request a sample report: https://www.orbisresearch.com/contacts/request-sample/6249201?utm_source=SLP

    Hot Extrusion Medical Products Market Key Players

    AbbVie
    Formex
    BASF Pharmaceuticals
    omipa
    Biogrund
    Lubrizol

    The report studies key parameters of the Medical Hot Melt Extrusion Products industry, including the macroeconomic situation, current status, research and development initiatives, and ongoing merger and acquisition activities. The report studies key indicators of the Hot Melt Extrusion Medical Devices industry defining the current economic situation and financial performance of the market. The major ongoing developments in the industry such as mergers and acquisitions and research and developments locally and globally are highlighted in the report.

    Hot Extrusion Medical Products Industry Different product categories include:

    Movies
    Taste masking
    Drug eluting devices
    Others

    The global hot extrusion medical products industry has a number of end-user applications, including:

    Research Laboratory
    Contract manufacturing organization
    Pharmaceutical companies

    The above mentioned activities from 2019 to 2021 are covered in the report with an assessment of pandemic effect on Medical Hot Melt Extrusion Products industry. Additionally, the changes that the pandemic brings to the market, new business models, supply and demand scenario, regulatory framework, technological innovations shaping the market. Then, the report focuses on the key developments that the hot melt extrusion medical products market will witness in 2021 and the developments that occurred in 2020 due to the pandemic. The hot melt extrusion medical products market drivers evident in the market in recent years are studied in the report. This detailed information presented in the report enables market players to make informed decisions and design innovative and sustainable business models.

    Investigate before accessing the report at: https://www.orbisresearch.com/contacts/enquiry-before-buying/6249201?utm_source=SLP

    What does the Hot Extrusion Medical Products Market report include?

    – Factors that may affect future business ventures.
    – The future growth rate and expected growth of the Medical Extruders industry and your business.
    – The business models and business strategies executed by players of the Hot Melt Extrusion Medical Products market.
    – Market, financial and other risks related to local and international commercial activities of hot melt extrusion medical products.
    – Global hot extrusion medical products market industry-related revenue.
    – The report highlights the opportunities arising from the pandemic for the hot melt extrusion medical products market players over the current and upcoming years.
    – The report includes details of revenue and market share losses suffered during the pandemic.
    – The report recognizes the drivers of change in the Hot Melt Extrusion Medical Devices industry ahead of 2020.
    – The risks and uncertainties that may arise in the Hot Melt Extrusion Medical Devices market are discussed in the report.
    – Segments or regions that have extreme growth potential and are expected to witness huge growth in the Hot Melt Extrusion Medical Devices market in the future are detailed in the report.
    – The report provides a neutral perspective of the global hot extrusion medical products market and its performance.
    – The report explains how players in the hot extrusion medical products market can adapt to the changing market.
    – Detailed details of supply chain operations by segment.
    – Financial and economic conditions of the Hot Extrusion Medical Products industry market.
    – Analysis of revenue growth of all business segments.

    About Us:

    Orbis Research (orbisresearch.com) is a one-stop-shop for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in delivering customized reports according to our clients’ requirements. We have complete information about our publishers and therefore are sure of the accuracy of the industries and verticals of their specialization. This helps our clients map their needs and we produce the perfect market research required for our clients.

    Contact us:

    Hector Costello
    Senior Manager – Client Engagements
    Central Highway 4144N,
    Suite 600, Dallas,
    Texas – 75204, USA
    Telephone number: United States: +1 (972)-362-8199 | IND: +91 895 659 5155
    Email ID: [email protected]

    Click here to see the full table of contents: https://www.orbisresearch.com/contact/purchase-single-user/6249201?utm_source=SLP



    read more
    Prescription drugs

    Cheaper prescription drug formulations could cut costs by 40%, study finds

    Rising prescription drug costs paid by insurers and consumers may be partly due to ordering more expensive formulations, according to a new study. File photo by John Angelillo/UPI | License picture

    February 4 (UPI) — In the United States, people can save up to 40% on prescription drug costs by switching to different formulations of the same drug, when available, according to research published Friday by the JAMA Health Forum.

    In the cost analysis of 28 drugs available in tablet or capsule form, 33% of prescription orders were placed for the high-priced formulation, the data showed.

    Similarly, for 21 drugs distributed as a cream or ointment, 47% of orders were for the most expensive formulation, the researchers said.

    If the lower-cost formulation had been ordered, expenses for the analyzed drugs — both in terms of out-of-pocket expenses and those covered by health insurance — would have been reduced by 42%, according to the researchers.

    “Our results shed light on the abrupt and often unexplained price variation that can exist between similar drug treatments,” study co-author Sunita Desai told UPI in an email.

    “They also underscore the need for greater price transparency to enable patients and providers to balance clinical and cost considerations when making treatment decisions,” said Desai, assistant professor of health at the population NYU School of Medicine in New York.

    Out-of-pocket costs, or expenses beyond what is covered by insurance, have increased in recent years in the United States, fueled at least in part by rising prices for brand name drugs and reduced availability of alternatives. generics, according to research.

    Studies have found that up to 18 million people nationwide cannot afford the medications they have been prescribed and an estimated 13 million skip doses or delay taking medication due to costs.

    According to Desai and his colleagues, drug prices can differ depending on a number of factors, including the formulation used.

    For example, amoxicillin, a commonly used antibiotic, is available in tablet or capsule form.

    In their analysis, the researchers found that the most expensive tablet formulation was ordered about 45% of the time, they said.

    If the cheaper capsule had been ordered instead, users of the prescription drug would have saved around 30% on out-of-pocket costs, according to the data.

    Similarly, hydrocortisone, which is used to treat rheumatoid arthritis, among other conditions, was ordered in its more expensive ointment formulation when the cheaper cream option would have saved patients around 10% of expenses, the researchers said.

    Although prescribing healthcare providers may prefer one formulation over another for convenience, safety, or effectiveness, increased transparency regarding price differences would allow patients and providers to make more informed decisions, according to the researchers.

    “Many drugs come in multiple formulations, and prices between two formulations can vary significantly,” Desai said.

    “In many cases, the convenience or clinical differences may be minor, and in those cases the patient and payer could save money if they knew about those price differences,” she said.

    read more
    Medical supplies

    Emergency Medical Supplies Market Expected For Unexpected Growth Globally, Key Players -Smith and Nephew Bayer Corporation. – Cleveland Sports Area

    New York, United States: Prospecting Emergency Medical Supplies Market report created by DECISIVE MARKET OVERVIEW explains an overview of global companies, including definitions, applications, industry chain construction and characterizations, etc. A precise evaluation of the CAGR rate over the forecast period of 2020-2027 has been instilled. A portion of the global market essentials are clarified like general usage and creation volume, absolute transaction and layout volume, importing, sending, hard stage examination, sales methodologies. expanded authorization, trading scenes, imperative limits for sufficient market valuation, market size, net margins, top-down value investigation, modern market guideline, asset management, etc. There are a portion of presentation designs in the world that are actually quite difficult to sort through. Along these lines, appropriate graphical representations are presented like bars, charts, graphs, etc. for an accurate understanding of these core presentation designs over the planned period of 2020-2027. The Gross Domestic Product is most likely the main element of the advertisement as it deals with the general development rate of the market. Different explanations behind its enhancement just like corruption are comprehensively amalgamated.

    To benefit from a sample copy of the report, visit @ https://www.decisivemarketsinsights.com/emergency-medical-supplies-market/15524773/request-sample

    Emergency Medical Supplies Market Segmentation-
    By type:
    Respiratory therapy devices, cardiac equipment, wound care consumables, diagnostic and monitoring equipment, patient treatment equipment, infection control products, personal protective equipment, other
    Per application:
    (cardiac care, respiratory care, traumatic injuries, other applications) End user (hospitals, ambulatory surgery centers, research and diagnostic laboratories, others)
    By key players: Smith and Nephew Bayer Corporation Becton and Dickinson Company Johnson and Johnson B. Braun Melsungen AG Stryker Corp. Medtronic plc Asahi Kasei Corporation Koninklijke Phillips NV GE Healthcare

    The COVID-19 pandemic has overwhelmed the entire global market and hampered its development significantly. Irrespective of these prevailing unfavorable circumstances, sorting out some vital systems is extremely crucial to track the maintainability of the overall market development.

    Please click on the link below if you intend to make a direct purchase @:-https://www.decisivemarketsinsights.com/emergency-medical-supplies-market/15524773/buy-now

    Why this Emergency Medical Supplies Market The report is valuable to the business:-
    Ø The most revised advances, just like the main continuous models of the world market, are completely clarified.
    Ø It contains a strong exam strategy with BCG and SWOT investigation inside and out and very framed.
    Ø The report outlines different effective methodologies as well as a set of refined approaches for additional essential business advancements.
    Ø An overview of the conduct and usefulness of the global market just like a global perspective available across the world has been given everywhere.
    Ø The CAGR rate over the fixed period of 2020-2027 has been accurately described.
    Ø Various time-limited procedures such as affiliate introduction, email promotion, etc. are completely joined.

    To inquire about the discount, please complete the form by clicking the link below:-https://www.decisivemarketsinsights.com/emergency-medical-supplies-market/15524773/request-discount

    Value chain investigation is a profoundly competent and modernized procedure applied by global market pioneers to properly sort out the arrangement of prime exercises that enhance the value of its end result and dissect these exercises as a whole for a huge cost reduction.

    Answers to key questions in this Emergency Medical Supplies Market report: –
    Ø What will be the effect of the COVID-19 pandemic on the development of the global market and what are the chances after the COVID-19 pandemic?
    Ø What are the fundamental limits that are vital for an accurate assessment of the market?
    Ø What are the important systems received by global pioneers for successful market development?
    Ø What will be the general economic situation in the next 6-7 years alongside its CAGR?
    Ø What are the various difficulties that a company is likely to face and what are the effective methods offered by mechanical specialists to overcome these overwhelming difficulties?

    In order to make a pre-order request, please click on the link below:-https://www.decisivemarketsinsights.com/emergency-medical-supplies-market/15524773/pre-order-enquiry

    Please contact us and our expert will get back to you within 30 minutes:

    Critical market insights
    Sunil Kumar
    Head of sales
    E-mail -[email protected]
    Website-https://www.decisivemarketsinsights.com/
    United States +18317045538
    UK +441256636046
    Address:- 26 Broadway, Suite 934, New York, 10004

    Social connections:
    Twitter-https://twitter.com/decisivemarket

    Linkedin-https://www.linkedin.com/company/decisive-markets-insights

    read more
    Prescription drugs

    In-depth research on emerging growth trends, regional status of major key players, driving factors, business strategies and industry size forecast to 2026 – Bristol City Supporters Trust

    The Non-prescription Drugs market report covers the whole scenario of the global market including key players, their future promotions, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. It aims to rationalize the expenses of the company. You can also find the current revenue generation rate and spend score here. The best thing about the Non-Prescription Drugs market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market highlighted here will be of great help in moving the business forward. Knowing the current market status is the most important thing covered here to help big players survive in the compatiator analysis market.

    This Non-Prescription Drugs Market study depicts the economic catastrophe induced by the COVID-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to several industrial closures and loss of income. Here, a high degree of information is offered to assess the market situation.

    Get Full Sample PDF Copy of Report: https://www.worldwidemarketreports.com/sample/720473

    The report helps to identify the major players in the non-prescription drugs market. It helps to analyze the competitive environment of the Non-Prescription Drugs market, including company overview, company total revenue, market opportunities, value, production sites and facilities , SWOT analysis, product details. The study also reveals the sales, revenue and market share of each market player included in this report for the period 2022-2026. It also helps to determine growth drivers and future prospects for the forecast schedule.

    The main key vendors in this market are: Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly , Teva, Bayer

    To understand how the impact of covid-19 is covered in these reports: https://www.worldwidemarketreports.com/covidimpact/720473

    By Product Type, the market is primarily split into: Branded Drugs, Generic Drugs

    By application, this report covers the following segments: Hospital, Clinic

    Regions Covered in the Non-prescription Drugs Market Report 2022:

    ✤ The Middle East and Africa (GCC countries and Egypt)
    ✤ North America (United States, Mexico and Canada)
    ✤ South America (Brazil etc.)
    ✤ Europe (Turkey, Germany, Russia UK, Italy, France etc.)
    ✤ Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

    Additionally, the report provides an overview of key market drivers, challenges, opportunities, and risks and vendor strategies. Key players are also profiled with their market shares in the discussed Global Non-prescription Drugs Market. Overall, this report covers the historical status, current status and future prospects of the global Non-prescription Drugs Market for 2016-2026.

    This Non-Prescription Drugs report provides a superior market perspective in terms of product trends, marketing strategy, future products, new geographic markets, future events, sales strategies, or actions or behaviors of clients. This market research presents actionable market insights with which sustainable and profitable business strategies can be created.

    For more information or query or customization before buying: https://www.worldwidemarketreports.com/quiry/720473

    Important report features:

    ✤ Detailed analysis of the Non-Prescription Drugs market
    ✤ Fluctuating industry market dynamics
    ✤ Detailed market segmentation
    ✤ Historical, current and projected market size in terms of volume and value
    ✤ Recent industry trends and developments
    ✤ Competitive Landscape of Non-prescription Drugs Market
    ✤ Strategies of key players and product offerings
    ✤ Potential and niche segments/regions showing promising growth
    ✤ A neutral perspective on the performance of the non-prescription drug market.

    Report on reasons to buy:

    ✤ The report analyzes the future growth of the non-prescription drugs market.
    ✤ To analyze various perspectives of the Non-prescription Drugs market using Porter’s Five Forces Analysis.
    ✤ Study on which product type is expected to dominate the market and which regions are expected to grow fastest during the forecast period.
    ✤ To recognize the new developments, Non-Prescription Drugs Market shares, and policies employed by key market players.
    ✤ Competitive landscape, including Non-Prescription Drugs market share of major players along with key policies accepted for development over the past five years.
    ✤ Comprehensive company profiles covering product offerings, key financial information, recent developments, SWOT analysis and strategies employed by the leading player in the non-prescription drugs market.

    Click here for full report: https://www.worldwidemarketreports.com/buy/720473

    Report customization : In any case, please contact our sales team, who will ensure that your requirements are met.

    Contact us:

    Global Market Reports,

    Tel: USA +1-415-871-0703

    UK +44-203-289-4040

    Japan +81-50-5539-1737

    E-mail: [email protected]

    Website: https://www.worldwidemarketreports.com/

    read more
    Medical products

    Foreign medical products attract medical travel to Hainan, China

    Lecheng International Medical Tourism Zone in eastern Hainan Island, says it is three years ahead of schedule for the registration of foreign medical products, with the authorization of more than 200 medical devices and drugs requiring a special license for use. With the advanced foreign medical technology in the area, the local authority says Chinese citizens and foreigners have the opportunity to seek treatment on the island without having to travel to other countries where these drugs and equipment are produced. . They also note that treatment costs have come down and claim that corneal transplants in Hainan will now cost seven times less than in the United States.

    By the end of 2021, the Zone had registered more than 200 imported medical devices and medicines. The list of reimbursable drugs covered by its insurance system includes 100 types of special medical products, 75% of which are produced by foreign pharmaceutical companies.

    39 of these devices and drugs are designed to treat cancer, 38 help in the rehabilitation of patients after injuries and illnesses, 31 are used in the field of ophthalmology and 28 are used in cardiology.

    The minimum “Lecheng” national insurance package for the purchase of pharmaceuticals is 39 yuan per year (6 US dollars) and 29 yuan (5 US dollars) for residents of Hainan. Over 1.7 million people bought it in 2020.

    The number of patients using them in Hainan has increased by 454 percent according to the Lecheng area administration, reaching its goal not in 2025, but three years earlier.

    Authorities remain vague on actual numbers for 2021 but the 2025 target is 250,000 medical tourists. Almost all come from mainland China.

    Hainan reported 19,000 medical tourists in 2017, 32,000 in 2018, 68,000 in 2019, and 83,900 in 2020. An increase of 83,900 by 454% is 382,630. If the five years are added together, that’s about 250,000 .

    read more
    Medical products

    Medical Products Stock Earnings Feb. 2: BSX, TMO and More

    The last Revenue overview reflects a considerably strong quarterly performance for the Medical sector so far this reporting cycle. According to the sector scorecard, 8.9% of companies in the medical sector, constituting nearly 29.2% of the sector’s market capitalization, reported profits through January 26. Of these, 80% beat earnings estimates and 60% beat the same for revenue. Profits were up 27% year over year on revenue up 12.2%.

    This dashboard reflects stability in the United States on continued economic reopening amid the resurgence of COVID-19 cases. However, supply chain disruptions are still significant, thanks to the emergence of the Omicron variant. Additionally, many parts of the COVID-affected international market are still suffering due to lower cash flow and tough economic conditions.

    Overall, fourth-quarter profits for the medical sector are expected to rise 18.4% on a 12.2% increase in sales. That compares to reported earnings growth of 29.7% and revenue growth of 15.7% in the third quarter. It is worth mentioning that the medical sector is expected to be one of the seven sectors with the strongest earnings growth in the fourth quarter.

    Quarterly summary of medical products

    The dynamic nature of the COVID-19 crisis is rapidly transforming the landscape of the medical products industry. Medical products Corporate collective activities (within the broader medical sector) showed a sequential decline in terms of legacy core activity in the third quarter. So far, the fourth quarter reporting cycle has shown a sequential rebound in terms of the companies’ legacy core business despite the emergence of the new Omicron variant. This rebound can be attributed to the fiscal and monetary stimulus measures and the mass vaccination campaign at home and abroad. Although companies are seeing a sequential recovery in basic activity, the improvement in the overall trend is still below the pre-COVID level.

    It should be mentioned here that disruptions in the form of the emergence of newer, more infectious variants of COVID-19 have again begun to delay non-COVID-19 elective hospital admissions and procedures. Meanwhile, with resurgences of COVID-19 and rising case numbers, manufacturers of tests, vaccines and therapeutics have witnessed massive market uptake of their products and support services. COVID-related health care in the fourth quarter.

    Specifically, fourth-quarter diagnostic test inventory results have so far shown considerable growth, driven by an increase in demand for COVID-19 tests, which had seen a slowdown in demand in the third quarter, a report said. gained momentum in the fourth quarter, in line with industry trends.

    Let’s take a look at four Medical Products players who are due to announce their results on February 2.

    Boston Scientific Society BSX: In the fourth quarter, within the Urology/Pelvic Health division of Boston Scientific, sales of the Stone, Prostate Health and Pelvic Health franchises are expected to have recorded strong growth. The acquisition of Lumenis (closed in September) should have contributed a full quarter to the company’s sales. The LithoVue, SpaceOAR and Rezum product lines should have performed well. The company continues to expect urology/pelvic health to have one of the fastest potential recovery curves, aided by a higher in-office ASE mix for most elective procedures. (Read more: What do Boston Scientific’s fourth quarter results have in store for us?)

    Zacks’ consensus estimate for fourth-quarter earnings per share is pegged at 44 cents and revenue at $3.10 billion.

    Boston Scientific Corporation Award and EPS Surprise

    Boston Scientific Corporation price-eps-surprise | Boston Scientific Corporation Quote

    Boston Scientific doesn’t have the right combination of the two key ingredients – a silver lining ESP Earnings and a Zacks Rank #3 (Hold) or better. BSX has an ESP on gains of 0.00% and carries a Zacks rank of #4 (sell). You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

    You can see the full list of today’s Zacks #1 Rank (Strong Buy) stocks here.

    Thermo Fisher Scientific Inc. TMO: Thermo Fisher’s Life-Science Solutions segment is expected to have seen strong revenue contributions driven by growing demand for COVID-19 testing with the emergence of the Omicron variant during the fourth quarter. Additionally, vaccine and therapeutics production supplies (recognized in the BioProduction and Biosciences businesses) are expected to have contributed strongly to the company’s growth in the fourth quarter. Thermo Fisher is expected to have seen robust growth in the areas of genetic sciences, biosciences and biomanufacturing thanks to the surge in economic activity globally and the company’s response to the pandemic. (Read more: Increase in COVID testing to boost Thermo Fisher Q4 revenue)

    Zacks’ consensus estimate for its fourth-quarter earnings per share is set at $5.22. Revenue is expected to be $9.03 billion.

    Thermo Fisher Scientific Inc. Prize and EPS Surprise

    Thermo Fisher Scientific Inc. Prize and EPS Surprise

    Thermo Fisher Scientific Inc. price-eps-surprise | Quote from Thermo Fisher Scientific Inc.

    TMO has a +12.77% win ESP and a #3 Zacks rank.

    Hologic, Inc. HOLX: Hologic’s diagnostics business likely experienced robust growth in the first quarter of fiscal 2022 due to increased demand for COVID-19 testing. With that in mind, in November 2021, the company confirmed that its three SARS-CoV-2 tests detect the recently emerged Omicron variant of the coronavirus. This development should have boosted Hologic’s diagnostics revenue in the first fiscal quarter. The same month, Hologic launched the Novodiag system for on-demand molecular testing in Europe. This should have witnessed strong market uptake in the fiscal first quarter as it capitalized on the surge in coronavirus cases induced by the Omicron variant, thus adding to revenue. (Read more: Hologic to Report First Quarter Results: What’s in the Cards?)

    Zacks’ consensus estimate for its first-quarter earnings per share is set at $1.21. Revenue is expected to be $1.12 billion.

    Hologic, Inc. Price and EPS Surprise

    Hologic, Inc. Price and EPS Surprise

    Hologic, Inc. price-eps-surprise | Hologic, Inc. Quote

    The company has an ESP on Earnings of -1.65% and a #2 Zacks Rank (Buy).

    McKesson Corporation MCK: The company’s US pharmaceutical and specialty solutions segment likely acted as a key growth driver in the third quarter of fiscal 2022. The segment should have benefited from market growth and higher volumes of specialties during the quarter to appear. However, brand-to-generic conversions may have weighed on segment performance. The growing demand for COVID-19 testing (due to the resurgence of COVID-19) and improved primary care patient visits have likely positively impacted the company’s medical-surgical solutions segment. (Read more: McKesson to Report Third Quarter Results: What’s in the Cards?).

    Zacks’ consensus estimate for its third-quarter earnings per share is set at $5.38. Revenue is expected to be $66.13 billion.

    McKesson Corporation and EPS Surprise Award

    McKesson Corporation and EPS Surprise Award

    McKesson Corporation price-eps-surprise | Quote from McKesson Corporation

    MCK has a +1.86% earnings ESP and a #3 Zacks rank.

    Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

    7 best stocks for the next 30 days

    Just Released: Experts distill 7 elite stocks from the current Zacks No. 1 Ranking 220 Strong Buys list. They consider these tickers “most likely for early price increases.”

    Since 1988, the full list has beaten the market more than 2 times with an average gain of +25.3% per year. So be sure to give your immediate attention to these 7 handpicked ones.

    Discover them now >>

    Click to get this free report

    Boston Scientific Corporation (BSX): Free Stock Analysis Report

    Thermo Fisher Scientific Inc. (TMO): Free Inventory Analysis Report

    McKesson Corporation (MCK): Free Stock Analysis Report

    Hologic, Inc. (HOLX): Free Stock Analysis Report

    To read this article on Zacks.com, click here.

    Zacks Investment Research

    The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

    read more
    Prescription drugs

    Prescription Drug Consumption Market Size 2022 and Analysis by 2029

    New Jersey, United States,-The report attempts to offer an accurate and high-quality analysis of the global Prescription Drug Consumption Market, keeping in mind market forecast, competitive intelligence, risks and technological advancements, and other important topics. Its carefully crafted market insights enable market players to understand the most significant developments in the global Prescription Drug Consumption market that are impacting their business. Readers can become aware of crucial opportunities available in the Global Prescription Drug Consumption Market along with key factors driving and restraining the market growth. The research study also provides an in-depth geographical analysis of the global Prescription Drug Consumption market and sheds light on important applications and products that market players can focus on to achieve high growth.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=419994

    You can thoroughly assess the strengths and weaknesses of your competitors with our competitive analysis. The report also provides access to a comprehensive analysis of production and shipment, from origin to end-user purchase. Plus, you’ll be updated on the latest industry developments to help you stay ahead of your competition. Our analysts are always on their toes to continuously monitor and analyze any changes or developments in the quality prescription drug consumption industry. The report is filled with statistical announcements, market figures related to annual revenue, volume, average and share, as well as global and regional market forecasts.

    The report includes a detailed segmentation study of the global Prescription Drug Consumption market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the attractiveness index of the segment, allowing players to inform about the profitable revenue pockets of the global Prescription Drug Consumption market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Prescription Drug Consumption Market.

    Key Players Covered in the Prescription Drug Consumption Markets:

    • Pfizer
    • rock
    • Sanofi
    • Johnson & Johnson
    • Merck & Co. (MSD)
    • Novartis
    • AbbVie
    • Gilead Sciences
    • GlaxoSmithKline (GSK)
    • Amgen
    • Astra Zeneca
    • Bristol Myers Squibb
    • Eli Lily
    • Suits you
    • Bayer
    • Novo Nordisk
    • Allergan
    • County
    • Boehringer Ingelheim
    • Takeda

    Prescription Drug Consumption Market Breakdown by Type:

    Prescription Drug Consumption Market Split By Application:

    The Prescription Drug Consumption Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Prescription Drug Consumption Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Prescription Drug Consumption market and its growth potential in the years to to come.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=419994

    Scope of Prescription Drug Consumption Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Base year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Market Analysis Prescription Drug Consumption can be represented as follows:

    Each regional Prescription Drug Consumption industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global prescription drug consumption market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Answers to key questions in the report:

    • What is the growth potential of the consumer prescription drug markets?
    • Which product segment will take the lion’s share?
    • Which regional market will impose itself as a precursor in the years to come?
    • Which application segment will grow at a rapid pace?
    • What are the growth opportunities that may emerge in the Lock Washers industry in the coming years?
    • What are the major challenges that the global prescription drug consumption markets may face in the future?
    • Who are the leading companies in the Global Prescription Drug Consumption Market?
    • What are the key trends that are positively impacting market growth?
    • What are the growth strategies considered by the players to sustain their hold in the global Prescription Drug Consumption market?

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-prescription-drugs-consumption-market-size-and-forecast/

    The study thoroughly explores the profiles of major market players and their major financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the Prescription Drug Consumption market production, revenue, market share and growth rate for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical breakdown data of prescription drug use from 2016 to 2020 and forecast to 2021-2029.

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical supplies

    Comprehensive report on Medical Supplies Market predicted to gain significant value by 2026





    A latest report titled Global Medical Devices Market, the report has been prepared by expert and knowledgeable market analysts and researchers. They have explored the competitive landscape, segmentation, geographic expansion, and revenue, production, and consumption growth of the global Medical Supplies Market and added in the report. The major key players can use the accurate market facts, figures and analytical studies provided in the report to understand the current and future growth of the global market. The report contains data on the competitive scenario, supply and demand situation, and market growth challenges.

    The main objective of the Medical Supplies market report is to predict the performance of the industry for the upcoming years to help the stakeholders to take right decisions and improve their revenue flow. Moreover, key trends and growth opportunities are discussed in detail in the document followed by comprehensive data on the approaches to tackling the challenges faced by the industry. Also, it provides recent updates on the business scenario across the globe along with concise details regarding the revenue outlook post Covid-19 pandemic.

    Request a sample copy of this report @ https://www.getnewsalert.com/request-sample/10243

    Main highlights of the Covid-19 impact analysis:

    • Impact of Covid-19 on the global economy.
    • Changes in the share of supply and demand.
    • Predictions of the long-term effects of the Covid-19 pandemic on the growth matrix.

    An overview of the regional landscape:

    • The medical supplies market is segmented into several regional markets, namely North America, Europe, Asia-Pacific, South America, Middle East and Africa.
    • Each region’s contribution to overall growth is calculated by looking at important metrics like total sales and net income.
    • The growth rate of each regional market over the forecast period is also provided.

    Other key takeaways from the Medical Supplies Market report:

    • The report fragments the product scope of the Medical Supplies market into
      • Diagnostic
      • Dialysis
      • Wound care
      • Inhalation
      • infection control
      • Infusion
      • Intubation and PPE

      .

    • Data supporting revenue share and volume estimates for each product category are provided.
    • The study highlights the market share, production model and growth rate of each product type over the forecast period.
    • In terms of scope, the medical supplies market is categorized into
      • Hospital
      • Clinical
      • Rest house
      • Geographically
      • detailed production analysis
      • the trade of the following countries is covered in chapter 4.2
      • 5:
      • United States
      • Europe
      • China
      • Japan and India

      .

    • The market share and growth rate forecasts of each application segment are extensively discussed.
    • Major companies influencing the medical supplies market trends are
      • Baxter International Inc.
      • Thermo Fisher Scientific Inc.
      • Medtronic plc
      • Cardinal Health
      • Inc.
      • Dickinson and company
      • Johnson & Johnson
      • stryker
      • Abbott
      • Boston Scientific Society
      • B. Braun Melsungen AG
      • 3M Company and BD

      .

    • Evaluation of companies based on their production models, product and service portfolio, pricing model, gross margins, market compensation and market share is included.
    • Major competitive trends and their business implications are elaborated.
    • A granular assessment of the industry supply chain, with details on manufacturers, raw material and equipment suppliers, and consumers, is housed in the document.
    • The report also has a dedicated section for determining the feasibility of a new project using various methods such as Porter’s five forces analysis and SWOT analysis.

    Contents

    1. Global Medical Supplies Market Research Report
    2. Overview of the global medical supplies market
    3. Global economic impact on the industry
    4. Global Medical Supplies Market Competition by Manufacturer
    5. Global production, revenue by region
    6. Global Market Analysis by Application
    7. Medical Supplies Market Manufacturing Cost Analysis
    8. Marketing Strategy Analysis, Distributors/Traders
    9. Global Medical Supplies Market Forecast
    10. Global Medical Supplies Market competition by players/vendors, revenue, market share, growth rate
    11. Conclusion

    Customization request on this report @ https://www.getnewsalert.com/request-for-customization/10243





    read more
    Prescription drugs

    Pfizer, Gilead Sciences, Johnson & Johnson, Roche, AbbV – The Oxford Spokesperson

    The Global Prescription drugs The industry report gives a comprehensive report on the global prescription drugs market. Details such as market size, key players, segmentation, SWOT analysis, pestle, carrier 5, most influential trends and business environment are mentioned in this report. Additionally, this report contains tables and figures that give a clear outlook of the prescription drugs market. With the help of this report, an organization can achieve its goals and build its unique strategy. A sample report is available in 20 different formats, so let us know your exact requirements so we can focus on your area.

    These are the few market players in this industry-

    Pfizer, Gilead Sciences, Johnson & Johnson, Roche, AbbVie, Sanofi, Amgen, Novartis, Merck & Co. (MSD), GlaxoSmithKline (GSK), Bayer, Takeda, AstraZeneca, Takeda, Novo Nordisk, Teva, Bristol-Myers Squibb, Boehringer Ingelheim, Allergan, Eli Lilly

    We have recent updates from the Prescription Drugs Market in sample copy @ https://www.maccuracyreports.com/report-sample/91238

    prescription drug market

    Hospital, Clinic, Other.

    Application as below

    Brand drugs, generic drugs.

    Fundamental is well established in the important study. The report features up-to-date data on product details, roadmap, investment strategy, revenue figures and sales of major companies. In addition, the details also give the global prescription drugs market revenue and its forecast. Business model strategies of key companies in the Prescription Drugs market are also included. The key strengths, weaknesses and threats shaping the major market players have also been included in this research report. You can make a plan just by looking at this market research.

    Browse Full Report with Facts and Figures of Prescription Drugs Market Report at @ https://www.maccuracyreports.com/reportdetails/reportview/91238

    MR Accuracy Reports has published the report which gives a detailed overview of the key segments of the market. Both fastest and slowest growing market segments are covered in this report. Key emerging opportunities of the fastest growing global prescription drug market segments are also discussed in this report. The market size, share and forecast of each segment and sub-segment are available in this report. Additionally, the region segmentation and trends driving the major geographic region and emerging region have been presented in this report.

    Regional assessment and diversification of segments.

    North America (United States, Canada, Mexico)
    Europe (UK, France, Germany, Spain, Italy, Central and Eastern Europe, CIS)
    Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
    Latin America (Brazil, Rest of LA)
    Middle East and Africa (Turkey, GCC, Rest of Middle East)

    Make a request before purchase @ https://www.maccuracyreports.com/checkout/91238

    The research team has gathered the study on the Global Prescription Drugs Market and also presents a history of the tactical activities of mergers, acquisitions, collaborations and partnerships in the market. Senior analysts’ valuable recommendations on strategic investment in research and development can help new entrants or established players to penetrate emerging sectors of the Prescription Drugs Market. Investors will get a clear insight into the dominating players in this industry and their future predictions. Additionally, readers will get a clear perspective on the high demand and unmet consumer needs that will drive the growth of this market. This material has been very useful for all TOP players.

    read more
    Medical supplies

    Steady growth in the medical supplies market will be witnessed by 2021 to 2028 – The Oxford Spokesman

    Global medical supplies market research is an intelligence report with meticulous efforts undertaken to study the correct and valuable information. The data that has been reviewed takes into account both existing top players and upcoming competitors. The business strategies of key players and new industries entering the market are studied in detail. A well-explained SWOT analysis, revenue share and contact information are shared in this report analysis. It also provides market information in terms of development and its capabilities.

    MR Accuracy Reports authored the report, titled Global Medical Supplies Market 2021 is a methodical research study based on the Medical Supplies Market analyzing the competitive landscape of the industry across the globe. Using effective analytical tools such as SWOT analysis and Porter’s Five Forces analysis, the report provides a comprehensive assessment of the Medical Supplies market. Our large research team was able to capture all the important chapters of the final report as they strived for it.

    Download a free PDF sample report with a full table of contents, figures and graphs (with covid 19 impact analysis): https://www.maccuracyreports.com/report-sample/476944

    At the time of this report, official counts of COVID-19 cases and deaths have exceeded 4,000,000 and 280,000. Many governments have announced plans to reopen the national economy, but many countries are still in the process. at the ascent stage. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to rebuild the global industrial chain. . Faced with the global industrial mutation of the post-epidemic era, enterprises in different countries need to take precautions.

    The chemical and petrochemical industries have noticed the adverse effects of the COVID-19 outbreak. They are in the midst of a two-pronged crisis, besides the impact of COVID-19, another is the oil price war. Oil prices are falling due to the failure of agreements on production cuts between OPEC and Russia in April and the need for chemicals and refined products is slowing due to industrial slowdowns and travel restrictions at the following this global pandemic.

    The chemical industry plays an important role in the production of countless products such as plastics, fertilizers, medicines, packaging products, etc., with the spread of the coronavirus, many production facilities of several industries in downstream have been stopped. However, an increase in the demand for packaging materials has been raised to prevent contamination of food, drugs, personal care and medical products, thus creating a large demand for chemicals used in the packaging industry .

    In such an environment, XYZ-research has published a comprehensive analysis of key market trends in the global 3160 Medical Supplies Market. It includes discussion of historical trends, current market status, competitive landscape, opportunities for growth and challenges that are supported by factual commentary.

    According to MRA analysis, the medical supplies market will reach xx million USD by the end of 2020, growing at a CAGR of xx% during the forecast period 2021-2026, the XX segment of the medical supplies market is expected to reach a market value of xx million USD by 2020 from an initial market value of xx million USD in 2019. The market value of China in 2019 is around xx million USD and the production of medical supplies is xx. The US market value in 2019 is around xx million USD and the production of medical supplies is xx. The market value of Europe in 2019 is around xx million USD and the production of medical supplies is XX.

    Regional Segmentation (Value; Revenue, USD Million, 2015 – 2026) of the Medical Supplies Market by MRA Include

    China

    EU

    United States

    Japan

    India

    South East Asia

    South America

    Competitive analysis; Who are the major players in the Medical Supplies market?

    Medtronic (Ireland)

    Cardinal Health (USA)

    comics (US)

    Johnson & Johnson (USA)

    B. Braun Melsungen AG (Germany)

    Boston Scientific Corporation (USA)

    Thermo Fisher Scientific (USA)

    Baxter International Inc. (US)

    Avanos Medical Inc. (US)

    3M (USA)

    Smith & Nephew (Ireland)

    ConvaTec Group Plc. (UK)

    Abbott (USA)

    Medical cook (USA)

    Merit Medical Systems (USA)

    Stryker (USA)

    Terumo Corporation (Japan)

    Teleflex Incorporated (USA)

    Fresenius Medical Care (Germany)

    Coloplast Group (Denmark)

    Major Types of Medical Supplies Covered in MRA Report:

    Diagnostic supplies

    Dialysis consumables

    Inhalation products

    Consumables for wound care

    Radiology consumables

    Infection control supplies

    Infusion products

    Intubation and ventilation supplies

    Personal Protective Equipment (PPE)

    Others

    Application segments covered in the ARM market

    Urology

    Wound care

    Radiology

    Respiratory

    infection control

    Cardiology

    DIV

    Other

    For any other requirements, do not hesitate to contact us and we will provide you with a personalized report.

    Get an exclusive discount on this report: https://www.maccuracyreports.com/check-discount/476944

    Key questions answered by the report include:

    • What will be the market size and growth rate by the end of the forecast period?
    • What are the key trends in the global medical supplies market impacting market growth?
    • What are the potential growth opportunities and threats faced by the major market competitors?
    • What are the key findings of Porter’s Five Forces analysis and SWOT analysis of key players operating in the global medical supplies market?
    • This report gives all the information regarding the industry overview, analysis and revenue of this market.
    • What are the market opportunities and threats faced by the vendors in the global Medical Supplies Market?

    If you have any special requirements, please let us know and we will offer the report as you wish.

    You can buy the full report @ https://www.maccuracyreports.com/checkout/476944

    About Us:

    MR Accuracy Reports’ well-researched contributions that encompass areas ranging from IT to healthcare enable our valued clients to capitalize on key growth opportunities and protect against credible threats prevailing in the market in the scenario current and those expected in the near future. Our research reports provide our clients with macro-level insights in various key regions of the world that provide them with a broader perspective to align their strategies to take advantage of lucrative growth opportunities in the market.

    Contact us:
    MR Accuracy Reports,
    USA: +1 804 500 1224
    UK: +44 741841 3666
    ASIA: +91 747888728100
    Email: [email protected]
    Website: https://www.maccuracyreports.com

    read more
    Prescription drugs

    F Hoffmann La Roche Ltd, Alizyme, Arena Pharmaceuticals, Orex – The Oxford Spokesperson

    MRI Accuracy Reports published a new report on Global Anti-obesity prescription drugs Industry. This report is in high demand as TOP as well as emerging players leverage this report. This is the most accurate and qualitative research study collected by a team carrying out primary and secondary research. This report is based on briefings and interviews conducted with product manufacturers and their consumers, along with demand research. The mixture of checks and balances combined with the involvement of industry players provides a clear and accurate picture of the entire global prescription anti-obesity drugs market.

    Some players mentioned below for your reference-

    F Hoffmann La Roche Ltd, Alizyme, Arena Pharmaceuticals, Ordemanden Therapeutics, Boehringer Ingelheim, Novo Nordisk A/s, Vivus, Glaxosmithkline

    We Have Recent Anti-Obesity Prescription Drugs Market Updates In Sample Copy @ https://www.maccuracyreports.com/report-sample/92092

    Prescription Anti-Obesity Drugs Market

    Pediatric, Adult.

    Application as below

    Orlistat, Phentermine and Topiramate, Bupropion and Naltrexone, Lorcaserin, Liraglutide.

    Furthermore, the research data contained in the report after working closely with investment bankers and financial analyst presents a clear idea about the investment scenario in the global Prescription Anti-Obesity Drugs market. The report assesses market prospects for public companies, assesses business cases of several private companies, and discusses investment trends in the global anti-obesity prescription drugs market. The analyst suggested that there would be a turning point in this market, so it needs to draw attention away in order to sustain in the market.

    The global Prescription Anti-Obesity Drugs market report covers current and future trends in consumer preferences that will shape the industry. The report assesses the buying trends along with the buying process, technology preference, expenditure, and end-user manufacturer and service provider preferences in the global Prescription Anti-Obesity Drugs Market.

    Browse Full Report with Facts and Figures of Prescription Anti-Obesity Drugs Market Report at @ https://www.maccuracyreports.com/reportdetails/reportview/92092

    The report digs deeper by providing consumer preferences by region and their impact on market revenue and growth. The report also presents the current regulatory scenario of individual regional sectors in the global Prescription Anti-obesity Drugs market. Furthermore, the current regulatory scenario as well as the upcoming regulations that will come into force in the coming years have also been mentioned in this report.

    Regional assessment and diversification of segments.

    North America (United States, Canada, Mexico)
    Europe (UK, France, Germany, Spain, Italy, Central and Eastern Europe, CIS)
    Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
    Latin America (Brazil, Rest of LA)
    Middle East and Africa (Turkey, GCC, Rest of Middle East)

    Several key players operating in the global Prescription Anti-obesity Drugs market have been profiled in this report. The business overview of key players, product offering, revenue share, business strategies and latest innovations have been included in this report. The in-depth competitive framework of the Global Prescription Anti-Obesity Drugs Market will help clients to formulate the best strategies for a desired business outcome. Therefore, contact us to get the sample basic report.

    Please click here today to purchase the full report @ https://www.maccuracyreports.com/checkout/92092

    We have published over 2 million reports and are recognized as the best market research reporting company in the world. As EDITOR, we are always focused on your needs, advice and growth.

    read more
    Prescription drugs

    Overview, Opportunities, Key Companies and Forecasts to 2028 – Pfizer, Merck, Isis Pharmaceuticals, Immuron Limited, GlaxoSmithKline Pharmaceuticals, Formac Pharmaceuticals, Esperion Therapeutics, Eli Lilly, and more. – Oxford Spokesperson

    The research report, titled “Global Prescription Drugs for Hyperlipidemia Market 2022, presents crucial insights and statistical data on the Prescription Hyperlipidemia Drugs Market with respect to the world. The Market Report provides an all-inclusive analytical study of the Prescription Drugs for Hyperlipidemia Market, considering the growth drivers, restraints, and future prospects. The prevailing trends and opportunities are also discussed in this study.

    The report analyzes the global Prescription Drugs for Hyperlipidemia market on the basis of various key segments on the basis of product types, applications and end users. The regional Prescription Hyperlipidemia Drugs market is also considered for the analysis, the results of which are used to predict the performance of the Prescription Hyperlipidemia Drugs market globally over the period of 2022 to 2028.

    Each of the market verticals of the Prescription Drugs for Hyperlipidemia Market is qualitatively and quantitatively analyzed to present a comparative assessment of the market. Basic information such as definition, industry chain powering the market, and policies are also covered in the report.

    Request a sample copy of Prescription Drugs for Hyperlipidemia Market Report (Use company email id for higher priority) @ https://www.maccuracyreports.com/report-sample/519367

    Summary

    According to GRD survey data, the global Hyperlipidemia Drugs market is estimated to be worth million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR % during the forecast period between 2022 and 2028.

    This report studies the Prescription Drugs for Hyperlipidemia market dynamics from angles such as new entries, mergers and acquisitions, financings, exits, and major technological advancements. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competitive landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Five Forces Analysis. Carry.

    Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Hyperlipidemia Drugs in these regions, from 2016 to 2027, covering

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)

    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)

    South America (Brazil, Argentina, Colombia, etc.)

    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

    Market Overview, By Product Type

    HMG COA reductase inhibitors

    Fibric acid derivatives

    nicotinic acid

    Bile acid sequestering agents

    Cholesterol absorption inhibitors

    Combination drug therapy

    Market Overview, By Application

    Hospital

    Clinical

    Key Market Players Analyzed In This Report Including:

    Pfizer

    Merck

    Isis Pharmaceuticals

    Immuron Limited

    GlaxoSmithKline Pharmaceuticals

    Formac Pharmaceuticals

    Therapeutic Hope

    Eli Lily

    Dr. Reddy’s Laboratories

    Amgen

    The research objectives of this report are:

    To study and analyze the global Prescription Drugs for Hyperlipidemia market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.

    To understand the structure of the Prescription Drugs for Hyperlipidemia market industry by identifying its various subsegments.

    Share detailed information on key factors influencing market growth (growth potential, opportunities, drivers, industry-specific challenges and risks).

    To identify the major global Hyperlipidemia Drugs manufacturers and typical regional players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans over the next few years.

    To analyze the Prescription Drugs for Hyperlipidemia market with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of Hyperlipidemia Drugs submarkets, with respect to key regions (along with their respective key countries).

    Analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

    Establish a strategic profile of key players and analyze in depth their growth strategies.

    In this study, the years considered to estimate the market size of Hyperlipidemia Prescription Drugs are as follows:

    Historical year: 2016-2020

    Reference year: 2020

    Estimated year: 2021

    Forecast year 2021 to 2027

    This report includes the estimation of market size in terms of value (USD Million) and volume from top-down approach by analyzing major sub-markets and their key driving factors, and verified from bottom-up approaches . Major market players have been identified through secondary research and their market shares have been determined through primary and secondary research. All shares, breakdowns and percentage breakdowns have been determined using secondary sources and verified from primary sources.

    For data information by region, company, type and application, 2020 is taken as the base year. Whenever data information was not available for the reference year, the previous year was taken into account.

    Main stakeholders taken into account in the study:

    commodity sellers

    Distributors/Traders/Wholesalers/Suppliers

    Regulatory authorities, including government agencies and NGOs

    Commercial research and development (R&D) institutions

    Importers and exporters

    Government organizations, research organizations and consulting firms

    Trade/industry associations

    End-use industries

    Get up to 30% off the first purchase of Hyperlipidemia Prescription Drugs Market Rreport @: https://www.maccuracyreports.com/check-discount/519367

    The products available in the market are studied on the basis of their manufacturing chain, the price of the products and the profit they generate. An in-depth analysis is then carried out on the various regional Prescription Hyperlipidemia Drugs markets, examining the production volume and efficiency of the Prescription Hyperlipidemia Drugs market globally. The demand and supply statistics for the Prescription Hyperlipidemia Drugs market along with the growth figures recorded by the Prescription Hyperlipidemia Drugs market are also presented for each regional market in this report.

    Various analytical tools are applied in the analysis of the Prescription Drugs for Hyperlipidemia Market to reach a precise understanding of the market players in the potential development of this market. These tools include feasibility analysis, ROI analyses, as well as SWOT analysis of key market players.

    Key questions answered in the Prescription Hyperlipidemia Drugs market report include:
    • What will be the market size and growth rate by the end of the forecast period?
    • What are the key trends in the Global Prescription Hyperlipidemia Drugs Market impacting the growth of the market?
    • What are the potential growth opportunities and threats faced by the major market competitors?
    • What are the key findings of Porter’s Five Forces analysis and SWOT analysis of key players operating in the global Prescription Hyperlipidemia Drugs market?
    • This report gives all the information regarding the industry overview, analysis and revenue of this market.
    • What are the market opportunities and threats faced by the vendors in the global Prescription Drugs for Hyperlipidemia Market?
    If you have any special requirements, please let us know and we will offer the report as you wish.
    Buy Now @ https://www.maccuracyreports.com/checkout/519367

    About Us:

    MRI Accuracy Reports provides customization of reports according to your needs. This report can be customized to meet your needs. Get in touch with our sales team, who will guarantee you get a report tailored to your needs.

    Contact us:

        Call: +1 804 500 1224 / +44 741841 3666 (International)

    E-mail: [email protected]

    Website: www.maccuracyreports.com

    read more
    Medical supplies

    Better Health brings medical supplies to patients’ homes

    The workplace isn’t the only thing building a permanent presence in our homes in the wake of the pandemic – health also finds its place in our personal spaces.

    After years of working in healthcare, Naama Stauber Beckler realized that the existing system was failing some people, especially those dealing with health issues that required home supplies. So she set out to found Better Health, a direct-to-consumer service provider that delivers medical supplies directly to patients’ doors.

    “I have identified a gap in the market for people with chronic conditions who need to use [medical devices at home]says Stauber Breckler of the operation, which she launched in 2019. ideal product for you, learning how to use them and integration into your life is really broken.

    Read more: Long story short: get ready for big changes in healthcare this year

    Traditionally, sending medical products home with patients from hospitals was a lengthy process – it started with a doctor’s referral, then required a lot of work on the patient’s part to find suppliers who would transport the product. Then they had to connect distributors and doctors, contact the insurers themselves, and finally, go out and collect their supplies.

    With Better Health, medical supplies, such as catheters and colostomy bags, are delivered directly to patients once approved by doctors and distributors, and comes with telehealth tools including education and peer support.

    More than 4.5 million people receive home health care and relying on businesses to provide and maintain their oxygen machines, wheelchairs, hospital beds, prosthetics and other durable home medical equipment, according to the CDC. And between 725,000 and one million people in the United States currently live with a stoma (a surgical opening to help waste material leave the body), according to the United Ostomy Associations of America. It is estimated that 100 million urinary catheters are sold worldwide each year.

    Read more: As long as employers control employee healthcare, life-saving technologies will be underutilized

    Before the pandemic, the the traditional method left a lot of room for error, says Stauber Beckler, noting that patients often had to travel to the hospital just to get needed supplies. COVID-19, of course, amplified the problem: as access to hospitals and doctors dwindled, patients with chronic illnesses at home found themselves looking for solutions.

    “What we’ve really seen over the last two years, and especially during the pandemic, is how far telehealth has evolved,” says Stauber Beckler, noting that using telehealth to educate patients is not will not only make life easier for consumers, but also alleviate unnecessary stress and demand on hospitals. “By serving underserved, perhaps smaller-volume populations — like those enrolled in Medicaid, the LGBTQ community, women — we’re already seeing better solutions emerge for them.”

    read more
    Medical supplies

    Personal perspective: How to strengthen the supply chain of essential medical supplies and medicines

    As the COVID-19 pandemic spread across the country, governments and the private sector tore through their stockpiles of personal protective equipment (PPE) and other resources. Several supply chain issues quickly emerged, including lack of visibility into sources of supply, a fragmented approach to ordering and fulfillment, and an overreliance on offshore manufacturing.

    While we have made progress in managing aspects of the pandemic, disruptions to the supply chain, including raw materials, manufacturing, shipping, distribution and “last mile” delivery remain. in a system that is not designed for the demands of a pandemic.

    With a few targeted strategies, it is possible to reverse these disturbances. For its part, Premier, a health care improvement company uniting 4,400 American hospitals and health systems and partner of the CHAMPS Purchasing group based in northeast Ohio, is concerned with the risk management of the supply chain for years, and we have developed forward-thinking capabilities. to help protect against interference.

    To strengthen the supply chain, Premier and CHAMPS are calling for the implementation of key national priorities to meet the growing demand for essential medical supplies and medicines. We need to take a broader approach to creating an end-to-end supply chain that is transparent, diverse and reliable. Beyond quantities, we must also ensure that the United States has established contractual relationships that include contingency plans to increase production as soon as future needs are identified.

    Specifically, we need to address the following points.

    • The need for domestic manufacturing: The pandemic has underscored the need for better local access to essential medical supplies, which is why we are advocating for a short-term tax incentive of 30% to support domestic manufacturing. We also believe that the private sector can play a role in promoting change related to the manufacturing of essential goods.

    In March 2020, Premier launched a unionized model to ensure a robust and resilient supply chain for essential medical products. The program provides a vehicle through which Premier and its members pool capital to invest in domestic manufacturers who can supply products in short supply, providing initial cash needed to expand production capacity and modernize the plant, as well as long-term purchasing commitments to incentivize innovation. This ensures that providers have a cost-effective national alternative for their patient care needs. Here in Northeast Ohio, CHAMPS Group Purchasing has partnered with JobsOhio to implement agreements with suppliers of PPE and related products as part of our commitment to supporting local national suppliers, diversified and small businesses to advance the region’s economy.

    • The need for an innovative global sourcing strategy: Past situations such as H1N1, Ebola, and Hurricane Maria have highlighted the vulnerabilities associated with over-reliance on a single country for medical supplies and medicines. In response, several organizations (including ours) have diversified PPE production, expanding operations to multiple countries and regions to mitigate ongoing risks of product shortages. As part of this, we must also ensure that suppliers have a say in determining what should be included in the national strategic stock of equipment.
    • Tech-enabling supply chain: Until recently, hospitals were alone in translating local outbreaks of COVID-19 into immediately meaningful information regarding capacity and supplies. Now, providers are using technology to be better informed about how quickly cases are spreading and what supplies they need at any given time. This new technology takes advantage of real-time monitoring capabilities, providing early warnings, predicting surges and helping organizations plan coordinated responses where they are needed most.

    Additionally, the federal government needs technology that will provide visibility into what supplies are in inventory, distribution, and hospital inventories during national emergencies. This will allow allocation to places in need and reduce hoarding and the illicit market, issues that have challenged America during the first nine months of the pandemic.

    When healthcare providers can predict COVID-19-related hospitalizations and have confidence in the sufficiency of supplies of essential commodities, this creates a positive ripple effect – relieving pressure on supply chains, ensuring more responsive care in communities and helping to keep businesses and schools open and running.

    Even as COVID-19 has exposed supply chain flaws and transformed the healthcare landscape, together we continue to show and improve to meet the challenges posed by the pandemic and drive healthcare innovation. health for the future.

    We must come together to ensure access to the supplies, data, analysis and intelligence needed to survive and thrive in a challenging environment.

    Lane is President and CEO of the Center for Health Affairs and CHAMPS Healthcare. Alkire is President and CEO of Premier Inc.

    read more
    Prescription drugs

    What’s in a name? When it comes to prescription drugs, many, experts say

    How do prescription drugs get their brand names? It’s a process, experts say. Photo by Sponge/Wikimedia Commons

    January 21 (UPI) — The Food and Drug Administration announced Wednesday that it has approved a drug called Quviviq for the treatment of insomnia, a disorder that causes trouble sleeping.

    The brand name of this drug, which is expected to hit the market in the United States in May if it meets FDA standards for controlled substances, may seem like a mouthful.

    However, there is most likely a lot of thought and money behind Quviviq.

    “The manufacturer says it improves sleep with less drowsiness, so they may think ‘viviq’ connotes vital, lively, or less groggy,” said Arlene Teck, creative director, name development at Ixxeo Healthcare in Rockaway, NJ. , a pharmaceutical brand strategy consulting firm. UPI in a telephone interview.

    “The high pitch of the last syllable can evoke a sense of alertness,” Teck said, adding that neither she nor Ixxeo had worked on the brand.

    Although drug brand names seen in TV commercials, magazine ads and elsewhere may seem bizarre, there’s usually a method behind the apparent madness, experts said.

    “Companies spend a lot of time trying to get the right names to achieve their marketing goals,” Dr. G. Caleb Alexander, an epidemiologist whose research focuses on drug use and safety, told UPI by phone. on prescription.

    “The name shapes product perception, but it’s only part of a broad, thorough and coordinated marketing strategy,” said Alexander, a professor at Johns Hopkins University in Baltimore.

    Here is an overview of the process behind the brand naming of prescription drugs.

    Drug manufacturers develop a chemical name for a new drug based on a set of rules established by the International Union of Pure and Applied Chemistry and the United States Adopted Name Council.

    This latter group is operated under the auspices of the American Medical Association, the American Pharmaceutical Association and the US Pharmacopeial Convention, and any new name must refer to the underlying ingredients and mechanism of action of a drug. , according to the board.

    The chemical or generic name must also receive authorization from the World Health Organization’s International Nonproprietary Name program.

    Bring in the consultants

    Once the chemical name has been cleared for use and the drug has entered clinical trials, manufacturers will engage consultants such as Ixxeo Healthcare, with the goal of developing a brand name that allows the product to be marketed effectively, without violate FDA guidelines.

    New drugs go through three stages of clinical trials, and the process of creating brand names usually begins right at the start of phase 2 trials, Teck said.

    “By then, we’re pretty sure it’ll be a keeper and won’t die along the way” in the research and development process, she said.

    According to Tina Goldstone, director of marketing at Interbrand, a New York-based marketing consultancy, consultants typically work with clients to understand the drug, its category and class, and how it works or how it works.

    From a potential list of hundreds of names, the best options are selected and “pre-selected” against currently available databases of names and legal terms, as well as world languages ​​to avoid possible conflicts, she said.

    A famous example occurred in the 1960s, when Vicks marketed its cough drops in Germany, not realizing that the letter “v” was pronounced like the English letter “f” in German.

    As a result, the name Vicks read like a vulgar slang term for Germans.

    Beware of existing products

    It’s also important for new drug brands to make sure their names aren’t too close to those of existing products, Teck and Goldstone said.

    In addition to causing potential confusion for doctors and consumers, drugs with similar names could increase the risk of medication errors or incorrectly prescribed drugs, according to Teck.

    This has become an even bigger issue in recent years as prescribing has become high-tech, with prescribers and pharmacists often using software systems or devices with drop-down menus, she said.

    About 1.5 million people in the United States suffer health complications or even death each year from improperly prescribed medications, the Institute of Medicine estimates.

    A 2020 analysis published by the journal BMJ Quality and Safety found that 27 brand names of drugs used in the United States were identical to those of 38 products in other countries with different active ingredients.

    “How a drug is named can have big implications for the safe use of a drug,” said Johns Hopkins’ Alexander.

    Doctors and pharmacists are usually trained to learn the chemical names of drugs because brand names differ from country to country and often become unnecessary when generic forms hit the market, he said.

    FDA limits

    The FDA’s 42-page drug naming guidelines are publicly available.

    In addition to ensuring that the brands do not create possible consumer sources for prescribers, pharmacists and the public, the names cannot refer to the drug’s active ingredients or exaggerate their effectiveness or benefits, Teck said. Ixxeo.

    According to the agency, up to a third of all drug names submitted for FDA approval are rejected.

    “The attributes of the compound can influence the name — if it’s a potent, high-potency product, one might want to go for a potent name,” Interbrand’s Goldstone said.

    However, “the actual name of the compound or generic will not influence the name because a [brand] a name too close to the name of the compound would be rejected by regulatory authorities,” she said.

    What a drug is and what it does – its mechanism of action – will most likely appear in the name, particularly if it is a first-class drug or a drug that works differently than those already on the market, Teck mentioned.

    Additionally, names should also be easy to remember and pronounce, Teck said.

    At her agency, potential names are spoken, sung, shouted and even spoken by people “holding their noses”, she said.

    “We try to imagine someone with a cold, or these days wearing a face mask, walking up to the pharmacy counter and saying the name of the medicine,” Teck said.

    At the same time, with direct-to-consumer advertising of prescription drugs — the United States is one of the few countries in the world that allows it, although it is regulated by the FDA — the name brand name of a drug can also affect its “marketability”. “, according to Goldstone.

    An example of a drug brand name that lends itself well to marketing is the erectile dysfunction drug Viagra, a moniker designed to evoke vitality, virility and vigor, experts said.

    More recently, Comirnaty, the brand name for Pfizer-BioNTech’s COVID-19 vaccine, “represents a combination of the terms COVID-19, mRNA, community, and immunity,” according to the makers and the Miami-based Brand Institute, which helped in the naming process.

    Often these names are tested with groups of doctors, pharmacists and consumers to make sure they resonate with all three, Goldstone said.

    However, given FDA restrictions, the extent to which their feedback ultimately influences the final brand choice is often limited, Ixxeo’s Teck said.

    “This is not an area of ​​pharmaceutical product development that most consumers are aware of,” Johns Hopkins’ Alexander said.

    “Yes, there’s an interest in having something that’s easy to remember, fairly easy to pronounce, and sticky, and the stickier the better, but those are just some of the considerations involved” , did he declare.

    read more
    Medical products

    FDA Suspends Non-Mission-Critical Domestic and Foreign Inspections – Medical Product Supply Chain Week in Review | Alston and bird

    Just before the New Year holidays, the FDA announced it was suspending non-mission-critical domestic and foreign inspection activities. The FDA amended the EUA of the Moderna COVID-19 vaccine recall. The Center for Drug Evaluation and Research has released its annual report. This week, the Senate HELP Committee approved the appointment of Dr. Robert Califf as Commissioner of the FDA. The senators introduced legislation that would require certain foreign establishments to register with the FDA. Please see details of these and other supply chain developments below:

    • On December 29, the FDA implemented changes to its inspection program due to record levels of COVID-19 infections. National mission-critical inspections will continue until January 19, while “some inspection activities” have been temporarily postponed. Mission-critical foreign inspections will continue; however, the agency will reassess feasibility if travel restrictions warrant. The program of priority surveillance foreign inspections which was to begin in February 2022 has been interrupted. It is likely that the FDA will not conduct any uncritical inspections, domestic or foreign, until the United States has passed the peak of the current omicron wave.
    • January 4, HHS amended its declaration under the Public Preparedness and Emergency Preparedness Act (PREP) to include pharmacists and certain pharmacy trainees as “qualified persons” who can administer flu vaccines in states where they are not not authorized or certified. The PREP Act allows the Secretary of HHS to issue a statement and grant immunity from liability to such individuals.
    • On January 5, White House Press Secretary Jen Psaki and Port Envoy to the White House Supply Chain Task Force John Porcari tenuous a briefing on the progress of supply chain improvements and new actions to come. Porcari reported that consumers received 97% to 99% of their packages on time or with minimal delays during the holiday season. Porcari added that the ports of Los Angeles and Long Beach are imposing a new tax on long-lived empty containers. Porcari stressed that procedures are in place to prioritize the distribution of medical supplies. One such procedure is to “bulk stow” medical supplies on ships for easy identification and retrieval. He also discussed the impact of the omicron variant on operations and the procedures in place to deal with any disruptions.
    • On January 7, the FDA amended the EUA of the Moderna COVID-19 vaccine recall. The agency authorized the administration of the booster dose five months (previously six months) after the primary vaccination of the vaccine.
    • On January 10, the FDA Posted draft guidance, “Notification to the FDA of a Permanently Discontinuing or Discontinuing Manufacture of a Device Under 506J of the FD&C Act”. These draft guidelines, authorized under the CARES Act of 2020, are intended to prevent shortages of medical devices before and during a public health emergency and to provide a mechanism by which manufacturers notify the FDA of their intention to cease or suspend production. The draft guidelines apply to “devices essential to public health during a public health emergency, including those that are essential to life, sustaining life or intended for use in the medical care of emergency or during surgery” or “devices for which the FDA determines information about possible significant supply disruptions are needed during or before a public health emergency. Comments are due no later than March 11, 2022.
    • On January 10, Senators Gary Peters (D-MI) and Susan Collins (R-ME) introduced S. 3449, a bill that would require foreign drug and device establishments to register with the FDA whether or not the drug or device undergoes further processing at a separate facility outside the United States. States before being imported into the United States. The goal is to give the FDA greater regulatory oversight authority to not only monitor products entering the supply chain and determine shortages, but also ensure that products are safe for the public. The Bill has been referred to the Health, Education, Labor and Pensions (HELP) Committee.
    • On January 13, the Senate HELP committee vote 13 to 8 to advance the President’s nominee for FDA Commissioner Dr. Robert Califf. His confirmation hearing took place on December 14, 2021. The nomination now goes to the Senate for a final vote and confirmation.
    • FDA Center for Drug Evaluation and Research (CDER) published its annual report, “Advancing Health Through Innovation: New Drug Therapy Approvals”. The report highlights CDER approvals of new therapies, biosimilars, and new indications for approved products. A post-marketing safety surveillance review is also included. The number of products approved (50) was above average despite the pandemic-related challenges, with more than half (27) being first-line drugs. CDER also met its action targets under the Prescription Drug User Fees Act for 49 of the 50 submissions.

    [View source.]

    read more
    Medical products

    Monetizing healthcare with disposable medical products – Hunter Women’s Chronicle

    Reading time:3 minutes, 13 seconds

    This report analyzes the single-use endoscope market, with the United States being the largest. The monetization of healthcare with disposable medical devices and recurring revenue from monitoring, a smaller and lighter product, creates new opportunities for broader consumer and commercial markets. Improving product quality, reducing costs and profitable growth are the keys to dominating this lucrative market. However, poor design and prototype design can be linked to several challenges. Technological innovation, integrated services and reduced R&D costs could significantly increase a company’s revenue.

    Click on the tab below to benefit from the sample copy of the report

    Sample request

    Introduction to Single Use Endoscopes Market

    Strict government regulations make it difficult for doctors, hospitals and large corporations to raise capital in the current economic climate. There has been a shift in the way pharmaceutical organizations have approached the development of disposable medical products. Pharmaceutical companies are now offering their services and expertise in this area to medical device manufacturers without costly milestone payments to third parties.

    Global Endoscope Explosion

    Slowing economic growth and rising import tariffs have led to a slowdown in global healthcare spending, which presents a unique opportunity for the disposable medical products market. This can be attributed in particular to the greatly increased use of endoscopes in recent years. According to Global Industry Analysts (GIA) Inc., one of the leading research companies, there were around 1 billion daisies installed globally across the globe in 2020 alone.

    Defining the key players in the single use endoscopes market

    The pharmaceutical industry is striving to develop and introduce more disposable products, which makes the single-use endoscope market an attractive area for new investment. A few years ago, only knives and needles were included in the disposable medical market as antibacterials. The discovery of a new way to use endoscopes, which includes test strips to determine the appropriate medications that could be prescribed without harming patients while they undergo medical tests, has increasingly served to increase the number of observers included in this market.

    An analysis of the low, medium, high and technological platform; their role in product development

    In March 2020, the American Society of Gastroenterology declared that endoscopes are writable and disposable. This means that with proper treatment and monitoring, these devices can last up to six months, providing a frictionless revenue stream with negligible cost to hospitals. For insights into a new market segment and the opportunities ahead, download the report Single-Use Endoscopes Market: Monetizing Healthcare with Disposable Medical Products today.

    Regulations and cost variables in the preparation of single-use endoscopes

    The use of disposable medical instruments, such as endoscopes, is increasing rapidly. This is due to government regulations and regulatory requirements that reduce costs for outsourced healthcare providers. Additionally, the demand for more flexible options in disposable medical devices is pushing manufacturers towards more specialized instruments with various functionalities.

    Click on the tab below for the instant purchase of the report with a flat rate discount of $500

    Instant Buy Request

    Supply chain approach for manufacturer pharmaceutical process for disposable medical products

    Due to stringent government regulations and increasing attention to patient safety and human factor issues, the healthcare industry is moving towards a system where the emphasis is on the quality life cycle. Patient safety issues leading to contaminated supply chains pose a major challenge to manufacturers. Reports show that healthcare interventions are highly dependent on the use of home medical products, but it has been difficult from a business perspective to effectively plan for a market with multiple users of these products. Manufacturers are required to closely monitor the demand for single-use endoscopes for the development of replacement products. A supply chain approach will be more effective in achieving affordability and meeting regulatory requirements unlike other methods that manufacturers have tried in the past.

    happy

    happy


    0 %

    Sad

    Sad


    0 %

    Excited

    Excited


    0 %

    Sleepy

    Sleepy


    0 %

    Angry

    Angry


    0 %

    Surprise

    Surprise


    0 %

    read more
    Medical products

    FDA suspends non-mission-critical domestic and foreign inspections – Medical Products Supply Chain Week in Review – Food, Drugs, Healthcare, Life Sciences

    United States: FDA suspends non-mission-critical domestic and foreign inspections – Medical Product Supply Chain Week in Review

    To print this article, all you need to do is be registered or log in to Mondaq.com.

    Just before the New Year holidays, the FDA announced it was suspending non-mission-critical domestic and foreign inspection activities. The FDA amended the EUA of the Moderna COVID-19 vaccine recall. The Center for Drug Evaluation and Research has released its annual report. This week, the Senate HELP Committee approved the appointment of Dr. Robert Califf as Commissioner of the FDA. The senators introduced legislation that would require certain foreign establishments to register with the FDA. Please see details of these and other supply chain developments below:

    • On December 29, the FDA implemented changes to its inspection program due to record levels of COVID-19 infections. National mission-critical inspections will continue until January 19, while “some inspection activities” have been temporarily postponed. Mission-critical foreign inspections will continue; however, the agency will reassess feasibility if travel restrictions warrant. The program of priority surveillance foreign inspections which was to begin in February 2022 has been interrupted. It is likely that the FDA will not perform any uncritical inspections, domestic or foreign, until the United States has passed the peak of the current omicron wave.
    • January 4, HHS amended its declaration under the Public Preparedness and Emergency Preparedness Act (PREP) to include pharmacists and certain pharmacy trainees as “qualified persons” who can administer flu vaccines in states where they are not not authorized or certified. The PREP Act allows the Secretary of HHS to issue a statement and grant immunity from liability to such individuals.
    • On January 5, White House Press Secretary Jen Psaki and Port Envoy to the White House Supply Chain Task Force John Porcari tenuous a briefing on the progress of supply chain improvements and new actions to come. Porcari reported that consumers received 97% to 99% of their packages on time or with minimal delays during the holiday season. Porcari added that the ports of Los Angeles and Long Beach are imposing a new tax on long-lived empty containers. Porcari stressed that procedures are in place to prioritize the distribution of medical supplies. One such procedure is to “bulk stow” medical supplies on ships for easy identification and removal. He also discussed the impact of the omicron variant on operations and the procedures in place to deal with any disruptions.
    • On January 7, the FDA amended the EUA of the Moderna COVID-19 vaccine recall. The agency authorized the administration of the booster dose five months (previously six months) after the primary vaccination of the vaccine.
    • On January 10, the FDA Posted draft guidance, “Notification to the FDA of a Permanently Discontinuing or Discontinuing Manufacture of a Device Under 506J of the FD&C Act.” These draft guidelines, authorized under the CARES Act of 2020, are intended to prevent shortages of medical devices before and during a public health emergency and to provide a mechanism by which manufacturers notify the FDA of their intention to cease or suspend production. The draft guidelines apply to “devices essential to public health during a public health emergency, including those that are essential to life, sustaining life or intended for use in the medical care of emergency or during surgery” or “devices for which the FDA determines information about possible significant supply disruptions are needed during or before a public health emergency.” Comments are due by March 11, 2022.
    • On January 10, Senators Gary Peters (D-MI) and Susan Collins (R-ME) introduced S. 3449, a bill that would require foreign drug and device establishments to register with the FDA whether or not the drug or device undergoes further processing at a separate facility outside the United States. States before being imported into the United States. The goal is to give the FDA greater regulatory oversight authority to not only monitor products entering the supply chain and determine shortages, but also ensure that products are safe for the public. The Bill has been referred to the Health, Education, Labor and Pensions (HELP) Committee.
    • On January 13, the Senate HELP committee vote 13 to 8 to advance the President’s nominee for FDA Commissioner Dr. Robert Califf. His confirmation hearing took place on December 14, 2021. The nomination now goes to the Senate for a final vote and confirmation.
    • FDA Center for Drug Evaluation and Research (CDER) published its annual report, “Advancing Health Through Innovation: Approvals of New Drug Therapies”. The report highlights CDER approvals of new therapies, biosimilars, and new indications for approved products. A post-marketing safety surveillance review is also included. The number of products approved (50) was above average despite pandemic-related challenges, with more than half (27) being first-line drugs. CDER also met its action targets under the Prescription Drug User Fees Act for 49 of the 50 submissions.

    The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

    POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

    read more
    Prescription drugs

    This is why prescription drugs are so expensive

    Oligopoly: a state of limited competition, in which a market is shared by a small number of producers or sellers.

    SALT LAKE CITY — Why are prescription drugs so expensive? An advocate for open access, transparency and competitive markets in the pharmaceutical industry shares his mind-blowing insights into the prescription drug industry and how insiders, whose job it is to watch over consumers, rake in a fortune.

    Welcome to the show

    Heather Kelly, host of Money Making Sense, talks with Antonio Ciaccia, president of 3 Axis Advisors, about pharmacy benefit managers and their role in controlling prescription drug costs.

    “How do prescription drugs get to our pharmacies? asked Kelly.

    In simple terms, Ciaccia explained the main pillars of the prescription drug supply chain:

    • A drug manufacturer sells to a drug wholesaler, such as McKesson, Cardinal Health, or AmerisourceBergen.
    • The wholesaler then sells the medicine to pharmacies, hospitals and medical practices.
    • And with each step, the price of the drug increases for the end consumer.

    PBMs administer prescription drug benefits on behalf of health insurers, Medicare Part D drug plans, large employers and other payers.

    By negotiating with drug manufacturers and pharmacies to control drug spending, PBMs have a significant behind-the-scenes impact on determining total drug costs for insurers, patient access to drugs, and provider compensation. pharmacies, according to the Commonwealth Fund.

    “Keep these discounts to themselves”

    “They’re not doing a great job, especially for my mom,” Kelly said, explaining that her mom, who is on Medicare, pays $250 out of pocket every month for a drug she needs. “She still has to buy four or five more. So these PBMs don’t do a great job. I’m just telling you now.

    “Unfortunately, the system was supposed to work much better,” Ciaccia said.

    He added that PBMs were designed to counterbalance the drugmaker, wholesalers and pharmacies and negotiate greater discounts for consumers.

    “The problem is that PBMs are really good at negotiating these discounts, but they’re even better at keeping these discounts to themselves, often forcing the patient to pay the full list price when they’ve negotiated a price themselves. far different and better for himself,” he said.

    Ciaccia said PBMs used to be just claims processors, but have since landed on the list of America’s biggest and richest companies.

    The top 10 Fortune 500 companies in the United States include:

    • CVS Health, owner of CVS Pharmacy, a chain of retail pharmacies; CVS Caremark, a pharmaceutical benefits manager;
      UnitedHealthGroup, which offers healthcare products and insurance services;
      McKesson, which distributes pharmaceuticals and provides health information technology, medical supplies and care management tools; and
      AmerisourceBergen, a wholesale drug company.

    Who watches the watchdog?

    “They’re bigger than the pharmaceutical companies and drugmakers they were hired to police in the first place,” Ciaccia said.

    He said PBMs ended up making prescription drug pricing more complicated and expensive.

    “The PBM uses all of us as individuals to negotiate deep discounts that they get at the end of the transaction. But they don’t pass them on to us as a patient,” Ciaccia said.

    Heather said her blood was starting to boil “a little bit right now”.

    No one knows the price of drugs

    Ciaccia said if you walked into a grocery store and it cost $20 for a gallon of milk, you’d know right away you were being ripped off. You would take your money to another grocery store where the price of milk would match market expectations.

    It’s “what ultimately holds quality and price accountable in your grocery store. Nobody knows what the prices of thousands of different drugs are or what they should be,” he said.

    Ciaccia said that due to the “enormous” lack of transparency, the pharmaceutical market is ripe for exploitation.

    “Let’s be clear, PBMs aren’t the only villains in the drug supply chain, but they’re the only ones whose existence is predicated on trying to save us money,” he said. declared.

    Related:

    read more
    Medical products

    2022 Emergency Oxygen Kits Market Analysis by Major Key Players

    New Jersey, United States,-

    A new report titled “(Emergency Oxygen Kits Market)” by Market Research Intellect sheds light on the industry dynamics and current and future trends that play a key role in determining the expansion of the market. ‘business. The report also highlights the key driving factors and restraints affecting the growth. For a comprehensive understanding, experts reviewed regulatory scenarios, market entry strategies, industry best practices, pricing strategies, technology and consumer environment, sales and demand outlook . It also included growth estimates to provide users with accurate statistics and facts. The report will provide readers with a broader and more transparent picture of the overall scenario.

    Corona impact outlook 19

    This section of the report shows the impact of the global Corona outbreak on businesses. The report describes the impact on manufacturing activity, production, demand, supply chain, logistics management and distribution networks. The analysts have highlighted the measures or strategies taken by the company to combat the impact of Corona 19. In addition, they have identified a major opportunity to emerge after Corona 19. This will help players take advantage of the opportunity to recover losses and stabilize the activity.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=559836

    Additionally, market revenue based on region and country is provided in the Emergency Oxygen Kits report. The authors of the report also shed light on common business tactics adopted by players. Key players of the global Emergency Oxygen Kits market and their comprehensive profiles are included in the report. Additionally, investment opportunities, recommendations, and current trends in the global Emergency Oxygen Kits market are mapped by the report. Using this report, key players in the global Emergency Oxygen Kits Market will be able to make sound decisions and plan their strategies accordingly to stay ahead.

    The competitive landscape is an essential aspect that every key player must know. The report highlights the competitive scenario of the Global Emergency Oxygen Kits Market to know the competition at country and global level. Market experts have also provided an outline of each major player in the global Emergency Oxygen Kits market, considering key aspects such as business areas, production, and product portfolio. Additionally, the companies in the report are studied based on key factors such as company size, market share, market growth, revenue, production volume, and profit.

    Major Players Covered by Emergency Oxygen Kits Markets:

    • Mada Medical Products
    • Inc.
    • Marine Medical Antibes
    • Corporate Life
    • FERNO
    • Allied Health Care
    • Mega medical

    Emergency Oxygen Kits Market Split By Type:

    Emergency Oxygen Kits Market Split By Application:

    • Hospitals and Clinics
    • Industrial and factories
    • Public facilities

    The Emergency Oxygen Kits Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Emergency Oxygen Kits Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Emergency Oxygen Kits market and its growth potential in the years future.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=559836

    Scope of the Emergency Oxygen Kits Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Analysis of the Emergency Oxygen Kits Market can be represented as follows:

    Each regional Emergency Oxygen Kits industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global emergency oxygen kit market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Answers to key questions in the report:

    • What is the growth potential of the Emergency Oxygen Kits markets?
    • Which product segment will take the lion’s share?
    • Which regional market will impose itself as a precursor in the years to come?
    • Which application segment will grow at a rapid pace?
    • What are the growth opportunities that may emerge in the Lock Washers industry in the coming years?
    • What are the major challenges that the global emergency oxygen kit markets may face in the future?
    • Who are the leading companies in the Global Emergency Oxygen Kits Market?
    • What are the key trends that are positively impacting market growth?
    • What are the growth strategies considered by the players to maintain their hold in the global emergency oxygen kits market?

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-emergency-oxygen-kits-market-size-forecast/

    The study thoroughly explores the profiles of major market players and their major financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the Emergency Oxygen Kits market production, revenue, market share and growth rate for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical failure data of emergency oxygen kits from 2016 to 2020 and forecast to 2021-2029.

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. customers, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical supplies

    Life for Relief and Development (LIFE) provides millions of medical supplies worldwide

    Image captured from an ambulance donated by LIFE in Bangladesh

    Image captured of medical supplies distributed in Sierra Leone

    LIFE is providing nearly $10 million worth of medical supplies during 2021 to eight different countries around the world

    SOUTHFIELD, MICHIGAN, USA, January 13, 2022 /EINPresswire.com/ — Many countries around the world lack essential health care and the COVID-19 pandemic has only made these situations worse. To help fill this shortage, Life for Relief and Development (LIFE) sent a total of 21 shipments to eight different countries around the world, totaling almost $10 million during 2021. Countries such as Somalia, Somaliland, Lebanon, Mali, Senegal, Sierra Leone , Pakistan and Ghana have all benefited from these remittances. Medical supplies included a variety of items, as needed, such as PPE, respiratory supplies, surgical equipment, wheelchairs, walkers, crutches, oxygen concentrators and more. Ambulances were also donated to Lebanon and Bangladesh to improve transport to health facilities.

    “The helping hand you extended and your generous donation of medical supplies and medical equipment have been well received and will go to our general hospital to continue serving our community. Thank you once again for your kind and generous support and we look forward to maintaining a liaison with you,” said Sister Nicolas Akiki, Director of Wardieh Hospital – Rosary Sisters Hospital in Lebanon.

    LIFE is constantly striving to get medical supplies to the countries that need them most, and at times like these, many countries are in dire need of help.

    “Health care is a right, not a privilege, and we make it our priority at LIFE to be able to provide it to those in need around the world, giving hope to those who may not see not the light at the end of a very dark time. After all, where there is LIFE, there is hope,” said Dr. Hany Saqr, CEO of LIFE.

    Life for Relief and Development is a global relief and development organization, headquartered in Southfield, Michigan, USA. Life is dedicated to providing humanitarian aid to people regardless of race, gender, religion and cultural background. As a registered 501(c)(3) nonprofit organization, Life has consultative status with the United Nations Economic and Social Council. He is also a member of InterAction, the largest alliance of US-based NGOs and partners of humanitarian agencies such as UNICEF, Brothers Brother Foundation and World Medical Relief. Over the past 29 years, LIFE has distributed more than $520 million in humanitarian and relief aid to more than 46 countries. Life works diligently to help the poor and needy in a number of countries such as: Afghanistan, Ghana, Haiti, Iraq, Jordan, Lebanon, Pakistan, Palestine (through our office in Israel), Sierra Leone, Syria and the United States as well. like other countries. When natural disasters strike, LIFE rushes in to answer the call for help and provide basic humanitarian aid.

    Hala M Sanyurah
    +1 330-815-4706
    [email protected]
    Life for relief and development
    Visit us on social media:
    Facebook
    Twitter
    Other

    read more
    Medical supplies

    ISSA Trust and Partners For World Health Donate $ 57 Million in Medical Supplies

    Issa Trust Foundation (ITF) delivered PPE, medical supplies and equipment worth around $ 57 million to regional health authorities in the West and North East.

    The 40 foot donation container included vital oxygen concentrators, approximately 400,000 KN95 and surgical masks, face shields, approximately 12,000 isolation gowns; 2,888 gallons of bleach and hand sanitizers and wipes; neonatal monitors; patient monitors; lab coats, lab supplies and thousands of gloves and many other items.

    Since 2005, the Issa Trust Foundation has worked to create and strengthen sustainable health and education programs in the communities where Couples Resorts employees live and work.

    The total value of donations made last year is approximately $ 675 million.

    “The pandemic has provided an opportunity to strengthen existing relationships in Jamaica and the United States,” commented Diane Pollard, ITF President and CEO. “Access to equipment and supplies and harnessing resources are all important to impacting children and families, and closer partnerships will provide and facilitate, and ultimately improve, the care of a particular population. vulnerable during this period. “

    Partners for World Health (PWH) and the Issa Trust Foundation (ITF) have been proud collaborators for many years, noted Elizabeth McLellan, President and Founder of PWH.

    “PWH is proud of our ability to support the aspirations of the ITF and help the Jamaican people. In the past year alone, we’ve increased our ability to help our partners with more equipment and supplies, especially to help hospitals, medical teams, and people deal with the additional challenges of COVID-19. I look forward to a long and lasting partnership with the ITF, ”she said.

    read more
    Medical products

    Alimed, Bioseal, Cypress Medical Products, Deroyal, Dukal Corporation, Dynarex Corporation – Industrial Computing

    The global tourniquet market 2021 The report is a collection of details related to each market related parameter. Each aspect is studied in detail in the analysis report. The market analysis report provides a comprehensive analysis of all financial topics associated with the Tourniquet industry. The growth pattern observed in the Turnstile industry performance over time is studied in the market report. The study helps provide an in-depth understanding of fundamental changes in the state of the market over time. The analysis report also provides an in-depth discussion about all the aspects that are likely to impact on the performance of the Tourniquet market.

    The report profiles the following companies, which include

    • Alimed
    • Bioseal
    • Cypress Medical Products
    • Deroyal
    • Dukal Corporation
    • Dynarex Company
    • Graham-Field Inc
    • Integrated Life Sciences
    • Medline
    • Cardinal Health
    • Patterson Medical
    • Stryker
    • Tetra Medical Supply Corp
    • VBM
    • Zimmer
    • Longtai
    • Lantian

    The industry report analyzes the set of deliberate movements in the Tourniquet industry on a global level. The research includes an in-depth study of the growth and development activities taking place in the Tourniquet industry. The research based on the global Turnstiles market provides details associated with fundamental events and investments made in the market. The research provides details related to popular trends widely accepted by entities in the Tourniquet market. The industry analysis report includes an in-depth discussion of several industry analysis strategies used by researchers while documenting the research.

    Download a free sample at: https://courant.biz/report/global-tourniquet-market/61152/

    Global Tourniquets Market: Product Segment Analysis

    • Non-inflatable tourniquets (electronic tourniquet systems connected to inflatable armbands.)
    • Pneumatic tourniquets, the cuffs of which are inflated by compressed gas.

    Global Tourniquets Market: Application Segment Analysis

    • Surgical framework
    • Emergency use

    Global Tourniquet Market: Regional Segment Analysis

    • United States
    • Europe
    • Japan
    • China
    • India
    • South East Asia

    Research includes the analysis of all deliberate movements, policies, technological developments, discoveries, trends, tools, products, development plans, news, etc. The analysis of the global Tourniquet market covers detailed data about the anticipated growth rate for the anticipated era. In addition, a detailed discussion about the future scope of the Turnstile market is also included in the study report. The report on the global Tourniquet industry focuses on the expansion of the market in the coming times. It offers readers detailed data on several strategies and development plans implemented by market entities across the world. The report aims to provide a 360 degree view of the tourniquet industry.

    The content of the study topics includes a total of 10 chapters:

    1. About Tourniquet Industry (Industry Definition, Types, Main Market Activities)
    2. Global Market Competition Landscape (Markets by Regions, Market Revenue (M USD), Market Sales and Growth Rate 2016-2021, Major Players Revenue by Regions)
    3. Global Tourniquet Market Share (Production and Revenue Market Share by Regions and Players)
    4. Supply chain (raw material analysis, raw material market analysis, cost of production, manufacturing equipment and end user analysis)
    5. Company Profiles (Company Details, Product Info, Revenue, Profit Analysis)
    6. Globalization and commerce (business locations, supply channels, marketing strategy, etc.)
    7. Distributors and customers (Information on the main distributors and customers by region)
    8. Import, export, consumption and consumption value by major countries
    9. Global Tourniquet Market Forecast to 2026 (Demand, Price Revenue, Regions, Types, Applications)
    10. Key success factors and market overview

    Access the full report here:https://courant.biz/report/global-tourniquet-market/61152/

    Customization of the report:

    This report can be customized to meet customer requirements. Please connect with our sales team ([email protected]), which will make sure you get a report that’s right for you. You can also contact our leaders at +1 (210) 807 3402 to share your research needs.

    Contact us:
    Nancy smith
    Business sales specialist
    [email protected]
    Phone number: United States: +1 (210) 807 3402
    current.biz

    read more
    Generic drugs

    Fitch, Health News, ET HealthWorld

    India will become the world’s largest production hub for general Covid-19 antiviral drugs after the Drugs Controller granted emergency use authorization to several pharmaceutical companies in the country to manufacture and market generic versions of molnupiravir, said Fitch Solutions on Friday.

    Increased access to molnupiravir will keep hospitalizations and deaths in India manageable as Omicron infections rise, Fitch Solutions said in a report.

    Those that have obtained clearance from the Drugs Controller General of India (DCGI) include Dr. Reddy’s Laboratories, Torrent Pharmaceuticals, Cipla, Sun Pharma, Natco Pharma, Viatris, Hetero Drugs and Mankind Pharma.

    Lagevrio (Molnupiravir) was developed by Merck and Ridgeback Biotherapeutics, and it is the first-ever oral antiviral drug for the treatment of high-risk adults with mild to moderate Covid-19.

    Following clearance, Cipla, Sun Pharma and Dr. Reddy’s Laboratories are expected to market molnupiravir capsules in the coming weeks, with other companies to follow.

    “This will make India the world’s largest hub for the production of generic Covid-19 antiviral drugs,” he said. “Efficacy of molnupiravir during its Phase III MOVe-OUT trial has been broadly promising, with a 50% reduction in hospitalizations and deaths in early-stage infections.” However, safety concerns remain over its risk of inducing harmful mutagenesis if the drug is prescribed worldwide, creating the potential for new strains of Covid-19.

    The second wave of Covid-19 in India peaked in April and May 2021 when daily average cases exceeded 4 lakh. The number of cases has fallen significantly since then, with the national tally remaining below 10,000 cases per day for the rest of the year.

    However, in recent days there has been an increase in daily cases of Covid-19 driven by the Omicron variant which is expected to overtake Delta as the dominant variant.

    On January 6, 2022, Covid-19 cases rose to 1,17,100, with 3,007 cases confirmed to be the Omicron variant, according to the Union Health Ministry.

    “Additionally, India continues to lag behind in its Covid-19 vaccine rollout target as 44.5% of the population has been fully vaccinated,” Fitch Solutions quoted Our World In Data as saying. “Therefore, given the slow pace of vaccination and the recent sharp increase in Covid-19 cases, generic versions of molnupiravir could significantly reduce the risk of hospitalization or death.”

    Generic molnupiravir will increase access in India and other low- and middle-income (LMIC) countries, while simplifying current supply chain barriers, he said.

    A full five-day course of molnupiravir in the United States costs around US$712 (Rs. 52,909). Generic versions of the drug will cost between $18.79 (about Rs. 1,400) and $21.48 (about Rs. 1,600) for a five-day course, which is significantly lower, according to Fitch Solutions.

    For example, Dr. Reddy has priced his generic version of molnupiravir, molflu, at US$0.4693 (Rs. 35) per capsule and US$18.79 (Rs. 1,400) for a five-day course of 40 capsules. .

    “With this relatively low cost, we expect generic versions of molnupiravir to significantly increase access in India and other LRICs after regulatory approvals,” he said.

    Additionally, these oral antiviral drugs will result in lower transportation and distribution costs compared to intravenous Covid-19 antivirals such as Ronapreve (casirivimab/imdevimab) or Veklury (remdesivir).

    Having a solid and compact shape, oral medications do not require glass vial containment requirement and the tablets can be packed tightly without risk of breakage. Likewise, more of the drug can be contained in a defined space, increasing the rate at which the drug can be dispensed, he added.

    read more
    Generic drugs

    Outlook Analysis of Generic Inhalation Nasal Spray Drugs Market 2021 by Major Key Players

    New Jersey, United States, – The global Generic Inhalation and Nasal Spray Drugs Market report is one of the most comprehensive and significant addition to the market research archive of Market Research Intellect. Provides detailed research and analysis of the major aspects of the global Generic Inhalation and Nasal Spray Drugs market. The market analysts who produced the report have provided detailed information on key growth drivers, restraints, challenges, trends, and opportunities to provide a comprehensive analysis of the global Generic Inhalation and Nasal Spray Drugs market. Market players can use the analysis of market dynamics to plan effective growth strategies and prepare for future challenges in advance.

    Each trend in the global Generic Inhalation Nasal Spray Drugs market is carefully analyzed and researched by market analysts. Market analysts and researchers have performed an in-depth analysis of the global Generic Inhalation Nasal Spray market using research methodologies such as Pestle and Porter’s Five Forces Analysis.

    They have provided accurate and reliable market data and helpful recommendations with the aim of helping players gain insight into the overall current and future market scenario. The Generic Inhalation and Nasal Spray Drugs report includes in-depth research on potential segments, including product types, applications, and end-users, along with their contribution to the overall market size.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=276114

    The Major Players Covered By Generic Inhalation And Nasal Spray Drugs Markets:

    • Suits you
    • Beximco Pharma
    • Sandoz (Novartis SA)
    • Allergan SA
    • Cipla
    • Mylan
    • Sun Pharma (Ranbaxy)
    • Akorn
    • Nephron Pharma
    • Apotex
    • Hikma (Roxane)
    • XIANJU PHARMA

    Market segmentation of automated drug delivery systems:

    The Automated Drug Delivery Systems market report has categorized the market into segments comprising product type and application. Each segment is evaluated based on share and growth rate. Meanwhile, analysts looked at potential areas that could prove rewarding for builders in the years to come. The regional analysis includes reliable forecast on value and volume, thereby helping market players to gain in-depth insights into the entire industry.

    Generic inhalation and nasal spray market breakdown by type:

    • Corticosteroids
    • Bronchodilators
    • Combinations
    • Decongestant sprays
    • Others

    Generic Inhalation Nasal Spray Drugs Market Split By Application:

    • Asthma
    • COPD
    • Allergic rhinitis
    • Other

    Based on geography: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina and Colombia, etc.), Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa).

    Get | Discount on purchasing this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=276114

    Scope of Generic Inhalation Nasal Spray Drugs Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in millions of USD and CAGR from 2021 to 2027
    Covered segments Types, applications, end users, etc.
    Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free customization of reports (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
    Price and purchase options Take advantage of custom shopping options to meet your exact research needs. Explore purchasing options

    Key questions answered in the report:

    • What is the growth potential of the generic inhalation and nasal spray markets?
    • Which product segment will take the lion’s share?
    • Which regional market will emerge as a precursor in the years to come?
    • Which application segment will grow at a sustained rate?
    • What are the growth opportunities that could emerge in the lock washer industry in the years to come?
    • What are the main challenges that the global generic inhalation and nasal spray markets may face in the future?
    • Who are the major companies in the global generic inhalation and nasal spray market?
    • What are the main trends that are positively impacting the growth of the market?
    • What are the growth strategies considered by the players to maintain their grip on the global Generic Inhalation and Nasal Spray Drugs market?

    For more information or a query or a personalization before purchasing, visit @ https://www.marketresearchintellect.com/product/global-inhalation-nasal-spray-generic-drugs-market-size-and-forecast/

    The study thoroughly explores the profiles of the major market players and their main financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the production, revenue, market share and growth rate of the Generic Inhalation and Nasal Spray Drugs market for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical generic inhalation and nasal spray distribution data from 2016 to 2020 and forecast to 2021-2029.

    About Us: Market Research Intelligence

    Market Research Intellect provides syndicated and personalized research reports to clients from various industries and organizations in addition to the goal of providing personalized and in-depth research studies. range of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients make more data-driven decisions, admit push predictions, grossly capitalize on opportunities, and maximize efficiency by acting as their criminal belt to adopt accurate mention and essential without compromise. clients, we have provided expertly-behaved affirmation research facilities to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    United States: +1 (650) -781-48080
    UK: +44 (753) -715-0008
    APAC: +61 (488) -85-9400
    US Toll Free: +1 (800) -782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Prescription drugs

    Analysis of 2021 Non-prescription Drugs Market Outlook by Major Key Players

    New Jersey, United States, – The Global Non-Prescription Drugs Market report is one of the most comprehensive and significant addition to the market research archive of Market Research Intellect. Provides detailed research and analysis of the major aspects of the global Non-Prescription Drugs market. The market analysts who produced the report have provided in-depth information on key growth drivers, restraints, challenges, trends, and opportunities to provide a comprehensive analysis of the global Non-Prescription Drugs Market. Market players can use the analysis of market dynamics to plan effective growth strategies and prepare for future challenges in advance.

    Each trend in the global Non-Prescription Drugs market is carefully analyzed and researched by market analysts. Market analysts and researchers have performed an in-depth analysis of the global non-prescription drug market using research methodologies such as Pestle and Porter’s Five Forces Analysis.

    They have provided accurate and reliable market data and helpful recommendations with the aim of helping players gain insight into the overall current and future market scenario. The Non-prescription Drugs report includes in-depth research on potential segments including product types, applications, and end-users, along with their contribution to the overall market size.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=215723

    The main players covered by the non-prescription drugs markets:

    • Pfizer
    • rock
    • Sanofi
    • Johnson & johnson
    • Merck & Co. (msd)
    • Novartis
    • Abbvie
    • Gilead Sciences
    • Glaxosmithkline (gsk)
    • Amgen
    • Astrazeneca
    • Bristol-myers Squibb
    • Eli lilly
    • Suits you
    • Bayer
    • Novo Nordisk
    • Allergan
    • Takeda
    • Boehringer Ingelheim
    • Takeda

    Market segmentation of automated drug delivery systems:

    The Automated Drug Delivery Systems market report has categorized the market into segments comprising product type and application. Each segment is evaluated based on share and growth rate. Meanwhile, analysts looked at potential areas that could prove rewarding for builders in the years to come. The regional analysis includes reliable forecast on value and volume, thereby helping market players to gain in-depth insights into the entire industry.

    Market Breakdown of Non-Prescription Drugs by Type:

    Non-prescription Drugs Market Split By Application:

    Based on geography: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina and Colombia, etc.), Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa).

    Get | Discount on purchasing this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=215723

    Scope of Non-Prescription Drugs Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in millions of USD and CAGR from 2021 to 2027
    Covered segments Types, applications, end users, etc.
    Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free customization of reports (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
    Price and purchase options Take advantage of custom shopping options to meet your exact research needs. Explore purchasing options

    Key questions answered in the report:

    • What is the growth potential of the non-prescription drug markets?
    • Which product segment will take the lion’s share?
    • Which regional market will emerge as a precursor in the years to come?
    • Which application segment will grow at a sustained rate?
    • What are the growth opportunities that could emerge in the lock washer industry in the years to come?
    • What are the main challenges that the global Non-Prescription Drug markets could face in the future?
    • Who are the leading companies in the global non-prescription drug market?
    • What are the main trends that are positively impacting the growth of the market?
    • What are the growth strategies envisioned by the players to maintain their grip on the global Non-Prescription Drugs market?

    For more information or a query or a personalization before purchasing, visit @ https://www.marketresearchintellect.com/product/global-non-prescription-drugs-market-size-and-forcast/

    The study thoroughly explores the profiles of the major market players and their main financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the production, revenue, market share and growth rate of the Non-prescription Drugs market for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical non-prescription drug breakdown data from 2016 to 2020 and forecast to 2021-2029.

    About Us: Market Research Intelligence

    Market Research Intellect provides syndicated and personalized research reports to clients from various industries and organizations in addition to the goal of providing personalized and in-depth research studies. range of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients make more data-driven decisions, admit push predictions, grossly capitalize on opportunities, and maximize efficiency by acting as their criminal belt to adopt accurate mention and essential without compromise. clients, we have provided expertly-behaved affirmation research facilities to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    United States: +1 (650) -781-48080
    UK: +44 (753) -715-0008
    APAC: +61 (488) -85-9400
    US Toll Free: +1 (800) -782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Prescription drugs

    Dog Prescription Drug Market Drivers and Restraints for Each Segment

    New Jersey, United States, – The Global Dog Prescription Drugs Market report is one of the most comprehensive and significant additions to the market research archive of Market Research Intellect. Provides detailed research and analysis of the major aspects of the global Dog Prescription Drugs market. The market analysts who produced the report have provided detailed information on key growth drivers, restraints, challenges, trends, and opportunities to provide a comprehensive analysis of the global Prescription Drugs for Dogs market. Market players can use the analysis of market dynamics to plan effective growth strategies and prepare for future challenges in advance.

    Each trend in the global Prescription Drugs for Dogs market is carefully analyzed and researched by market analysts. Market analysts and researchers have performed an in-depth analysis of the global prescription dog drugs market using research methodologies such as Pestle and Porter’s Five Forces Analysis.

    They have provided accurate and reliable market data and helpful recommendations with the aim of helping players get an overview of the overall current and future market scenario. The Dog Prescription Drugs report includes in-depth research on potential segments including product types, applications, and end-users along with their contribution to the overall market size.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=228634

    The Major Players Covered By The Prescription Drugs For Dogs Markets:

    • Elanco Animal Health
    • Ceva Animal Health
    • MSD Animal Health
    • Zoetis
    • Virbac
    • Dechra
    • Vetoquinol
    • Animal care group
    • Ourofino Saude Animal
    • Boehringer Ingelheim

    Market segmentation of automated drug delivery systems:

    The Automated Drug Delivery Systems market report has categorized the market into segments comprising by product type and application. Each segment is evaluated based on share and growth rate. Meanwhile, analysts looked at potential areas that could prove rewarding for builders in the years to come. The regional analysis includes reliable forecast on value and volume, thereby helping market players to acquire in-depth insights into the entire industry.

    Prescription Dog Medication Market Split By Type:

    • Oral type
    • Type of smear
    • Injection type
    • Spray type

    Dog Prescription Drugs Market Split By Application:

    Based on geography: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina and Colombia, etc.), Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa).

    Get | Discount on purchasing this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=228634

    Scope of Dog Prescription Drugs Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in millions of USD and CAGR from 2021 to 2027
    Covered segments Types, applications, end users, etc.
    Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free customization of reports (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
    Price and purchase options Take advantage of custom shopping options to meet your exact research needs. Explore purchasing options

    Key questions answered in the report:

    • What is the growth potential of the Prescription Drugs for Dogs markets?
    • Which product segment will take the lion’s share?
    • Which regional market will emerge as a precursor in the years to come?
    • Which application segment will grow at a sustained rate?
    • What are the growth opportunities that could emerge in the lock washer industry in the years to come?
    • What are the major challenges that the global Prescription Drugs for Dogs markets could face in the future?
    • Who are the major companies in the global prescription dog medication market?
    • What are the main trends that are positively impacting the growth of the market?
    • What are the growth strategies envisioned by the players to maintain their hold on the global Dog Medicines market?

    For more information or a query or a personalization before purchasing, visit @ https://www.marketresearchintellect.com/product/global-dog-prescription-drugs-market-size-and-forecast/

    The study thoroughly explores the profiles of the major market players and their main financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the production, revenue, market share and growth rate of the Prescription Drugs market for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical dog prescription drug distribution data from 2016 to 2020 and forecast to 2021-2029.

    About Us: Market Research Intelligence

    Market Research Intellect provides syndicated and personalized research reports to clients from various industries and organizations in addition to the goal of providing personalized and in-depth research studies. range of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients make more data-driven decisions, admit push predictions, grossly capitalize on opportunities, and maximize efficiency by acting as their criminal belt to adopt accurate mention and essential without compromise. clients, we have provided expertly-behaved affirmation research facilities to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    United States: +1 (650) -781-48080
    UK: +44 (753) -715-0008
    APAC: +61 (488) -85-9400
    US Toll Free: +1 (800) -782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Prescription drugs

    Analysis of 2021 Pet Prescription Drugs Market Outlook by Major Key Players

    New Jersey, United States, – The Global Pet Prescription Drugs Market report is one of the most comprehensive and significant addition to the market research archive of Market Research Intellect. Provides detailed research and analysis of the major aspects of the global Animal Prescription Drugs market. The market analysts who produced the report have provided detailed information on key growth drivers, restraints, challenges, trends, and opportunities to provide a comprehensive analysis of the global Animal Drugs market. Market players can use the analysis of market dynamics to plan effective growth strategies and prepare for future challenges in advance.

    Each trend in the global Animal Drugs market is carefully analyzed and studied by market analysts. Market analysts and researchers have performed an in-depth analysis of the global pet prescription drugs market using research methodologies such as pestle and Porter’s five forces analysis.

    They have provided accurate and reliable market data and helpful recommendations with the aim of helping players get an overview of the overall current and future market scenario. The Pet Prescription Drugs report includes in-depth research on potential segments including product types, applications, and end-users along with their contribution to the overall market size.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=228630

    The Major Players Covered By The Pet Prescription Drugs Markets:

    • Elanco Animal Health
    • Ceva Animal Health
    • MSD Animal Health
    • Zoetis
    • Virbac
    • Dechra
    • Vetoquinol
    • Animal care group
    • Ourofino Saude Animal
    • Boehringer Ingelheim

    Market segmentation of automated drug delivery systems:

    The Automated Drug Delivery Systems market report has categorized the market into segments comprising product type and application. Each segment is evaluated based on share and growth rate. Meanwhile, analysts looked at potential areas that could prove rewarding for builders in the years to come. The regional analysis includes reliable forecast on value and volume, thereby helping market players to gain in-depth insights into the entire industry.

    Prescription Medicines for Animals Market Breakdown by Type:

    • Oral type
    • Type of smear
    • Injection type
    • Spray type

    Animal Medicines Market Split By Application:

    • Pet
    • Livestock

    Based on geography: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina and Colombia, etc.), Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa).

    Get | Discount on purchasing this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=228630

    Scope of Pet Prescription Drugs Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in millions of USD and CAGR from 2021 to 2027
    Covered segments Types, applications, end users, etc.
    Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free customization of reports (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
    Price and purchase options Take advantage of custom shopping options to meet your exact research needs. Explore purchasing options

    Key questions answered in the report:

    • What is the growth potential of the pet prescription drug markets?
    • Which product segment will take the lion’s share?
    • Which regional market will emerge as a precursor in the years to come?
    • Which application segment will grow at a sustained rate?
    • What are the growth opportunities that could emerge in the lock washer industry in the years to come?
    • What are the main challenges that the global pet prescription drug markets may face in the future?
    • Who are the leading companies in the global veterinary drugs market?
    • What are the main trends that are positively impacting the growth of the market?
    • What are the growth strategies envisioned by the players to maintain their grip on the global veterinary drugs market?

    For more information or a query or a personalization before purchasing, visit @ https://www.marketresearchintellect.com/product/global-animal-prescription-drugs-market-size-and-forecast/

    The study thoroughly explores the profiles of the major market players and their main financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the production, revenue, market share and growth rate of the Animal Drugs market for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical animal prescription drug breakdown data from 2016 to 2020 and forecast to 2021-2029.

    About Us: Market Research Intelligence

    Market Research Intellect provides syndicated and personalized research reports to clients from various industries and organizations in addition to the goal of providing personalized and in-depth research studies. range of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients make more data-driven decisions, admit push predictions, grossly capitalize on opportunities, and maximize efficiency by acting as their criminal belt to adopt accurate mention and essential without compromise. clients, we have provided expertly-behaved affirmation research facilities to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    United States: +1 (650) -781-48080
    UK: +44 (753) -715-0008
    APAC: +61 (488) -85-9400
    US Toll Free: +1 (800) -782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical supplies

    Disposable Medical Supplies Market 2022 by Types, Applications, and Major Key Players – Abbott, Baxter, Weigao, Medtronic, Novartis – Industrial IT

    Disposable Medical Supplies Market Report is the most important research for those looking for comprehensive information about Disposable Medical Supplies Markets. The report covers all the information on the global and regional markets including past and future trends for market demand, size, trade, supply, competitors and prices as well as the information of global major vendors. . The report also provides a comprehensive overview of the disposable medical supplies markets; including top players or vendors, app, type, sharing, and the latest market trends.

    In-depth market analysis is combined with precise forecasts and projections in this Disposable Medical Supplies Market report resulting in comprehensive research solutions that provide absolute industry clarity for strategic decision making. Raw market data is collected and analyzed on a large scale. Data is also collected from a number of publications in our archives, as well as a number of well-known paid databases. The data in this Disposable Medical Supplies market report has been gathered from raw material vendors, resellers, and customers to get a complete understanding of the industry; therefore, this report is extremely helpful to the buyer.

    Disposable Medical Supplies Market: Competition Landscape

    The Disposable Medical Supplies market report includes information on product launches, sustainability, and outlook for major vendors, including: (Abbott, Baxter, Weigao, Medtronic, Novartis, Ansell, Teleflex, Fresenius, Johnson & Johnson, BD, Medline, Nitto Medical, Lohmann & Rauscher, BSN medical, B. Braun, 3M, Halyard Health, Coloplast, Smith & Nephew, CR Bard, Boston Scientific, Smiths Group, ConvaTec, Terumo Corporation)

    Click the Link for Free Sample Copy of Report @ https://crediblemarkets.com/sample-request/disposable-medical-supplies-market-224454?utm_source=Komal&utm_medium=SatPR

    Disposable medical supplies market: segmentation

    The Disposable Medical Supplies market is divided by type and by application for the period 2022-2028, the growth among the segments provides accurate devices and sales forecast by type and by application in terms of volume and value. This analysis can help you grow your business by targeting qualified niche markets.

    By types:

    Diagnostic supplies
    Dialysis consumables
    Radiology consumables
    Infusion products
    Intubation and ventilation supplies
    Hypodermic products
    Sterilization consumables
    Nonwoven medical supplies
    Consumables for wound care
    Others

    By applications:

    Cardiovascular
    Cerebrovascular
    Ophthalmology
    Gynecology
    Urology
    Orthopedics
    Others

    Disposable Medical Supplies Market: Regional Analysis

    All the regional segmentation has been studied on the basis of recent and future trends, and the market is forecast throughout the forecast period. The countries covered in the regional analysis of the Global Disposable Medical Supplies Market report are United States, Canada and Mexico in North America, Germany, France, United Kingdom, Russia, Italy , in Spain, Turkey, the Netherlands, Switzerland, Belgium and the rest of Europe. in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) Asia- Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of Middle East and Africa (MEA), and Argentina, Brazil and the rest of South America as part of South America.

    Direct purchase this Market Research Report Now @ https://crediblemarkets.com/reports/purchase/disposable-medical-supplies-market-224454?license_type=single_user;utm_source=Komal&utm_medium=SatPR

    Main points covered by the table of contents:

    To present: Besides a detailed overview of the Global Disposable Medical Supplies Market, this segment provides an overview of the report to give insight into the nature and substance of the review study.

    Analysis of the strategies of the main players: Market players can use this analysis to gain a competitive advantage over their competitors in the Disposable Medical Supplies market.

    Study on the main market trends: This part of the report offers a more meaningful assessment of recent and future examples of the market.

    Market Forecast: Buyers of the report will tackle accurate and approved valuations of all market sizes in terms of value and volume. The report further gives usage, creation, offerings, and different conjectures for the Disposable Medical Supplies market.

    Analysis of local growth: All critical regions and countries have been covered in the report. Neighborhood review will help uplift players to exploit rejected common business areas, prepare express philosophies for target regions, and consider improving each regional market.

    Segmental analysis: The report gives precise and solid conjectures on the slice of the pie for significant parts of the Disposable Medical Supplies market. Market members can use this review to pinpoint key interests in key development pockets of the market.

    Do you have a specific question or requirement? Ask Our Industry Expert @ https://crediblemarkets.com/enquire-request/disposable-medical-supplies-market-224454?utm_source=Komal&utm_medium=SatPR

    Key questions answered in the report:

    • What will be the pace of development of the Disposable Medical Supplies market?
    • What are the key factors driving the global Disposable Medical Supplies market?
    • Who are the main manufacturers in the market?
    • What are the market openings, the market risks and the main lines of the market?
    • What are the sales, revenue, and price analyzes of the major manufacturers of the Disposable Medical Supplies market?
    • Who are the distributors, traders and resellers of the Disposable Medical Supplies market?
    • What are the Disposable Medical Supplies market opportunities and threats faced by the vendors of the global Disposable Medical Supplies industries?
    • What is Offerings, Revenue, and Value Review by Types and Uses in the Market?
    • What is the Review of Transactions, Revenue and Value by Business Line?

    About Us

    Credible Markets is a new age market research company with a firm grip on the pulse of global markets. Credible Markets has become a reliable source for the market research needs of companies in a rapid period of time. We have partnered with leading market information publishers and our reporting pool coverage spans all key industry verticals and thousands of micro markets. The massive repository allows our clients to choose from recently published reports from a range of publishers who also provide in-depth regional and national analysis. Plus, pre-booked research reports are some of our best deals.

    The collection of market information reports is regularly updated to provide visitors with easy access to the most recent market information. We provide round-the-clock support to help you reuse search parameters and thus benefit from a full range of reserved reports. After all, it’s all about helping you make an informed strategic decision about purchasing the right report that meets all of your market research demands.

    Contact us

    Credible market analyzes
    99 Wall Street 2124 New York, NY 10005
    E-mail: [email protected]

    read more
    Medical products

    FDA Cleared Booster Dose for Teens – Medical Products Supply Chain Weekly Review – Food, Drugs, Healthcare, Life Sciences

    United States: FDA Approves Booster Dose for Teens – Medical Products Supply Chain Weekly Review

    To print this article, simply register or connect to Mondaq.com.

    During the holidays, the CDC updated its recommendations for quarantine and post-exposure masking. The FDA has cleared the booster dose of Pfizer vaccine for adolescents 12 to 15 years old and for immunocompromised children 5 to 11 years old. The FDA has released draft guidelines for manufacturers of medical devices marketed under EUA or enforcement discretion policies to help them transition to traditional approvals at the end of the health emergency. public. The Administration has convened the Supply Chain Disruption Working Group for an update on its progress. The FDA has issued guidance for lab staff and manufacturers on technical considerations for new strains in developing COVID-19 tests and reading current test results. Please see details of these and other supply chain developments below:

    • On December 22, the President convened a meeting of the Supply Chain Disruption Task Force with stakeholders from the business sector. The implementation of the recommendations of the Working Group has led to drastic improvements in the flow of goods in the main ports. Dwell times in the ports of Long Beach and Los Angeles have been reduced from 12 to 5 days and from 9 to 4 days, respectively. The Port of Savannah with the Georgia Ports Authority has set up inland pop-up container sites that are accessible by truck and train, speeding up the movement of containers to these locations. The involvement of commercial carriers has also accelerated the movement of goods through the supply chain. The ports of Long Beach and Los Angeles are still operating towards 24/7 operation.
    • On December 22, administration officials met with EU officials on COVID-19 and global health security to assess each country’s progress towards the goal of the partnership cemented in September to defeat the global pandemic . Increasing the global production of vaccines and supplies is a major component of the initiative. The meeting also focused on developing strategies for future actions, including establishing a source of funding for such efforts.
    • On December 22, the FDA Center for Device and Radiological Health (CDRH) released a draft guidance document “Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUA) During Coronavirus Disease 2019 (COVID-19) Public health emergency ”and“ Transition plan for medical devices that fall under enforcement policies during the public health emergency of coronavirus disease 2019 (COVID-19). These proposed transition plans are guided by the principles of ensuring continued access of patients, providers and consumers to quality products; adequately prepare manufacturers and other stakeholders for the transition; and avoid supply chain disruptions. The plans would provide guidance on the requirements and timelines for marketing presentations. Assessment methods would include a risk-based approach that takes into account the intended uses, regulatory history and the level of risk of the device. A notice will be published for manufacturers 180 days before the expiration date of the EUA declaration. An EUA declaration is separate from a public health emergency declaration. Once an EUA declaration is terminated, all EUAs authorized under the EUA declaration are also terminated. Manufacturers must notify the FDA if they intend to continue marketing their products. The FDA intends to apply a phased approach to products marketed under discretionary enforcement policies that allow manufacturers to prepare for new requirements to avoid disruption. Comments on these draft guidelines are expected by March 23, 2022. We recommend that stakeholders carefully review the documents, submit comments if necessary, and start preparing for transitions early.
    • On December 22, the FDA released a draft guideline, “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations,” to provide sponsors and other stakeholders with guidance on how to assess digital health technology (DHT) used in their clinical investigations. The draft guidance includes how to assess a DHT as suitable for use. When evaluating a product, sponsors and stakeholders should consider the rationale for using the product and its descriptions. Sponsors and stakeholders should also consider whether the product can offer verification, validation and usability information. In addition, investigators should determine whether DHT would provide data permitting an appropriate assessment of clinical parameters from the data from any statistical analysis. The draft guidance also emphasizes that risk considerations regarding clinical risks, confidentiality and informed consent should be considered. Comments are due by March 22, 2022.
    • On December 23, the FDA released a revised guideline, “SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests,” which contains specific information regarding the omicron variant. The agency asks labs to be aware that some molecular tests fail to detect omicron and that there are other tests that detect modified omicron. Tests that do not detect omicron should not be used. Laboratories that use tests with multiple genetic targets should be aware that omicron demonstrates genetic abandonment in the results. Although this result may indicate the presence of omicron, it is not definitive. In light of this, the FDA advises labs to consider genetic sequencing if available.
    • On December 27, the CDC announced that it was recommending a five-day window for isolation and the use of masks for asymptomatic people with positive COVID-19 results. The CDC has also changed its recommendations for people exposed to someone with COVID-19 in isolation with strict mask use for five days after exposure for those exposed who are not vaccinated or have been vaccinated more. six months previously (two months for Johnson & Johnson). For those who have received a booster, isolation is not required; however, the use of a mask for five days followed by a test on the fifth day is recommended.
    • On December 29, the Center for Devices and Radiological Health (CDRH) issued an EUA for CLINITEST, a rapid self-test of the COVID-19 antigen from Siemens. This EUA is particularly important because the validation data was collected through the FDA’s collaboration with the National Institutes of Health (ITAP) Independent Testing Assessment Program. SD Biosensor Inc. has also been granted EUA for its home COVID-19 test.
    • On January 3, the FDA announced changes to the EUA for the Pfizer vaccine. The agency decided to allow a booster dose for adolescents 12 to 15 years old and to shorten the recommended time between the primary vaccination and the booster dose to five months, instead of six months. The decision was made on the basis of actual data from Israel which showed no additional security concerns. The decision to reduce the time between the primary series and the booster is taken in response to the prevalence of the more transmissible omicron variant and the need to strengthen the immune response of the population. The FDA has also cleared a third dose of Pfizer vaccine for immunocompromised children 5 to 11 years old. The agency defines immunocompromised as those who have undergone a solid organ transplant or similar conditions that compromise their immune system. The aim is to strengthen their immune response to “enable these children to obtain the maximum potential benefit from the vaccination”.

    The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

    POPULAR ARTICLES ON: Food, Medicines, Health Care, Life Sciences of the United States

    Alston and Birds Health Care Week in Review, December 17, 2021

    Alston & Bird

    Below is Alston & Bird’s Healthcare Week review, which provides a summary of the latest healthcare regulatory news, advice and guidance; federal legislation and the work of congressional committees; reports, studies and analyzes; and other health policy news.

    read more
    Prescription drugs

    2021 Prescription Drug Market Size Analysis by Major Companies and Forecast to 2028

    New Jersey, United States, – Market Research Intellect has been analyzing the prescription drug technology and markets since 2018. Since then, through the analysis of company research, we have been very close to the latest research and market developments.

    In addition, Market Research Intellect works closely with many clients to help them better understand technology and the market environment and develop innovation and commercialization strategies.

    Market Research Intellect offers extensive expertise in analyzing the prescription drug market. We have been in this industry for 20 years and have closely followed the rise and / or fall, success and / or disappointment of many emerging technologies during this time.

    This gives us a unique eye of experience when it comes to analyzing emerging technologies in electronic materials. This is very important as it helps to build a realistic market and technology roadmap that reflects the true potential of the technology based on its intrinsic characteristics and the true level of technology and business challenges it faces.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=202717

    Further, the market revenue by region and country is provided in the Prescription Drugs report. The report’s authors also shed light on common business tactics adopted by players. The major players in the global bPrescription Drugs Market and their complete profiles are included in the report. Additionally, investment opportunities, recommendations, and current trends in the global Prescription Drug market are mapped by the report. As a result of this report, major players in the global Prescription Drugs Market will be able to make right decisions and plan their strategies accordingly to stay ahead of the game.

    The competitive landscape is an essential aspect that any key player should be aware of. The report highlights the competitive scenario of the Global Prescription Drug Market to know the competition at the national and global level. The market experts also provided an overview of each major player in the global Prescription Drugs Market, taking into account key aspects such as business areas, production, and product portfolio. Further, the companies in the report are studied on the basis of key factors such as company size, market share, market growth, revenue, production volume, and profit.

    The main players covered by the prescription drugs markets:

    • Pfizer
    • rock
    • Sanofi
    • Johnson & johnson
    • Merck & Co. (msd)
    • Novartis
    • Abbvie
    • Gilead Sciences
    • Glaxosmithkline (gsk)
    • Amgen
    • Astrazeneca
    • Bristol-myers Squibb
    • Eli lilly
    • Suits you
    • Bayer
    • Novo Nordisk
    • Allergan
    • Takeda
    • Boehringer Ingelheim
    • Takeda

    Prescription Drugs Market Breakdown by Type:

    Prescription Drugs Market Split By Application:

    The Prescription Drug Market report has been separated into distinct categories such as product type, application, end user, and region. Each segment is rated on the basis of CAGR, share and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Prescription Drug Market in the coming years. This segmental analysis will surely prove to be a useful tool for the readers, stakeholders and market players to get a complete picture of the global Prescription Drugs Market and its growth potential in the coming years.

    Get | Discount on purchasing this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=202717

    Scope of Prescription Drugs Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in millions of USD and CAGR from 2021 to 2027
    Covered segments Types, applications, end users, etc.
    Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free customization of reports (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
    Price and purchase options Take advantage of custom shopping options to meet your exact research needs. Explore purchasing options

    Regional Prescription Drugs Market Analysis can be represented as follows:

    Each regional Prescription Drug industry is carefully studied to understand its current and future growth scenarios. It helps the players to strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and to ensure you stay ahead of the competition.

    Based on geography, the global prescription drug market has segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia-Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Key questions answered in the report:

    • What is the growth potential of the prescription drug markets?
    • Which product segment will take the lion’s share?
    • Which regional market will emerge as a precursor in the years to come?
    • Which application segment will grow at a sustained rate?
    • What are the growth opportunities that could emerge in the lock washer industry in the years to come?
    • What are the main challenges that the global prescription drug markets could face in the future?
    • Who are the leading companies in the global prescription drug market?
    • What are the main trends that are positively impacting the growth of the market?
    • What are the growth strategies considered by the players to maintain their grip on the global Prescription Drugs market?

    For more information or a query or a personalization before purchasing, visit @ https://www.marketresearchintellect.com/product/prescription-drugs-market-size-and-forecast/

    Visualize Prescription Drug Market Using Verified Market Intelligence: –

    Verified Market Intelligence is our BI platform for telling the story of this market. VMI provides in-depth predictive trends and accurate insight into over 20,000 emerging and niche markets to help you make key revenue impact decisions for a bright future. VMI provides a comprehensive overview and global competitive landscape by regions, countries and segments, as well as as key players in your market. Present your market reports and findings with built-in presentation capabilities, delivering over 70% of time and resources to investors, sales and marketing, R&D and product development. VMI supports data delivery in interactive Excel and PDF formats and provides over 15 key market indicators for your market.

    Visualize the Prescription Drug Market Using VMI @ https: //www.marketresearchintellect.com/mri-intelligence/

    The study thoroughly explores the profiles of the major market players and their main financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the production, revenue, market share and growth rate of the Prescription Drugs market for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and. applications. Historical prescription drug distribution data from 2016 to 2020 and forecast to 2021-2029.

    About us: Market research intelligence

    Market Research Intellect provides syndicated and personalized research reports to clients from various industries and organizations in addition to the goal of providing personalized and in-depth research studies. range of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients make more data-driven decisions, admit push predictions, grossly capitalize on opportunities, and maximize efficiency by acting as their criminal belt to adopt accurate mention and essential without compromise. clients, we have provided expertly-behaved affirmation research facilities to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    United States: +1 (650) -781-480
    UK: +44 (753) -715-0008
    APAC: +61 (488) -85-9400
    US Toll Free: +1 (800) -782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical products

    FDA clears two oral drugs for COVID-19 – Medical Products Supply Chain Weekly Review – Food, Drugs, Healthcare, Life Sciences

    United States: FDA clears two oral drugs for COVID-19 – Medical products supply chain review of the week

    To print this article, simply register or connect to Mondaq.com.

    Last week, the FDA cleared oral antivirals from Pfizer and Merck for the treatment of COVID-19. The Biden-Harris administration released the trucking action plan. The CDC approved the ACIP preference recommendation for the Pfizer-BioNTech and Moderna vaccine boosts. The new recommended Tris vaccine buffer leads to greater stability and does not require dilution. Please see details of these and other supply chain developments below:

    • On December 15, the FDA approved Eagle Pharmaceuticals’ Abbreviated New Drug Application (ANDA) for injection of vasopressin (20 units / ml in multidose vials), a product that has grown in demand during the COVID-pandemic. 19. The FDA said that this approval, the first approval from an ANDA for this product, represents the agency’s commitment “to facilitate access to medical products to help meet the critical needs of the American public.”
    • On December 16, the Authority released its Trucking Action Plan to help reduce supply chain disruption as part of initiatives promoted by the Chain Disruption Task Force. supply. Globally, the plan aims to implement measures to reduce barriers to the issuance of commercial driver’s licenses (CDLs); accelerate the learning of trucking; recruit veterans, especially those with previous trucking experience, into the industry; and schedule listening sessions with the current workforce to implement improvement strategies. In order to promote immediate implementation, the plan also includes specific actions for 30, 60 and 90 days to implement the objectives of the plan.
    • On December 16, the FDA approved the use of Tris buffer for the manufacture of Pfizer-BioNTech’s Comirnaty COVID-19 vaccine. This new formulation offers two key advantages to vaccinators: (1) it increases the stability of the vaccine longer at refrigerated temperatures; and (2) it does not require dilution by the supplier before use.
    • On December 16, the CDC approved the Advisory Committee on Immunization Practices (ACIP) recommendations that the Pfizer-BioNTech and Moderna vaccines are preferred for booster use over the Johnson & Johnson vaccine. ACIP met earlier today and based its decision on data including a review of efficacy and adverse events.
    • On December 17, the FDA announced that it was considering a program that would impose sterilization changes to the master file pilot program for 510 (k) approved medical devices. The change applies to the established Category B or to new sterilization methods. In addition to manufacturers in the innovation challenge, current 510 (k) holders can also participate in two previous programs where the FDA (1) has challenged manufacturers to develop new ways to develop alternatives to the ethylene oxide; and (2) reduce emissions of ethylene oxide. If changes are made to sterilization methods when ethylene oxide is used, participants can now refer to their master files instead of submitting a new 510 (k).
    • On December 20, Moderna announced that it was continuing to advance clinical trials to develop an omicron-specific vaccine for use as a booster. He also noted that the antibodies from his 50mcg and 100mcg booster doses demonstrated a 37- and 83-fold increase in antibody levels. Clinical trials of vaccines targeting both omicron and delta are underway.
    • On December 21, the Center for Devices and Radiological Health (CDRH) released a plan for how the CDRH intends to manage reviewer workload in 2022 based on the increase in the total number of submissions. In 2021, the CDRH saw an increase in medical device submissions for approval through the traditional processes, namely the PMA, 510 (k) and Q-sub processes, which it addressed through the implementation of new approaches to review, including triage of cases, reallocation of staff and resources to COVID-19 products, use of contractors and overtime. Despite these approaches, some issues related to meeting review deadlines still need to be addressed. For devices other than in vitro diagnostics, the CDRH expects to be able to comply with the review deadlines of the Medical Device User Fee Agreement (MDUFA) in 2022 despite the influx of medical products subject to review. For in vitro diagnostic products, the CDRH will also try to meet the deadlines promised by the MDUFA. Non-COVID products that were not prioritized during the pandemic will require extended review times. In addition, the pre-submission request program will be reinstated as of January 1, 2022.
    • On December 22, the FDA cleared Pfizer’s oral antiviral drug, Paxlovid, for the treatment of mild to moderate COVID-19 in adults and children 12 years of age or older (weighing 40 kg or more). This is the first oral antiviral treatment for COVID-19 to receive emergency use authorization. The clearance was based on data from the EPIC-HR trial, which demonstrated that Paxlovid significantly reduced hospitalizations and deaths from all causes in the study population compared to those randomized to receive a placebo. Paxlovid is a combination of nirmatrelvir and ritonavir – the former inhibits the replication of SARS-CoV-2 and the latter slows down the breakdown of nirmatrelvir in the body. The FDA will continue to monitor clinical trial data for the safety and effectiveness of the drug.
    • On December 23, the FDA cleared Merck’s oral antiviral drug, molnupiravir, for the treatment of mild to moderate COVID-19 in adults at high risk of progression to severe COVID-19 and for whom options for Alternative treatment to COVID-19 is not available. accessible or clinically appropriate.

    The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

    POPULAR ARTICLES ON: Food, Medicines, Health Care, Life Sciences of the United States

    read more
    Generic drugs

    Generic drugs provide information to doctors, so why is Health Canada promoting pharmaceutical brand names?

    Generic drug names are often long, but they can tell doctors what type of drug it is and how it works. But it is the brand names that appear first and most prominently in Health Canada documents.

    Brand names are widely used when we want to refer to a specific product – an Apple computer, a Tesla car. Sometimes brand names are used so widely that they take over – we ask for a Kleenex instead of a tissue.

    Drugs have two names. The brand name is the one chosen by the company that manufactures it and that company is the only one authorized to use the name. (The name proposed by the company is being reviewed by Health Canada.) Brand names are almost always short and catchy so that physicians will remember them.

    Generic names are assigned globally by the World Health Organization in collaboration with national naming authorities. These names are often long, but part of the reason for this is that they tell doctors about the pharmacological properties and / or chemical structure of the drug.

    The generic name of the US $ 2 million per patient new drug for spinal muscular atrophy is onasemnogene abeparvovec. The brand name is Zolgensma. Which one will physicians (and patients) retain and use? The answer is obvious.

    One of the associate editors of the Canadian Medical Association Journal notes that “some brand names are created to be reassuring or promising – so-called ‘benefit-oriented’ names such as Paxil, Celebrex, and Gluconorm – while they should in fact be prescribed with great care and taking into account the potential effects of the drug on each patient.

    Is using brand names the right way to talk about prescription drugs? Apparently, Health Canada thinks so. Do you want information on safety issues with a medicine? On the Canadian recall site, you will see the brand name in CAPITALS and the generic name in lower case and in parentheses.

    Want to see if there is a shortage of the drug your doctor just prescribed for you? Go to Drug Shortages Canada and you will find the brand names of the drugs, again in all caps.

    If you want to know why Health Canada approved a particular drug, the Basis of Approval Summary document will help you understand. But again, the brand name is the most important, and again it’s in all caps.

    What’s in a name?

    In medical school, students learn to use generic names. Medical journals require authors to use generic names in the articles they write. Does the name used by doctors matter? The answer is yes.

    When Australian anesthesiologists and doctors trained to be anesthesiologists at two university hospitals were given the brand names of the drugs, they could only correctly identify the therapeutic group from which the drug came in just over half of the cases. Without knowing which therapeutic group the drug was from, doctors could have accidentally used another drug from the same group or they could have used the drug incorrectly.

    The more money doctors received from drug companies in the form of meals, travel arrangements, and property royalties, the less likely they were to prescribe by generic name. Seeing pharmaceutical company sales representatives more frequently is associated with increased prescriptions for brand name products, resulting in more expensive prescriptions. Sales representatives also typically omit important information about the safety of the drugs they are promoting. Therefore, besides more expensive prescriptions, they can also be more likely to harm patients.

    Brand names, drug regulation (the domain of Health Canada) and drug promotion came together particularly blatantly in the case of buprenorphine-naloxone, the brand name Suboxone, an opioid drug used to treat addiction. opioids.

    Even though generic formulations of the drug have been available in Canada since 2013 (and even earlier in the United States), the drug is widely referred to by its brand name, including in the media, by policymakers, and by physicians.

    Brand education

    This happened in particular through the promotion of an “educational” program developed and implemented by Indivior, the company which owns the rights to Suboxone. In some provinces, completing this branded program is a prerequisite for prescribing buprenorphine-naloxone. The same strategy was used for a related injectable form of buprenorphine, also owned by Indivior.

    This use of the branded program is the case even though there are already some very good accredited, non-industry educational programs to teach proper opioid addiction care and prescriptions to doctors, nurses and pharmacists.

    The inclusion of the brand name in the title of this program is against recommended practices and accreditation standards for Canadian medical education programs.

    Yet the brand-name program is fully endorsed by Health Canada through that agency’s review and approval of the Suboxone Product Monograph. This document, which describes the nature of the drug and its approved uses in Canada, includes a description of the requirement to participate in the branded “training program”.

    As has been documented in the United States, Indivior and its parent company Reckitt Benckiser have engaged in various unscrupulous practices to promote their multibillion-dollar line of buprenorphine products – ultimately paying some of the largest fines in the world. pharmaceutical history of the United States. From this perspective, a branded “educational” program appears to be yet another vehicle for brand promotion, and one in which Health Canada is directly involved.

    When doctors use brand names, they may be less knowledgeable about the medications they are prescribing, their prescriptions cost more, and patients may be more likely to suffer from side effects. When Health Canada prioritizes brand names over generic names, it is actively contributing to all of these issues.

    Health Canada should know better and do better.

    In 2018-2021, Joel Lexchin received payments for writing a dissertation in a drug side effects action for Michael F. Smith, lawyer, and a second dissertation on the role of promotion in generating orders for Goodmans LLP and Canadian Institutes of Health Research for a presentation at a workshop on conflicts of interest in clinical practice guidelines. He is currently a member of research groups that receive funding from the Canadian Institutes of Health Research and the Australian National Health and Medical Research Council. He is a member of the Foundation Board of Health Action International and the Board of Canadian Doctors for Medicare. It receives royalties from the University of Toronto Press and James Lorimer & Co. Ltd. for the books he wrote.

    Abhimanyu Sud has received funding or has been consulted by the Canadian Institutes of Health Research, Health Canada, the Association of Faculties of Medicine of Canada, the University of Toronto, the Center for Effective Practice and the Mississauga-Halton Local Health Integration Network for research and medical education related to opioid use and drug policy.

    read more